JP2013107865A - Water-in-oil type emulsified cosmetic - Google Patents
Water-in-oil type emulsified cosmetic Download PDFInfo
- Publication number
- JP2013107865A JP2013107865A JP2011270658A JP2011270658A JP2013107865A JP 2013107865 A JP2013107865 A JP 2013107865A JP 2011270658 A JP2011270658 A JP 2011270658A JP 2011270658 A JP2011270658 A JP 2011270658A JP 2013107865 A JP2013107865 A JP 2013107865A
- Authority
- JP
- Japan
- Prior art keywords
- oil
- water
- acid
- nonionic surfactant
- emulsified cosmetic
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000002537 cosmetic Substances 0.000 title claims abstract description 71
- 239000002736 nonionic surfactant Substances 0.000 claims abstract description 44
- 239000002734 clay mineral Substances 0.000 claims abstract description 34
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 30
- 239000001993 wax Substances 0.000 claims abstract description 28
- 239000007788 liquid Substances 0.000 claims abstract description 21
- 239000007787 solid Substances 0.000 claims abstract description 19
- 150000002148 esters Chemical class 0.000 claims abstract description 17
- IAYPIBMASNFSPL-UHFFFAOYSA-N Ethylene oxide Chemical compound C1CO1 IAYPIBMASNFSPL-UHFFFAOYSA-N 0.000 claims abstract description 14
- 239000003921 oil Substances 0.000 claims description 87
- 239000002253 acid Substances 0.000 claims description 27
- 239000004359 castor oil Substances 0.000 claims description 19
- 235000019438 castor oil Nutrition 0.000 claims description 19
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 claims description 19
- 235000014113 dietary fatty acids Nutrition 0.000 claims description 16
- 239000000194 fatty acid Substances 0.000 claims description 16
- 229930195729 fatty acid Natural products 0.000 claims description 16
- XDOFQFKRPWOURC-UHFFFAOYSA-N 16-methylheptadecanoic acid Chemical group CC(C)CCCCCCCCCCCCCCC(O)=O XDOFQFKRPWOURC-UHFFFAOYSA-N 0.000 claims description 15
- 150000004665 fatty acids Chemical class 0.000 claims description 9
- JNYAEWCLZODPBN-JGWLITMVSA-N (2r,3r,4s)-2-[(1r)-1,2-dihydroxyethyl]oxolane-3,4-diol Chemical compound OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O JNYAEWCLZODPBN-JGWLITMVSA-N 0.000 claims description 6
- 239000004909 Moisturizer Substances 0.000 claims description 6
- 230000001333 moisturizer Effects 0.000 claims description 6
- 239000008385 outer phase Substances 0.000 claims description 6
- DCXXMTOCNZCJGO-UHFFFAOYSA-N tristearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCCCCCCCCCC)COC(=O)CCCCCCCCCCCCCCCCC DCXXMTOCNZCJGO-UHFFFAOYSA-N 0.000 claims description 6
- 239000008384 inner phase Substances 0.000 claims description 5
- POULHZVOKOAJMA-UHFFFAOYSA-N dodecanoic acid Chemical compound CCCCCCCCCCCC(O)=O POULHZVOKOAJMA-UHFFFAOYSA-N 0.000 claims description 4
- CMPDPBDUZTUXAD-UHFFFAOYSA-N [3-hydroxy-2-(16-methylheptadecanoyloxy)propyl] 16-methylheptadecanoate Chemical compound CC(C)CCCCCCCCCCCCCCC(=O)OCC(CO)OC(=O)CCCCCCCCCCCCCCC(C)C CMPDPBDUZTUXAD-UHFFFAOYSA-N 0.000 claims description 3
- 125000005210 alkyl ammonium group Chemical group 0.000 claims description 3
- JNAYPSWVMNJOPQ-UHFFFAOYSA-N 2,3-bis(16-methylheptadecanoyloxy)propyl 16-methylheptadecanoate Chemical compound CC(C)CCCCCCCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCCCCCCCC(C)C)COC(=O)CCCCCCCCCCCCCCC(C)C JNAYPSWVMNJOPQ-UHFFFAOYSA-N 0.000 claims description 2
- 239000005639 Lauric acid Substances 0.000 claims description 2
- 239000003906 humectant Substances 0.000 abstract description 4
- 235000019198 oils Nutrition 0.000 description 55
- 229920003171 Poly (ethylene oxide) Chemical class 0.000 description 44
- -1 polyoxybutylene Polymers 0.000 description 38
- 239000012071 phase Substances 0.000 description 32
- 230000003020 moisturizing effect Effects 0.000 description 20
- 239000004094 surface-active agent Substances 0.000 description 17
- 238000000034 method Methods 0.000 description 12
- 239000000203 mixture Substances 0.000 description 12
- 235000021355 Stearic acid Nutrition 0.000 description 11
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 11
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 11
- 239000002245 particle Substances 0.000 description 11
- 239000008117 stearic acid Substances 0.000 description 11
- 239000007762 w/o emulsion Substances 0.000 description 11
- 230000000052 comparative effect Effects 0.000 description 9
- 125000003976 glyceryl group Chemical class [H]C([*])([H])C(O[H])([H])C(O[H])([H])[H] 0.000 description 9
- KWLMIXQRALPRBC-UHFFFAOYSA-L hectorite Chemical compound [Li+].[OH-].[OH-].[Na+].[Mg+2].O1[Si]2([O-])O[Si]1([O-])O[Si]([O-])(O1)O[Si]1([O-])O2 KWLMIXQRALPRBC-UHFFFAOYSA-L 0.000 description 9
- 229910000271 hectorite Inorganic materials 0.000 description 9
- 239000008346 aqueous phase Substances 0.000 description 8
- 150000001875 compounds Chemical class 0.000 description 7
- 239000006071 cream Substances 0.000 description 7
- 229920000642 polymer Polymers 0.000 description 7
- 238000002360 preparation method Methods 0.000 description 7
- LDVVTQMJQSCDMK-UHFFFAOYSA-N 1,3-dihydroxypropan-2-yl formate Chemical class OCC(CO)OC=O LDVVTQMJQSCDMK-UHFFFAOYSA-N 0.000 description 6
- 239000004215 Carbon black (E152) Substances 0.000 description 6
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 6
- 239000004166 Lanolin Substances 0.000 description 6
- 239000010696 ester oil Substances 0.000 description 6
- 229930195733 hydrocarbon Natural products 0.000 description 6
- 150000002430 hydrocarbons Chemical class 0.000 description 6
- 235000019388 lanolin Nutrition 0.000 description 6
- 229940039717 lanolin Drugs 0.000 description 6
- 238000004519 manufacturing process Methods 0.000 description 6
- 239000000126 substance Substances 0.000 description 6
- 235000015112 vegetable and seed oil Nutrition 0.000 description 6
- 239000008158 vegetable oil Substances 0.000 description 6
- 239000000440 bentonite Substances 0.000 description 5
- 229910000278 bentonite Inorganic materials 0.000 description 5
- SVPXDRXYRYOSEX-UHFFFAOYSA-N bentoquatam Chemical compound O.O=[Si]=O.O=[Al]O[Al]=O SVPXDRXYRYOSEX-UHFFFAOYSA-N 0.000 description 5
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 5
- OGQYPPBGSLZBEG-UHFFFAOYSA-N dimethyl(dioctadecyl)azanium Chemical compound CCCCCCCCCCCCCCCCCC[N+](C)(C)CCCCCCCCCCCCCCCCCC OGQYPPBGSLZBEG-UHFFFAOYSA-N 0.000 description 5
- 229940079593 drug Drugs 0.000 description 5
- 239000003814 drug Substances 0.000 description 5
- 238000001035 drying Methods 0.000 description 5
- 230000000694 effects Effects 0.000 description 5
- 239000003995 emulsifying agent Substances 0.000 description 5
- 239000000839 emulsion Substances 0.000 description 5
- 238000002156 mixing Methods 0.000 description 5
- 150000002892 organic cations Chemical class 0.000 description 5
- 238000000926 separation method Methods 0.000 description 5
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 4
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 4
- 235000018330 Macadamia integrifolia Nutrition 0.000 description 4
- 240000000912 Macadamia tetraphylla Species 0.000 description 4
- 235000003800 Macadamia tetraphylla Nutrition 0.000 description 4
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 4
- 230000005856 abnormality Effects 0.000 description 4
- 239000004480 active ingredient Substances 0.000 description 4
- 235000015278 beef Nutrition 0.000 description 4
- 229920002678 cellulose Polymers 0.000 description 4
- 239000001913 cellulose Substances 0.000 description 4
- 235000010980 cellulose Nutrition 0.000 description 4
- GPLRAVKSCUXZTP-UHFFFAOYSA-N diglycerol Chemical compound OCC(O)COCC(O)CO GPLRAVKSCUXZTP-UHFFFAOYSA-N 0.000 description 4
- 125000005456 glyceride group Chemical group 0.000 description 4
- 239000000047 product Substances 0.000 description 4
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 4
- 229920002545 silicone oil Polymers 0.000 description 4
- 229910021647 smectite Inorganic materials 0.000 description 4
- 239000011734 sodium Substances 0.000 description 4
- 229910052708 sodium Inorganic materials 0.000 description 4
- 150000005846 sugar alcohols Polymers 0.000 description 4
- 230000002087 whitening effect Effects 0.000 description 4
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 3
- ULQISTXYYBZJSJ-UHFFFAOYSA-N 12-hydroxyoctadecanoic acid Chemical compound CCCCCCC(O)CCCCCCCCCCC(O)=O ULQISTXYYBZJSJ-UHFFFAOYSA-N 0.000 description 3
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 3
- SHZGCJCMOBCMKK-UHFFFAOYSA-N D-mannomethylose Natural products CC1OC(O)C(O)C(O)C1O SHZGCJCMOBCMKK-UHFFFAOYSA-N 0.000 description 3
- VGGSQFUCUMXWEO-UHFFFAOYSA-N Ethene Chemical compound C=C VGGSQFUCUMXWEO-UHFFFAOYSA-N 0.000 description 3
- 239000005977 Ethylene Substances 0.000 description 3
- 229910019142 PO4 Inorganic materials 0.000 description 3
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- HVUMOYIDDBPOLL-XWVZOOPGSA-N Sorbitan monostearate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O HVUMOYIDDBPOLL-XWVZOOPGSA-N 0.000 description 3
- PZQBWGFCGIRLBB-NJYHNNHUSA-N [(2r)-2-[(2s,3r,4s)-3,4-dihydroxyoxolan-2-yl]-2-octadecanoyloxyethyl] octadecanoate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OC[C@@H](OC(=O)CCCCCCCCCCCCCCCCC)[C@H]1OC[C@H](O)[C@H]1O PZQBWGFCGIRLBB-NJYHNNHUSA-N 0.000 description 3
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 3
- FWLORMQUOWCQPO-UHFFFAOYSA-N benzyl-dimethyl-octadecylazanium Chemical compound CCCCCCCCCCCCCCCCCC[N+](C)(C)CC1=CC=CC=C1 FWLORMQUOWCQPO-UHFFFAOYSA-N 0.000 description 3
- VBICKXHEKHSIBG-UHFFFAOYSA-N beta-monoglyceryl stearate Natural products CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 3
- 239000003795 chemical substances by application Substances 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 238000013329 compounding Methods 0.000 description 3
- 238000011161 development Methods 0.000 description 3
- 230000018109 developmental process Effects 0.000 description 3
- 238000004945 emulsification Methods 0.000 description 3
- 238000011156 evaluation Methods 0.000 description 3
- 238000009472 formulation Methods 0.000 description 3
- 239000004615 ingredient Substances 0.000 description 3
- 239000001630 malic acid Substances 0.000 description 3
- 235000011090 malic acid Nutrition 0.000 description 3
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 description 3
- 239000010466 nut oil Substances 0.000 description 3
- 239000010452 phosphate Substances 0.000 description 3
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 3
- 229920001451 polypropylene glycol Polymers 0.000 description 3
- 229920001296 polysiloxane Polymers 0.000 description 3
- 239000003760 tallow Substances 0.000 description 3
- HDTRYLNUVZCQOY-UHFFFAOYSA-N α-D-glucopyranosyl-α-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(O)C(O)C(CO)O1 HDTRYLNUVZCQOY-UHFFFAOYSA-N 0.000 description 2
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 2
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 2
- HOVAGTYPODGVJG-UVSYOFPXSA-N (3s,5r)-2-(hydroxymethyl)-6-methoxyoxane-3,4,5-triol Chemical compound COC1OC(CO)[C@@H](O)C(O)[C@H]1O HOVAGTYPODGVJG-UVSYOFPXSA-N 0.000 description 2
- GHOKWGTUZJEAQD-ZETCQYMHSA-N (D)-(+)-Pantothenic acid Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-ZETCQYMHSA-N 0.000 description 2
- AGBQKNBQESQNJD-SSDOTTSWSA-N (R)-lipoic acid Chemical compound OC(=O)CCCC[C@@H]1CCSS1 AGBQKNBQESQNJD-SSDOTTSWSA-N 0.000 description 2
- CMCBDXRRFKYBDG-UHFFFAOYSA-N 1-dodecoxydodecane Chemical compound CCCCCCCCCCCCOCCCCCCCCCCCC CMCBDXRRFKYBDG-UHFFFAOYSA-N 0.000 description 2
- WNWHHMBRJJOGFJ-UHFFFAOYSA-N 16-methylheptadecan-1-ol Chemical compound CC(C)CCCCCCCCCCCCCCCO WNWHHMBRJJOGFJ-UHFFFAOYSA-N 0.000 description 2
- MPDGHEJMBKOTSU-YKLVYJNSSA-N 18beta-glycyrrhetic acid Chemical compound C([C@H]1C2=CC(=O)[C@H]34)[C@@](C)(C(O)=O)CC[C@]1(C)CC[C@@]2(C)[C@]4(C)CC[C@@H]1[C@]3(C)CC[C@H](O)C1(C)C MPDGHEJMBKOTSU-YKLVYJNSSA-N 0.000 description 2
- ASKIVFGGGGIGKH-UHFFFAOYSA-N 2,3-dihydroxypropyl 16-methylheptadecanoate Chemical compound CC(C)CCCCCCCCCCCCCCC(=O)OCC(O)CO ASKIVFGGGGIGKH-UHFFFAOYSA-N 0.000 description 2
- AVBJHQDHVYGQLS-UHFFFAOYSA-N 2-(dodecanoylamino)pentanedioic acid Chemical compound CCCCCCCCCCCC(=O)NC(C(O)=O)CCC(O)=O AVBJHQDHVYGQLS-UHFFFAOYSA-N 0.000 description 2
- KIHBGTRZFAVZRV-UHFFFAOYSA-N 2-Hydroxyoctadecanoic acid Natural products CCCCCCCCCCCCCCCCC(O)C(O)=O KIHBGTRZFAVZRV-UHFFFAOYSA-N 0.000 description 2
- SVTBMSDMJJWYQN-UHFFFAOYSA-N 2-methylpentane-2,4-diol Chemical compound CC(O)CC(C)(C)O SVTBMSDMJJWYQN-UHFFFAOYSA-N 0.000 description 2
- NIXOWILDQLNWCW-UHFFFAOYSA-M Acrylate Chemical compound [O-]C(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-M 0.000 description 2
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 2
- 239000004375 Dextrin Substances 0.000 description 2
- 229920001353 Dextrin Polymers 0.000 description 2
- LCGLNKUTAGEVQW-UHFFFAOYSA-N Dimethyl ether Chemical compound COC LCGLNKUTAGEVQW-UHFFFAOYSA-N 0.000 description 2
- PNNNRSAQSRJVSB-SLPGGIOYSA-N Fucose Natural products C[C@H](O)[C@@H](O)[C@H](O)[C@H](O)C=O PNNNRSAQSRJVSB-SLPGGIOYSA-N 0.000 description 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 2
- AEMRFAOFKBGASW-UHFFFAOYSA-N Glycolic acid Chemical compound OCC(O)=O AEMRFAOFKBGASW-UHFFFAOYSA-N 0.000 description 2
- UQSXHKLRYXJYBZ-UHFFFAOYSA-N Iron oxide Chemical compound [Fe]=O UQSXHKLRYXJYBZ-UHFFFAOYSA-N 0.000 description 2
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
- SHZGCJCMOBCMKK-DHVFOXMCSA-N L-fucopyranose Chemical compound C[C@@H]1OC(O)[C@@H](O)[C@H](O)[C@@H]1O SHZGCJCMOBCMKK-DHVFOXMCSA-N 0.000 description 2
- DFPAKSUCGFBDDF-UHFFFAOYSA-N Nicotinamide Chemical compound NC(=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-UHFFFAOYSA-N 0.000 description 2
- 235000019482 Palm oil Nutrition 0.000 description 2
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 2
- 239000004698 Polyethylene Substances 0.000 description 2
- 235000019484 Rapeseed oil Nutrition 0.000 description 2
- VYGQUTWHTHXGQB-FFHKNEKCSA-N Retinol Palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C VYGQUTWHTHXGQB-FFHKNEKCSA-N 0.000 description 2
- 229920002472 Starch Polymers 0.000 description 2
- 229930006000 Sucrose Natural products 0.000 description 2
- DKGAVHZHDRPRBM-UHFFFAOYSA-N Tert-Butanol Chemical compound CC(C)(C)O DKGAVHZHDRPRBM-UHFFFAOYSA-N 0.000 description 2
- HDTRYLNUVZCQOY-WSWWMNSNSA-N Trehalose Natural products O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-WSWWMNSNSA-N 0.000 description 2
- ZJCCRDAZUWHFQH-UHFFFAOYSA-N Trimethylolpropane Chemical compound CCC(CO)(CO)CO ZJCCRDAZUWHFQH-UHFFFAOYSA-N 0.000 description 2
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 2
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 description 2
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 description 2
- XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 description 2
- 150000001298 alcohols Chemical class 0.000 description 2
- 150000001336 alkenes Chemical class 0.000 description 2
- 125000000217 alkyl group Chemical group 0.000 description 2
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 2
- HDTRYLNUVZCQOY-LIZSDCNHSA-N alpha,alpha-trehalose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-LIZSDCNHSA-N 0.000 description 2
- AGBQKNBQESQNJD-UHFFFAOYSA-N alpha-Lipoic acid Natural products OC(=O)CCCCC1CCSS1 AGBQKNBQESQNJD-UHFFFAOYSA-N 0.000 description 2
- 229940024606 amino acid Drugs 0.000 description 2
- 235000001014 amino acid Nutrition 0.000 description 2
- 239000010775 animal oil Substances 0.000 description 2
- 235000010323 ascorbic acid Nutrition 0.000 description 2
- 229960005070 ascorbic acid Drugs 0.000 description 2
- 239000011668 ascorbic acid Substances 0.000 description 2
- 239000010495 camellia oil Substances 0.000 description 2
- 229940106189 ceramide Drugs 0.000 description 2
- 235000019864 coconut oil Nutrition 0.000 description 2
- 239000003240 coconut oil Substances 0.000 description 2
- 229920001577 copolymer Polymers 0.000 description 2
- 235000005687 corn oil Nutrition 0.000 description 2
- 235000019425 dextrin Nutrition 0.000 description 2
- GUJOJGAPFQRJSV-UHFFFAOYSA-N dialuminum;dioxosilane;oxygen(2-);hydrate Chemical compound O.[O-2].[O-2].[O-2].[Al+3].[Al+3].O=[Si]=O.O=[Si]=O.O=[Si]=O.O=[Si]=O GUJOJGAPFQRJSV-UHFFFAOYSA-N 0.000 description 2
- 229940105990 diglycerin Drugs 0.000 description 2
- NOPFSRXAKWQILS-UHFFFAOYSA-N docosan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCCCCCO NOPFSRXAKWQILS-UHFFFAOYSA-N 0.000 description 2
- UKMSUNONTOPOIO-UHFFFAOYSA-N docosanoic acid Chemical compound CCCCCCCCCCCCCCCCCCCCCC(O)=O UKMSUNONTOPOIO-UHFFFAOYSA-N 0.000 description 2
- 235000019197 fats Nutrition 0.000 description 2
- BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 description 2
- BJRNKVDFDLYUGJ-RMPHRYRLSA-N hydroquinone O-beta-D-glucopyranoside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC=C(O)C=C1 BJRNKVDFDLYUGJ-RMPHRYRLSA-N 0.000 description 2
- 229910052500 inorganic mineral Inorganic materials 0.000 description 2
- ZXEKIIBDNHEJCQ-UHFFFAOYSA-N isobutanol Chemical compound CC(C)CO ZXEKIIBDNHEJCQ-UHFFFAOYSA-N 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 235000019136 lipoic acid Nutrition 0.000 description 2
- 235000010449 maltitol Nutrition 0.000 description 2
- 239000000845 maltitol Substances 0.000 description 2
- VQHSOMBJVWLPSR-WUJBLJFYSA-N maltitol Chemical compound OC[C@H](O)[C@@H](O)[C@@H]([C@H](O)CO)O[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O VQHSOMBJVWLPSR-WUJBLJFYSA-N 0.000 description 2
- 229940035436 maltitol Drugs 0.000 description 2
- HOVAGTYPODGVJG-UHFFFAOYSA-N methyl beta-galactoside Natural products COC1OC(CO)C(O)C(O)C1O HOVAGTYPODGVJG-UHFFFAOYSA-N 0.000 description 2
- LXCFILQKKLGQFO-UHFFFAOYSA-N methylparaben Chemical compound COC(=O)C1=CC=C(O)C=C1 LXCFILQKKLGQFO-UHFFFAOYSA-N 0.000 description 2
- 239000010445 mica Substances 0.000 description 2
- 229910052618 mica group Inorganic materials 0.000 description 2
- 239000004200 microcrystalline wax Substances 0.000 description 2
- 235000019808 microcrystalline wax Nutrition 0.000 description 2
- 239000011707 mineral Substances 0.000 description 2
- 235000010755 mineral Nutrition 0.000 description 2
- 239000002480 mineral oil Substances 0.000 description 2
- 229910052901 montmorillonite Inorganic materials 0.000 description 2
- GLDOVTGHNKAZLK-UHFFFAOYSA-N octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 description 2
- 229960001679 octinoxate Drugs 0.000 description 2
- OQILCOQZDHPEAZ-UHFFFAOYSA-N octyl palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OCCCCCCCC OQILCOQZDHPEAZ-UHFFFAOYSA-N 0.000 description 2
- JRZJOMJEPLMPRA-UHFFFAOYSA-N olefin Natural products CCCCCCCC=C JRZJOMJEPLMPRA-UHFFFAOYSA-N 0.000 description 2
- 230000003287 optical effect Effects 0.000 description 2
- 239000002540 palm oil Substances 0.000 description 2
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 2
- 239000012188 paraffin wax Substances 0.000 description 2
- 230000002688 persistence Effects 0.000 description 2
- 235000019271 petrolatum Nutrition 0.000 description 2
- 230000000704 physical effect Effects 0.000 description 2
- 229920000058 polyacrylate Polymers 0.000 description 2
- 229920000573 polyethylene Polymers 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 239000003755 preservative agent Substances 0.000 description 2
- 238000012545 processing Methods 0.000 description 2
- QELSKZZBTMNZEB-UHFFFAOYSA-N propylparaben Chemical compound CCCOC(=O)C1=CC=C(O)C=C1 QELSKZZBTMNZEB-UHFFFAOYSA-N 0.000 description 2
- 229940032044 quaternium-18 Drugs 0.000 description 2
- 229940101631 quaternium-18 hectorite Drugs 0.000 description 2
- 229940066675 ricinoleate Drugs 0.000 description 2
- 229960004889 salicylic acid Drugs 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- 229910000275 saponite Inorganic materials 0.000 description 2
- 238000010008 shearing Methods 0.000 description 2
- 239000000377 silicon dioxide Substances 0.000 description 2
- 239000002195 soluble material Substances 0.000 description 2
- 235000011076 sorbitan monostearate Nutrition 0.000 description 2
- 239000001587 sorbitan monostearate Substances 0.000 description 2
- 229940035048 sorbitan monostearate Drugs 0.000 description 2
- 239000000600 sorbitol Substances 0.000 description 2
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N squalane Chemical compound CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 2
- 239000008107 starch Substances 0.000 description 2
- 235000019698 starch Nutrition 0.000 description 2
- 239000005720 sucrose Substances 0.000 description 2
- 239000002562 thickening agent Substances 0.000 description 2
- 229960002663 thioctic acid Drugs 0.000 description 2
- 239000000811 xylitol Substances 0.000 description 2
- 235000010447 xylitol Nutrition 0.000 description 2
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 description 2
- 229960002675 xylitol Drugs 0.000 description 2
- NOOLISFMXDJSKH-UTLUCORTSA-N (+)-Neomenthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@@H]1O NOOLISFMXDJSKH-UTLUCORTSA-N 0.000 description 1
- DNIAPMSPPWPWGF-VKHMYHEASA-N (+)-propylene glycol Chemical compound C[C@H](O)CO DNIAPMSPPWPWGF-VKHMYHEASA-N 0.000 description 1
- WWUZIQQURGPMPG-UHFFFAOYSA-N (-)-D-erythro-Sphingosine Natural products CCCCCCCCCCCCCC=CC(O)C(N)CO WWUZIQQURGPMPG-UHFFFAOYSA-N 0.000 description 1
- XUFXOAAUWZOOIT-SXARVLRPSA-N (2R,3R,4R,5S,6R)-5-[[(2R,3R,4R,5S,6R)-5-[[(2R,3R,4S,5S,6R)-3,4-dihydroxy-6-methyl-5-[[(1S,4R,5S,6S)-4,5,6-trihydroxy-3-(hydroxymethyl)-1-cyclohex-2-enyl]amino]-2-oxanyl]oxy]-3,4-dihydroxy-6-(hydroxymethyl)-2-oxanyl]oxy]-6-(hydroxymethyl)oxane-2,3,4-triol Chemical compound O([C@H]1O[C@H](CO)[C@H]([C@@H]([C@H]1O)O)O[C@H]1O[C@@H]([C@H]([C@H](O)[C@H]1O)N[C@@H]1[C@@H]([C@@H](O)[C@H](O)C(CO)=C1)O)C)[C@@H]1[C@@H](CO)O[C@@H](O)[C@H](O)[C@H]1O XUFXOAAUWZOOIT-SXARVLRPSA-N 0.000 description 1
- MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical compound OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 description 1
- DSEKYWAQQVUQTP-XEWMWGOFSA-N (2r,4r,4as,6as,6as,6br,8ar,12ar,14as,14bs)-2-hydroxy-4,4a,6a,6b,8a,11,11,14a-octamethyl-2,4,5,6,6a,7,8,9,10,12,12a,13,14,14b-tetradecahydro-1h-picen-3-one Chemical compound C([C@H]1[C@]2(C)CC[C@@]34C)C(C)(C)CC[C@]1(C)CC[C@]2(C)[C@H]4CC[C@@]1(C)[C@H]3C[C@@H](O)C(=O)[C@@H]1C DSEKYWAQQVUQTP-XEWMWGOFSA-N 0.000 description 1
- BJDAUCLANVMIOB-UHFFFAOYSA-N (3-decanoyloxy-2,2-dimethylpropyl) decanoate Chemical compound CCCCCCCCCC(=O)OCC(C)(C)COC(=O)CCCCCCCCC BJDAUCLANVMIOB-UHFFFAOYSA-N 0.000 description 1
- BUDRQJIYQOCVNK-UHFFFAOYSA-N (3-methyl-1-silylbutyl) 2,3-dimethoxy-3-(2-methoxyphenyl)prop-2-enoate Chemical compound CC(C)CC([SiH3])OC(=O)C(OC)=C(OC)C1=CC=CC=C1OC BUDRQJIYQOCVNK-UHFFFAOYSA-N 0.000 description 1
- WCGUUGGRBIKTOS-GPOJBZKASA-N (3beta)-3-hydroxyurs-12-en-28-oic acid Chemical compound C1C[C@H](O)C(C)(C)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C(O)=O)CC[C@@H](C)[C@H](C)[C@H]5C4=CC[C@@H]3[C@]21C WCGUUGGRBIKTOS-GPOJBZKASA-N 0.000 description 1
- ALSTYHKOOCGGFT-KTKRTIGZSA-N (9Z)-octadecen-1-ol Chemical compound CCCCCCCC\C=C/CCCCCCCCO ALSTYHKOOCGGFT-KTKRTIGZSA-N 0.000 description 1
- OYHQOLUKZRVURQ-NTGFUMLPSA-N (9Z,12Z)-9,10,12,13-tetratritiooctadeca-9,12-dienoic acid Chemical compound C(CCCCCCC\C(=C(/C\C(=C(/CCCCC)\[3H])\[3H])\[3H])\[3H])(=O)O OYHQOLUKZRVURQ-NTGFUMLPSA-N 0.000 description 1
- JXNPEDYJTDQORS-HZJYTTRNSA-N (9Z,12Z)-octadecadien-1-ol Chemical compound CCCCC\C=C/C\C=C/CCCCCCCCO JXNPEDYJTDQORS-HZJYTTRNSA-N 0.000 description 1
- IKYKEVDKGZYRMQ-PDBXOOCHSA-N (9Z,12Z,15Z)-octadecatrien-1-ol Chemical compound CC\C=C/C\C=C/C\C=C/CCCCCCCCO IKYKEVDKGZYRMQ-PDBXOOCHSA-N 0.000 description 1
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 1
- QTNHIWWMGWTVJH-VOKNKEOFSA-N (Z)-octadec-9-enoic acid propane-1,2,3-triol Chemical compound OCC(O)CO.OCC(O)CO.OCC(O)CO.OCC(O)CO.OCC(O)CO.OCC(O)CO.OCC(O)CO.OCC(O)CO.OCC(O)CO.OCC(O)CO.CCCCCCCC\C=C/CCCCCCCC(O)=O.CCCCCCCC\C=C/CCCCCCCC(O)=O.CCCCCCCC\C=C/CCCCCCCC(O)=O.CCCCCCCC\C=C/CCCCCCCC(O)=O.CCCCCCCC\C=C/CCCCCCCC(O)=O QTNHIWWMGWTVJH-VOKNKEOFSA-N 0.000 description 1
- ZORQXIQZAOLNGE-UHFFFAOYSA-N 1,1-difluorocyclohexane Chemical compound FC1(F)CCCCC1 ZORQXIQZAOLNGE-UHFFFAOYSA-N 0.000 description 1
- 229940058015 1,3-butylene glycol Drugs 0.000 description 1
- YPFDHNVEDLHUCE-UHFFFAOYSA-N 1,3-propanediol Substances OCCCO YPFDHNVEDLHUCE-UHFFFAOYSA-N 0.000 description 1
- 150000004057 1,4-benzoquinones Chemical class 0.000 description 1
- JQJSFAJISYZPER-UHFFFAOYSA-N 1-(4-chlorophenyl)-3-(2,3-dihydro-1h-inden-5-ylsulfonyl)urea Chemical compound C1=CC(Cl)=CC=C1NC(=O)NS(=O)(=O)C1=CC=C(CCC2)C2=C1 JQJSFAJISYZPER-UHFFFAOYSA-N 0.000 description 1
- FDCJDKXCCYFOCV-UHFFFAOYSA-N 1-hexadecoxyhexadecane Chemical compound CCCCCCCCCCCCCCCCOCCCCCCCCCCCCCCCC FDCJDKXCCYFOCV-UHFFFAOYSA-N 0.000 description 1
- IXPNQXFRVYWDDI-UHFFFAOYSA-N 1-methyl-2,4-dioxo-1,3-diazinane-5-carboximidamide Chemical compound CN1CC(C(N)=N)C(=O)NC1=O IXPNQXFRVYWDDI-UHFFFAOYSA-N 0.000 description 1
- HBXWUCXDUUJDRB-UHFFFAOYSA-N 1-octadecoxyoctadecane Chemical compound CCCCCCCCCCCCCCCCCCOCCCCCCCCCCCCCCCCCC HBXWUCXDUUJDRB-UHFFFAOYSA-N 0.000 description 1
- RZRNAYUHWVFMIP-KTKRTIGZSA-N 1-oleoylglycerol Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OCC(O)CO RZRNAYUHWVFMIP-KTKRTIGZSA-N 0.000 description 1
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 1
- HCUIHIKPUYHKSQ-UHFFFAOYSA-N 12-(octadecanoyloxy)octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(=O)OC(CCCCCC)CCCCCCCCCCC(O)=O HCUIHIKPUYHKSQ-UHFFFAOYSA-N 0.000 description 1
- 229940114069 12-hydroxystearate Drugs 0.000 description 1
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 1
- DHGBAFGZLVRESL-UHFFFAOYSA-N 14-methylpentadecyl 16-methylheptadecanoate Chemical compound CC(C)CCCCCCCCCCCCCCC(=O)OCCCCCCCCCCCCCC(C)C DHGBAFGZLVRESL-UHFFFAOYSA-N 0.000 description 1
- OUZOBPPZPCBJAR-UHFFFAOYSA-N 14-methylpentadecyl hexadecanoate Chemical compound CCCCCCCCCCCCCCCC(=O)OCCCCCCCCCCCCCC(C)C OUZOBPPZPCBJAR-UHFFFAOYSA-N 0.000 description 1
- LGEZTMRIZWCDLW-UHFFFAOYSA-N 14-methylpentadecyl octadecanoate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCCCCCCCCCCCCCC(C)C LGEZTMRIZWCDLW-UHFFFAOYSA-N 0.000 description 1
- GFVYDNHWTCHDSN-UHFFFAOYSA-N 14-methylpentadecyl octanoate Chemical compound CCCCCCCC(=O)OCCCCCCCCCCCCCC(C)C GFVYDNHWTCHDSN-UHFFFAOYSA-N 0.000 description 1
- YICVJSOYNBZJAK-UHFFFAOYSA-N 14-methylpentadecyl tetradecanoate Chemical compound CCCCCCCCCCCCCC(=O)OCCCCCCCCCCCCCC(C)C YICVJSOYNBZJAK-UHFFFAOYSA-N 0.000 description 1
- BFGLKTHWZMNGHV-KTKRTIGZSA-N 16-methylheptadecyl (z)-icos-13-enoate Chemical compound CCCCCC\C=C/CCCCCCCCCCCC(=O)OCCCCCCCCCCCCCCCC(C)C BFGLKTHWZMNGHV-KTKRTIGZSA-N 0.000 description 1
- ABEXEQSGABRUHS-UHFFFAOYSA-N 16-methylheptadecyl 16-methylheptadecanoate Chemical compound CC(C)CCCCCCCCCCCCCCCOC(=O)CCCCCCCCCCCCCCC(C)C ABEXEQSGABRUHS-UHFFFAOYSA-N 0.000 description 1
- RWKSBJVOQGKDFZ-UHFFFAOYSA-N 16-methylheptadecyl 2-hydroxypropanoate Chemical compound CC(C)CCCCCCCCCCCCCCCOC(=O)C(C)O RWKSBJVOQGKDFZ-UHFFFAOYSA-N 0.000 description 1
- SAMYFBLRCRWESN-UHFFFAOYSA-N 16-methylheptadecyl hexadecanoate Chemical compound CCCCCCCCCCCCCCCC(=O)OCCCCCCCCCCCCCCCC(C)C SAMYFBLRCRWESN-UHFFFAOYSA-N 0.000 description 1
- RKJGFHYCZPZJPE-UHFFFAOYSA-N 2,2-bis(16-methylheptadecanoyloxymethyl)butyl 16-methylheptadecanoate Chemical compound CC(C)CCCCCCCCCCCCCCC(=O)OCC(CC)(COC(=O)CCCCCCCCCCCCCCC(C)C)COC(=O)CCCCCCCCCCCCCCC(C)C RKJGFHYCZPZJPE-UHFFFAOYSA-N 0.000 description 1
- FUTGDWNFCMWSJT-UHFFFAOYSA-N 2,3-bis(14-methylpentadecanoyloxy)propyl 14-methylpentadecanoate Chemical compound CC(C)CCCCCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCCCCCC(C)C)COC(=O)CCCCCCCCCCCCC(C)C FUTGDWNFCMWSJT-UHFFFAOYSA-N 0.000 description 1
- XFBOJHLYDJZYSP-UHFFFAOYSA-N 2,8-dioxoadenine Chemical compound N1C(=O)N=C2NC(=O)NC2=C1N XFBOJHLYDJZYSP-UHFFFAOYSA-N 0.000 description 1
- MTVLEKBQSDTQGO-UHFFFAOYSA-N 2-(2-ethoxypropoxy)propan-1-ol Chemical compound CCOC(C)COC(C)CO MTVLEKBQSDTQGO-UHFFFAOYSA-N 0.000 description 1
- ZSZRUEAFVQITHH-UHFFFAOYSA-N 2-(2-methylprop-2-enoyloxy)ethyl 2-(trimethylazaniumyl)ethyl phosphate Chemical compound CC(=C)C(=O)OCCOP([O-])(=O)OCC[N+](C)(C)C ZSZRUEAFVQITHH-UHFFFAOYSA-N 0.000 description 1
- 229920000536 2-Acrylamido-2-methylpropane sulfonic acid Polymers 0.000 description 1
- OBETXYAYXDNJHR-UHFFFAOYSA-N 2-Ethylhexanoic acid Chemical compound CCCCC(CC)C(O)=O OBETXYAYXDNJHR-UHFFFAOYSA-N 0.000 description 1
- XHZPRMZZQOIPDS-UHFFFAOYSA-N 2-Methyl-2-[(1-oxo-2-propenyl)amino]-1-propanesulfonic acid Chemical compound OS(=O)(=O)CC(C)(C)NC(=O)C=C XHZPRMZZQOIPDS-UHFFFAOYSA-N 0.000 description 1
- 229940058020 2-amino-2-methyl-1-propanol Drugs 0.000 description 1
- UXFQFBNBSPQBJW-UHFFFAOYSA-N 2-amino-2-methylpropane-1,3-diol Chemical compound OCC(N)(C)CO UXFQFBNBSPQBJW-UHFFFAOYSA-N 0.000 description 1
- LSHGMOIQPURPAK-UHFFFAOYSA-N 2-benzylidene-1,4,7,7-tetramethylbicyclo[2.2.1]heptan-3-one Chemical compound CC1(C)C(C2=O)(C)CCC1(C)C2=CC1=CC=CC=C1 LSHGMOIQPURPAK-UHFFFAOYSA-N 0.000 description 1
- ASJSAQIRZKANQN-CRCLSJGQSA-N 2-deoxy-D-ribose Chemical compound OC[C@@H](O)[C@@H](O)CC=O ASJSAQIRZKANQN-CRCLSJGQSA-N 0.000 description 1
- JGUMTYWKIBJSTN-UHFFFAOYSA-N 2-ethylhexyl 4-[[4,6-bis[4-(2-ethylhexoxycarbonyl)anilino]-1,3,5-triazin-2-yl]amino]benzoate Chemical compound C1=CC(C(=O)OCC(CC)CCCC)=CC=C1NC1=NC(NC=2C=CC(=CC=2)C(=O)OCC(CC)CCCC)=NC(NC=2C=CC(=CC=2)C(=O)OCC(CC)CCCC)=N1 JGUMTYWKIBJSTN-UHFFFAOYSA-N 0.000 description 1
- 239000004808 2-ethylhexylester Substances 0.000 description 1
- AOQBDFVNMYOCTO-UHFFFAOYSA-N 2-hydroxybutanedioic acid;octadecanoic acid Chemical compound OC(=O)C(O)CC(O)=O.CCCCCCCCCCCCCCCCCC(O)=O AOQBDFVNMYOCTO-UHFFFAOYSA-N 0.000 description 1
- ZVTDEEBSWIQAFJ-KHPPLWFESA-N 2-hydroxypropyl (z)-octadec-9-enoate Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OCC(C)O ZVTDEEBSWIQAFJ-KHPPLWFESA-N 0.000 description 1
- LEACJMVNYZDSKR-UHFFFAOYSA-N 2-octyldodecan-1-ol Chemical compound CCCCCCCCCCC(CO)CCCCCCCC LEACJMVNYZDSKR-UHFFFAOYSA-N 0.000 description 1
- KUIYXYIWGVFQPD-UHFFFAOYSA-N 2-octyldodecanoic acid Chemical compound CCCCCCCCCCC(C(O)=O)CCCCCCCC KUIYXYIWGVFQPD-UHFFFAOYSA-N 0.000 description 1
- BGRXBNZMPMGLQI-UHFFFAOYSA-N 2-octyldodecyl tetradecanoate Chemical compound CCCCCCCCCCCCCC(=O)OCC(CCCCCCCC)CCCCCCCCCC BGRXBNZMPMGLQI-UHFFFAOYSA-N 0.000 description 1
- QCDWFXQBSFUVSP-UHFFFAOYSA-N 2-phenoxyethanol Chemical compound OCCOC1=CC=CC=C1 QCDWFXQBSFUVSP-UHFFFAOYSA-N 0.000 description 1
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 1
- QGJZLNKBHJESQX-UHFFFAOYSA-N 3-Epi-Betulin-Saeure Natural products C1CC(O)C(C)(C)C2CCC3(C)C4(C)CCC5(C(O)=O)CCC(C(=C)C)C5C4CCC3C21C QGJZLNKBHJESQX-UHFFFAOYSA-N 0.000 description 1
- DBTMGCOVALSLOR-UHFFFAOYSA-N 32-alpha-galactosyl-3-alpha-galactosyl-galactose Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(OC2C(C(CO)OC(O)C2O)O)OC(CO)C1O DBTMGCOVALSLOR-UHFFFAOYSA-N 0.000 description 1
- CLOUCVRNYSHRCF-UHFFFAOYSA-N 3beta-Hydroxy-20(29)-Lupen-3,27-oic acid Natural products C1CC(O)C(C)(C)C2CCC3(C)C4(C(O)=O)CCC5(C)CCC(C(=C)C)C5C4CCC3C21C CLOUCVRNYSHRCF-UHFFFAOYSA-N 0.000 description 1
- MIJYXULNPSFWEK-GTOFXWBISA-N 3beta-hydroxyolean-12-en-28-oic acid Chemical compound C1C[C@H](O)C(C)(C)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C(O)=O)CCC(C)(C)C[C@H]5C4=CC[C@@H]3[C@]21C MIJYXULNPSFWEK-GTOFXWBISA-N 0.000 description 1
- UCNXEGMKUYUZIW-UHFFFAOYSA-N 4,5-bis(hydroxymethyl)-2-methylpyridin-3-ol dodecanoic acid Chemical compound CC1=C(O)C(CO)=C(CO)C=N1.CCCCCCCCCCCC(O)=O UCNXEGMKUYUZIW-UHFFFAOYSA-N 0.000 description 1
- HIQIXEFWDLTDED-UHFFFAOYSA-N 4-hydroxy-1-piperidin-4-ylpyrrolidin-2-one Chemical compound O=C1CC(O)CN1C1CCNCC1 HIQIXEFWDLTDED-UHFFFAOYSA-N 0.000 description 1
- SLXKOJJOQWFEFD-UHFFFAOYSA-N 6-aminohexanoic acid Chemical compound NCCCCCC(O)=O SLXKOJJOQWFEFD-UHFFFAOYSA-N 0.000 description 1
- BRORPGSJXSLXKN-UHFFFAOYSA-N 6-methylheptyl 3,5,5-trimethylhexanoate Chemical compound CC(C)CCCCCOC(=O)CC(C)CC(C)(C)C BRORPGSJXSLXKN-UHFFFAOYSA-N 0.000 description 1
- FHVDTGUDJYJELY-UHFFFAOYSA-N 6-{[2-carboxy-4,5-dihydroxy-6-(phosphanyloxy)oxan-3-yl]oxy}-4,5-dihydroxy-3-phosphanyloxane-2-carboxylic acid Chemical compound O1C(C(O)=O)C(P)C(O)C(O)C1OC1C(C(O)=O)OC(OP)C(O)C1O FHVDTGUDJYJELY-UHFFFAOYSA-N 0.000 description 1
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 1
- ZKHQWZAMYRWXGA-KQYNXXCUSA-J ATP(4-) Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](COP([O-])(=O)OP([O-])(=O)OP([O-])([O-])=O)[C@@H](O)[C@H]1O ZKHQWZAMYRWXGA-KQYNXXCUSA-J 0.000 description 1
- 244000215068 Acacia senegal Species 0.000 description 1
- ZKHQWZAMYRWXGA-UHFFFAOYSA-N Adenosine triphosphate Natural products C1=NC=2C(N)=NC=NC=2N1C1OC(COP(O)(=O)OP(O)(=O)OP(O)(O)=O)C(O)C1O ZKHQWZAMYRWXGA-UHFFFAOYSA-N 0.000 description 1
- 102000009027 Albumins Human genes 0.000 description 1
- 108010088751 Albumins Proteins 0.000 description 1
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
- 239000005995 Aluminium silicate Substances 0.000 description 1
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonium chloride Substances [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 1
- 239000004475 Arginine Substances 0.000 description 1
- JEBFVOLFMLUKLF-IFPLVEIFSA-N Astaxanthin Natural products CC(=C/C=C/C(=C/C=C/C1=C(C)C(=O)C(O)CC1(C)C)/C)C=CC=C(/C)C=CC=C(/C)C=CC2=C(C)C(=O)C(O)CC2(C)C JEBFVOLFMLUKLF-IFPLVEIFSA-N 0.000 description 1
- 241000416162 Astragalus gummifer Species 0.000 description 1
- 244000266618 Atriplex confertifolia Species 0.000 description 1
- 235000012137 Atriplex confertifolia Nutrition 0.000 description 1
- 235000021357 Behenic acid Nutrition 0.000 description 1
- KWIUHFFTVRNATP-UHFFFAOYSA-N Betaine Natural products C[N+](C)(C)CC([O-])=O KWIUHFFTVRNATP-UHFFFAOYSA-N 0.000 description 1
- DIZWSDNSTNAYHK-XGWVBXMLSA-N Betulinic acid Natural products CC(=C)[C@@H]1C[C@H]([C@H]2CC[C@]3(C)[C@H](CC[C@@H]4[C@@]5(C)CC[C@H](O)C(C)(C)[C@@H]5CC[C@@]34C)[C@@H]12)C(=O)O DIZWSDNSTNAYHK-XGWVBXMLSA-N 0.000 description 1
- JMGZEFIQIZZSBH-UHFFFAOYSA-N Bioquercetin Natural products CC1OC(OCC(O)C2OC(OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5)C(O)C2O)C(O)C(O)C1O JMGZEFIQIZZSBH-UHFFFAOYSA-N 0.000 description 1
- YDNKGFDKKRUKPY-JHOUSYSJSA-N C16 ceramide Natural products CCCCCCCCCCCCCCCC(=O)N[C@@H](CO)[C@H](O)C=CCCCCCCCCCCCCC YDNKGFDKKRUKPY-JHOUSYSJSA-N 0.000 description 1
- IZJWOALLOOMDRZ-GWHBCOKCSA-N CCCCCCCCCCCCCCCCCC(=O)N[C@@H](CCC(=O)O)C(=O)OC(CCCCCCCC)(CCCCCCCC)CCCCCCCCC Chemical compound CCCCCCCCCCCCCCCCCC(=O)N[C@@H](CCC(=O)O)C(=O)OC(CCCCCCCC)(CCCCCCCC)CCCCCCCCC IZJWOALLOOMDRZ-GWHBCOKCSA-N 0.000 description 1
- 102000011632 Caseins Human genes 0.000 description 1
- 108010076119 Caseins Proteins 0.000 description 1
- 244000146553 Ceiba pentandra Species 0.000 description 1
- 235000003301 Ceiba pentandra Nutrition 0.000 description 1
- 241000283153 Cetacea Species 0.000 description 1
- GHOKWGTUZJEAQD-UHFFFAOYSA-N Chick antidermatitis factor Natural products OCC(C)(C)C(O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-UHFFFAOYSA-N 0.000 description 1
- 102000008186 Collagen Human genes 0.000 description 1
- 108010035532 Collagen Proteins 0.000 description 1
- 229920000742 Cotton Polymers 0.000 description 1
- GUBGYTABKSRVRQ-CUHNMECISA-N D-Cellobiose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-CUHNMECISA-N 0.000 description 1
- YTBSYETUWUMLBZ-UHFFFAOYSA-N D-Erythrose Natural products OCC(O)C(O)C=O YTBSYETUWUMLBZ-UHFFFAOYSA-N 0.000 description 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
- WQZGKKKJIJFFOK-WHZQZERISA-N D-aldose Chemical compound OC[C@H]1OC(O)[C@@H](O)[C@@H](O)[C@H]1O WQZGKKKJIJFFOK-WHZQZERISA-N 0.000 description 1
- LKDRXBCSQODPBY-JDJSBBGDSA-N D-allulose Chemical compound OCC1(O)OC[C@@H](O)[C@@H](O)[C@H]1O LKDRXBCSQODPBY-JDJSBBGDSA-N 0.000 description 1
- ZAKOWWREFLAJOT-CEFNRUSXSA-N D-alpha-tocopherylacetate Chemical compound CC(=O)OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-CEFNRUSXSA-N 0.000 description 1
- HEBKCHPVOIAQTA-QWWZWVQMSA-N D-arabinitol Chemical compound OC[C@@H](O)C(O)[C@H](O)CO HEBKCHPVOIAQTA-QWWZWVQMSA-N 0.000 description 1
- YTBSYETUWUMLBZ-IUYQGCFVSA-N D-erythrose Chemical compound OC[C@@H](O)[C@@H](O)C=O YTBSYETUWUMLBZ-IUYQGCFVSA-N 0.000 description 1
- RXVWSYJTUUKTEA-UHFFFAOYSA-N D-maltotriose Natural products OC1C(O)C(OC(C(O)CO)C(O)C(O)C=O)OC(CO)C1OC1C(O)C(O)C(O)C(CO)O1 RXVWSYJTUUKTEA-UHFFFAOYSA-N 0.000 description 1
- WQZGKKKJIJFFOK-QTVWNMPRSA-N D-mannopyranose Chemical compound OC[C@H]1OC(O)[C@@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-QTVWNMPRSA-N 0.000 description 1
- QWIZNVHXZXRPDR-UHFFFAOYSA-N D-melezitose Natural products O1C(CO)C(O)C(O)C(O)C1OC1C(O)C(CO)OC1(CO)OC1OC(CO)C(O)C(O)C1O QWIZNVHXZXRPDR-UHFFFAOYSA-N 0.000 description 1
- AERBNCYCJBRYDG-UHFFFAOYSA-N D-ribo-phytosphingosine Natural products CCCCCCCCCCCCCCC(O)C(O)C(N)CO AERBNCYCJBRYDG-UHFFFAOYSA-N 0.000 description 1
- HMFHBZSHGGEWLO-SOOFDHNKSA-N D-ribofuranose Chemical compound OC[C@H]1OC(O)[C@H](O)[C@@H]1O HMFHBZSHGGEWLO-SOOFDHNKSA-N 0.000 description 1
- ZAQJHHRNXZUBTE-NQXXGFSBSA-N D-ribulose Chemical compound OC[C@@H](O)[C@@H](O)C(=O)CO ZAQJHHRNXZUBTE-NQXXGFSBSA-N 0.000 description 1
- ZAQJHHRNXZUBTE-UHFFFAOYSA-N D-threo-2-Pentulose Natural products OCC(O)C(O)C(=O)CO ZAQJHHRNXZUBTE-UHFFFAOYSA-N 0.000 description 1
- YTBSYETUWUMLBZ-QWWZWVQMSA-N D-threose Chemical compound OC[C@@H](O)[C@H](O)C=O YTBSYETUWUMLBZ-QWWZWVQMSA-N 0.000 description 1
- ZAQJHHRNXZUBTE-WUJLRWPWSA-N D-xylulose Chemical compound OC[C@@H](O)[C@H](O)C(=O)CO ZAQJHHRNXZUBTE-WUJLRWPWSA-N 0.000 description 1
- NOOLISFMXDJSKH-UHFFFAOYSA-N DL-menthol Natural products CC(C)C1CCC(C)CC1O NOOLISFMXDJSKH-UHFFFAOYSA-N 0.000 description 1
- XMSXQFUHVRWGNA-UHFFFAOYSA-N Decamethylcyclopentasiloxane Chemical compound C[Si]1(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O1 XMSXQFUHVRWGNA-UHFFFAOYSA-N 0.000 description 1
- 229920002307 Dextran Polymers 0.000 description 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
- IUMSDRXLFWAGNT-UHFFFAOYSA-N Dodecamethylcyclohexasiloxane Chemical compound C[Si]1(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O1 IUMSDRXLFWAGNT-UHFFFAOYSA-N 0.000 description 1
- SNRUBQQJIBEYMU-UHFFFAOYSA-N Dodecane Natural products CCCCCCCCCCCC SNRUBQQJIBEYMU-UHFFFAOYSA-N 0.000 description 1
- 206010013786 Dry skin Diseases 0.000 description 1
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 1
- 102000002322 Egg Proteins Human genes 0.000 description 1
- 108010000912 Egg Proteins Proteins 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- JKLISIRFYWXLQG-UHFFFAOYSA-N Epioleonolsaeure Natural products C1CC(O)C(C)(C)C2CCC3(C)C4(C)CCC5(C(O)=O)CCC(C)(C)CC5C4CCC3C21C JKLISIRFYWXLQG-UHFFFAOYSA-N 0.000 description 1
- 239000004386 Erythritol Substances 0.000 description 1
- UNXHWFMMPAWVPI-UHFFFAOYSA-N Erythritol Natural products OCC(O)C(O)CO UNXHWFMMPAWVPI-UHFFFAOYSA-N 0.000 description 1
- 206010056474 Erythrosis Diseases 0.000 description 1
- 239000001856 Ethyl cellulose Substances 0.000 description 1
- ZZSNKZQZMQGXPY-UHFFFAOYSA-N Ethyl cellulose Chemical compound CCOCC1OC(OC)C(OCC)C(OCC)C1OC1C(O)C(O)C(OC)C(CO)O1 ZZSNKZQZMQGXPY-UHFFFAOYSA-N 0.000 description 1
- 241000237858 Gastropoda Species 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- 229920002148 Gellan gum Polymers 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 1
- 239000004471 Glycine Substances 0.000 description 1
- MPDGHEJMBKOTSU-UHFFFAOYSA-N Glycyrrhetinsaeure Natural products C12C(=O)C=C3C4CC(C)(C(O)=O)CCC4(C)CCC3(C)C1(C)CCC1C2(C)CCC(O)C1(C)C MPDGHEJMBKOTSU-UHFFFAOYSA-N 0.000 description 1
- BIVBRWYINDPWKA-VLQRKCJKSA-L Glycyrrhizinate dipotassium Chemical compound [K+].[K+].O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@H]1CC[C@]2(C)[C@H]3C(=O)C=C4[C@@H]5C[C@](C)(CC[C@@]5(CC[C@@]4(C)[C@]3(C)CC[C@H]2C1(C)C)C)C(O)=O)C([O-])=O)[C@@H]1O[C@H](C([O-])=O)[C@@H](O)[C@H](O)[C@H]1O BIVBRWYINDPWKA-VLQRKCJKSA-L 0.000 description 1
- 229920002907 Guar gum Polymers 0.000 description 1
- 229920000084 Gum arabic Polymers 0.000 description 1
- CMBYOWLFQAFZCP-UHFFFAOYSA-N Hexyl dodecanoate Chemical compound CCCCCCCCCCCC(=O)OCCCCCC CMBYOWLFQAFZCP-UHFFFAOYSA-N 0.000 description 1
- 239000004354 Hydroxyethyl cellulose Substances 0.000 description 1
- 229920000663 Hydroxyethyl cellulose Polymers 0.000 description 1
- PMMYEEVYMWASQN-DMTCNVIQSA-N Hydroxyproline Chemical compound O[C@H]1CN[C@H](C(O)=O)C1 PMMYEEVYMWASQN-DMTCNVIQSA-N 0.000 description 1
- 229920002153 Hydroxypropyl cellulose Polymers 0.000 description 1
- MLSJBGYKDYSOAE-DCWMUDTNSA-N L-Ascorbic acid-2-glucoside Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O[C@@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O2)O)=C1O MLSJBGYKDYSOAE-DCWMUDTNSA-N 0.000 description 1
- ONIBWKKTOPOVIA-BYPYZUCNSA-N L-Proline Chemical compound OC(=O)[C@@H]1CCCN1 ONIBWKKTOPOVIA-BYPYZUCNSA-N 0.000 description 1
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 1
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 description 1
- 150000000996 L-ascorbic acids Chemical class 0.000 description 1
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 1
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 1
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 1
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 description 1
- SHZGCJCMOBCMKK-JFNONXLTSA-N L-rhamnopyranose Chemical compound C[C@@H]1OC(O)[C@H](O)[C@H](O)[C@H]1O SHZGCJCMOBCMKK-JFNONXLTSA-N 0.000 description 1
- PNNNRSAQSRJVSB-UHFFFAOYSA-N L-rhamnose Natural products CC(O)C(O)C(O)C(O)C=O PNNNRSAQSRJVSB-UHFFFAOYSA-N 0.000 description 1
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 1
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 1
- 229920000161 Locust bean gum Polymers 0.000 description 1
- UPYKUZBSLRQECL-UKMVMLAPSA-N Lycopene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1C(=C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=C)CCCC2(C)C UPYKUZBSLRQECL-UKMVMLAPSA-N 0.000 description 1
- JEVVKJMRZMXFBT-XWDZUXABSA-N Lycophyll Natural products OC/C(=C/CC/C(=C\C=C\C(=C/C=C/C(=C\C=C\C=C(/C=C/C=C(\C=C\C=C(/CC/C=C(/CO)\C)\C)/C)\C)/C)\C)/C)/C JEVVKJMRZMXFBT-XWDZUXABSA-N 0.000 description 1
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 1
- 239000004472 Lysine Substances 0.000 description 1
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 1
- 229930195725 Mannitol Natural products 0.000 description 1
- UEZVMMHDMIWARA-UHFFFAOYSA-N Metaphosphoric acid Chemical compound OP(=O)=O UEZVMMHDMIWARA-UHFFFAOYSA-N 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- CERQOIWHTDAKMF-UHFFFAOYSA-M Methacrylate Chemical compound CC(=C)C([O-])=O CERQOIWHTDAKMF-UHFFFAOYSA-M 0.000 description 1
- KWIUHFFTVRNATP-UHFFFAOYSA-O N,N,N-trimethylglycinium Chemical compound C[N+](C)(C)CC(O)=O KWIUHFFTVRNATP-UHFFFAOYSA-O 0.000 description 1
- BBAFBDLICMHBNU-MFZOPHKMSA-N N-(2-hydroxyoctadecanoyl)-4-hydroxysphinganine Chemical compound CCCCCCCCCCCCCCCCC(O)C(=O)N[C@@H](CO)[C@H](O)[C@H](O)CCCCCCCCCCCCCC BBAFBDLICMHBNU-MFZOPHKMSA-N 0.000 description 1
- WAYLDHLWVYQNSQ-KEFDUYNTSA-N N-2-hydroxylignoceroylsphingosine Chemical compound CCCCCCCCCCCCCCCCCCCCCCC(O)C(=O)N[C@@H](CO)[C@H](O)\C=C\CCCCCCCCCCCCC WAYLDHLWVYQNSQ-KEFDUYNTSA-N 0.000 description 1
- WHNWPMSKXPGLAX-UHFFFAOYSA-N N-Vinyl-2-pyrrolidone Chemical compound C=CN1CCCC1=O WHNWPMSKXPGLAX-UHFFFAOYSA-N 0.000 description 1
- CRJGESKKUOMBCT-VQTJNVASSA-N N-acetylsphinganine Chemical compound CCCCCCCCCCCCCCC[C@@H](O)[C@H](CO)NC(C)=O CRJGESKKUOMBCT-VQTJNVASSA-N 0.000 description 1
- ATGQXSBKTQANOH-UWVGARPKSA-N N-oleoylphytosphingosine Chemical compound CCCCCCCCCCCCCC[C@@H](O)[C@@H](O)[C@H](CO)NC(=O)CCCCCCC\C=C/CCCCCCCC ATGQXSBKTQANOH-UWVGARPKSA-N 0.000 description 1
- 241000772415 Neovison vison Species 0.000 description 1
- 239000004677 Nylon Substances 0.000 description 1
- YBGZDTIWKVFICR-JLHYYAGUSA-N Octyl 4-methoxycinnamic acid Chemical compound CCCCC(CC)COC(=O)\C=C\C1=CC=C(OC)C=C1 YBGZDTIWKVFICR-JLHYYAGUSA-N 0.000 description 1
- YBRJHZPWOMJYKQ-UHFFFAOYSA-N Oleanolic acid Natural products CC1(C)CC2C3=CCC4C5(C)CCC(O)C(C)(C)C5CCC4(C)C3(C)CCC2(C1)C(=O)O YBRJHZPWOMJYKQ-UHFFFAOYSA-N 0.000 description 1
- MIJYXULNPSFWEK-UHFFFAOYSA-N Oleanolinsaeure Natural products C1CC(O)C(C)(C)C2CCC3(C)C4(C)CCC5(C(O)=O)CCC(C)(C)CC5C4=CCC3C21C MIJYXULNPSFWEK-UHFFFAOYSA-N 0.000 description 1
- 239000005642 Oleic acid Substances 0.000 description 1
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 1
- 235000019483 Peanut oil Nutrition 0.000 description 1
- 239000004264 Petrolatum Substances 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- 239000004372 Polyvinyl alcohol Substances 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 description 1
- HDSBZMRLPLPFLQ-UHFFFAOYSA-N Propylene glycol alginate Chemical compound OC1C(O)C(OC)OC(C(O)=O)C1OC1C(O)C(O)C(C)C(C(=O)OCC(C)O)O1 HDSBZMRLPLPFLQ-UHFFFAOYSA-N 0.000 description 1
- 239000004373 Pullulan Substances 0.000 description 1
- 229920001218 Pullulan Polymers 0.000 description 1
- MUPFEKGTMRGPLJ-RMMQSMQOSA-N Raffinose Natural products O(C[C@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@@H](O[C@@]2(CO)[C@H](O)[C@@H](O)[C@@H](CO)O2)O1)[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 MUPFEKGTMRGPLJ-RMMQSMQOSA-N 0.000 description 1
- MJNIWUJSIGSWKK-BBANNHEPSA-N Riboflavin butyrate Chemical compound CCCC(=O)OC[C@@H](OC(=O)CCC)[C@@H](OC(=O)CCC)[C@@H](OC(=O)CCC)CN1C2=CC(C)=C(C)C=C2N=C2C1=NC(=O)NC2=O MJNIWUJSIGSWKK-BBANNHEPSA-N 0.000 description 1
- PYMYPHUHKUWMLA-LMVFSUKVSA-N Ribose Natural products OC[C@@H](O)[C@@H](O)[C@@H](O)C=O PYMYPHUHKUWMLA-LMVFSUKVSA-N 0.000 description 1
- 235000019774 Rice Bran oil Nutrition 0.000 description 1
- 240000000111 Saccharum officinarum Species 0.000 description 1
- 235000007201 Saccharum officinarum Nutrition 0.000 description 1
- 235000019485 Safflower oil Nutrition 0.000 description 1
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 1
- BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 description 1
- 244000044822 Simmondsia californica Species 0.000 description 1
- 235000004433 Simmondsia californica Nutrition 0.000 description 1
- 239000004288 Sodium dehydroacetate Substances 0.000 description 1
- 229920002385 Sodium hyaluronate Polymers 0.000 description 1
- 229920002125 Sokalan® Polymers 0.000 description 1
- UQZIYBXSHAGNOE-USOSMYMVSA-N Stachyose Natural products O(C[C@H]1[C@@H](O)[C@H](O)[C@H](O)[C@@H](O[C@@]2(CO)[C@H](O)[C@@H](O)[C@@H](CO)O2)O1)[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@H](CO[C@@H]2[C@@H](O)[C@@H](O)[C@@H](O)[C@H](CO)O2)O1 UQZIYBXSHAGNOE-USOSMYMVSA-N 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 1
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
- 241000270666 Testudines Species 0.000 description 1
- AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 description 1
- 239000004473 Threonine Substances 0.000 description 1
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 1
- RTAQQCXQSZGOHL-UHFFFAOYSA-N Titanium Chemical compound [Ti] RTAQQCXQSZGOHL-UHFFFAOYSA-N 0.000 description 1
- 235000006732 Torreya nucifera Nutrition 0.000 description 1
- 244000111306 Torreya nucifera Species 0.000 description 1
- 229920001615 Tragacanth Polymers 0.000 description 1
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 1
- DRQXUCVJDCRJDB-UHFFFAOYSA-N Turanose Natural products OC1C(CO)OC(O)(CO)C1OC1C(O)C(O)C(O)C(CO)O1 DRQXUCVJDCRJDB-UHFFFAOYSA-N 0.000 description 1
- MUPFEKGTMRGPLJ-UHFFFAOYSA-N UNPD196149 Natural products OC1C(O)C(CO)OC1(CO)OC1C(O)C(O)C(O)C(COC2C(C(O)C(O)C(CO)O2)O)O1 MUPFEKGTMRGPLJ-UHFFFAOYSA-N 0.000 description 1
- KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 description 1
- 229930003270 Vitamin B Natural products 0.000 description 1
- 229930003316 Vitamin D Natural products 0.000 description 1
- MECHNRXZTMCUDQ-UHFFFAOYSA-N Vitamin D2 Natural products C1CCC2(C)C(C(C)C=CC(C)C(C)C)CCC2C1=CC=C1CC(O)CCC1=C MECHNRXZTMCUDQ-UHFFFAOYSA-N 0.000 description 1
- 229910021536 Zeolite Inorganic materials 0.000 description 1
- NCHJGQKLPRTMAO-XWVZOOPGSA-N [(2R)-2-[(2R,3R,4S)-3,4-dihydroxyoxolan-2-yl]-2-hydroxyethyl] 16-methylheptadecanoate Chemical compound CC(C)CCCCCCCCCCCCCCC(=O)OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O NCHJGQKLPRTMAO-XWVZOOPGSA-N 0.000 description 1
- SZYSLWCAWVWFLT-UTGHZIEOSA-N [(2s,3s,4s,5r)-3,4-dihydroxy-5-(hydroxymethyl)-2-[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxolan-2-yl]methyl octadecanoate Chemical compound O([C@@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@]1(COC(=O)CCCCCCCCCCCCCCCCC)O[C@H](CO)[C@@H](O)[C@@H]1O SZYSLWCAWVWFLT-UTGHZIEOSA-N 0.000 description 1
- XKMYWNHZAQUEPY-YZGJEOKZSA-N [(3s,8s,9s,10r,13r,14s,17r)-10,13-dimethyl-17-[(2r)-6-methylheptan-2-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1h-cyclopenta[a]phenanthren-3-yl] 12-hydroxyoctadecanoate Chemical compound C([C@@H]12)C[C@]3(C)[C@@H]([C@H](C)CCCC(C)C)CC[C@H]3[C@@H]1CC=C1[C@]2(C)CC[C@H](OC(=O)CCCCCCCCCCC(O)CCCCCC)C1 XKMYWNHZAQUEPY-YZGJEOKZSA-N 0.000 description 1
- JBBRZDLNVILTDL-XNTGVSEISA-N [(3s,8s,9s,10r,13r,14s,17r)-10,13-dimethyl-17-[(2r)-6-methylheptan-2-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1h-cyclopenta[a]phenanthren-3-yl] 16-methylheptadecanoate Chemical compound C([C@@H]12)C[C@]3(C)[C@@H]([C@H](C)CCCC(C)C)CC[C@H]3[C@@H]1CC=C1[C@]2(C)CC[C@H](OC(=O)CCCCCCCCCCCCCCC(C)C)C1 JBBRZDLNVILTDL-XNTGVSEISA-N 0.000 description 1
- LDDUCKDUDZVHLN-UHFFFAOYSA-N [2-hydroxy-3-[2-hydroxy-3-(16-methylheptadecanoyloxy)propoxy]propyl] 16-methylheptadecanoate Chemical compound CC(C)CCCCCCCCCCCCCCC(=O)OCC(O)COCC(O)COC(=O)CCCCCCCCCCCCCCC(C)C LDDUCKDUDZVHLN-UHFFFAOYSA-N 0.000 description 1
- MIUIRGGKIICMBP-NFOZDHADSA-N [27-oxo-27-[[(2s,3s,4r)-1,3,4-trihydroxyoctadecan-2-yl]amino]heptacosyl] octadecanoate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCCCCCCCCCCCCCCCCCCCCCCCCCCC(=O)N[C@@H](CO)[C@H](O)[C@H](O)CCCCCCCCCCCCCC MIUIRGGKIICMBP-NFOZDHADSA-N 0.000 description 1
- ZGBFGAHZKZQSLG-UMCOJZBLSA-N [30-oxo-30-[[(e,2s,3r,6r)-1,3,6-trihydroxyoctadec-4-en-2-yl]amino]triacontyl] (9z,12z)-octadeca-9,12-dienoate Chemical compound CCCCCCCCCCCC[C@@H](O)\C=C\[C@@H](O)[C@H](CO)NC(=O)CCCCCCCCCCCCCCCCCCCCCCCCCCCCCOC(=O)CCCCCCC\C=C/C\C=C/CCCCC ZGBFGAHZKZQSLG-UMCOJZBLSA-N 0.000 description 1
- RCYWWJBNPIWJMJ-UHFFFAOYSA-N [4-(hexadecanoyloxymethyl)-5-hydroxy-6-methylpyridin-3-yl]methyl hexadecanoate Chemical compound CCCCCCCCCCCCCCCC(=O)OCC1=CN=C(C)C(O)=C1COC(=O)CCCCCCCCCCCCCCC RCYWWJBNPIWJMJ-UHFFFAOYSA-N 0.000 description 1
- PAUSGZCRNOTKPK-UHFFFAOYSA-N [5-hydroxy-6-methyl-4-(octanoyloxymethyl)pyridin-3-yl]methyl octanoate Chemical compound CCCCCCCC(=O)OCC1=CN=C(C)C(O)=C1COC(=O)CCCCCCC PAUSGZCRNOTKPK-UHFFFAOYSA-N 0.000 description 1
- ADANNTOYRVPQLJ-UHFFFAOYSA-N [dimethyl(trimethylsilyloxy)silyl]oxy-[[dimethyl(trimethylsilyloxy)silyl]oxy-dimethylsilyl]oxy-dimethylsilane Chemical compound C[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)C ADANNTOYRVPQLJ-UHFFFAOYSA-N 0.000 description 1
- YFCGDEUVHLPRCZ-UHFFFAOYSA-N [dimethyl(trimethylsilyloxy)silyl]oxy-dimethyl-trimethylsilyloxysilane Chemical compound C[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)C YFCGDEUVHLPRCZ-UHFFFAOYSA-N 0.000 description 1
- 239000006096 absorbing agent Substances 0.000 description 1
- 235000010489 acacia gum Nutrition 0.000 description 1
- 239000000205 acacia gum Substances 0.000 description 1
- 229960002632 acarbose Drugs 0.000 description 1
- XUFXOAAUWZOOIT-UHFFFAOYSA-N acarviostatin I01 Natural products OC1C(O)C(NC2C(C(O)C(O)C(CO)=C2)O)C(C)OC1OC(C(C1O)O)C(CO)OC1OC1C(CO)OC(O)C(O)C1O XUFXOAAUWZOOIT-UHFFFAOYSA-N 0.000 description 1
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 229960001456 adenosine triphosphate Drugs 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 235000004279 alanine Nutrition 0.000 description 1
- 229940072056 alginate Drugs 0.000 description 1
- 235000010443 alginic acid Nutrition 0.000 description 1
- 229920000615 alginic acid Polymers 0.000 description 1
- OENHQHLEOONYIE-UKMVMLAPSA-N all-trans beta-carotene Natural products CC=1CCCC(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C OENHQHLEOONYIE-UKMVMLAPSA-N 0.000 description 1
- 229940061720 alpha hydroxy acid Drugs 0.000 description 1
- 150000001280 alpha hydroxy acids Chemical class 0.000 description 1
- HMFHBZSHGGEWLO-UHFFFAOYSA-N alpha-D-Furanose-Ribose Natural products OCC1OC(O)C(O)C1O HMFHBZSHGGEWLO-UHFFFAOYSA-N 0.000 description 1
- WQZGKKKJIJFFOK-PHYPRBDBSA-N alpha-D-galactose Chemical compound OC[C@H]1O[C@H](O)[C@H](O)[C@@H](O)[C@H]1O WQZGKKKJIJFFOK-PHYPRBDBSA-N 0.000 description 1
- SRBFZHDQGSBBOR-STGXQOJASA-N alpha-D-lyxopyranose Chemical compound O[C@@H]1CO[C@H](O)[C@@H](O)[C@H]1O SRBFZHDQGSBBOR-STGXQOJASA-N 0.000 description 1
- DTOSIQBPPRVQHS-PDBXOOCHSA-N alpha-linolenic acid Chemical compound CC\C=C/C\C=C/C\C=C/CCCCCCCC(O)=O DTOSIQBPPRVQHS-PDBXOOCHSA-N 0.000 description 1
- 235000020661 alpha-linolenic acid Nutrition 0.000 description 1
- 235000012211 aluminium silicate Nutrition 0.000 description 1
- 229940009868 aluminum magnesium silicate Drugs 0.000 description 1
- WMGSQTMJHBYJMQ-UHFFFAOYSA-N aluminum;magnesium;silicate Chemical compound [Mg+2].[Al+3].[O-][Si]([O-])([O-])[O-] WMGSQTMJHBYJMQ-UHFFFAOYSA-N 0.000 description 1
- 150000003862 amino acid derivatives Chemical class 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 229960002684 aminocaproic acid Drugs 0.000 description 1
- CBTVGIZVANVGBH-UHFFFAOYSA-N aminomethyl propanol Chemical compound CC(C)(N)CO CBTVGIZVANVGBH-UHFFFAOYSA-N 0.000 description 1
- 235000019270 ammonium chloride Nutrition 0.000 description 1
- 150000003868 ammonium compounds Chemical class 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- PYMYPHUHKUWMLA-WDCZJNDASA-N arabinose Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)C=O PYMYPHUHKUWMLA-WDCZJNDASA-N 0.000 description 1
- PYMYPHUHKUWMLA-UHFFFAOYSA-N arabinose Natural products OCC(O)C(O)C(O)C=O PYMYPHUHKUWMLA-UHFFFAOYSA-N 0.000 description 1
- 229960000271 arbutin Drugs 0.000 description 1
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 1
- KQZNFGJQTPAURD-NBWQQBAWSA-N ascorbyl dipalmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](OC(=O)CCCCCCCCCCCCCCC)[C@H]1OC(=O)C(O)=C1O KQZNFGJQTPAURD-NBWQQBAWSA-N 0.000 description 1
- 229940067599 ascorbyl glucoside Drugs 0.000 description 1
- 235000003704 aspartic acid Nutrition 0.000 description 1
- 235000013793 astaxanthin Nutrition 0.000 description 1
- 239000001168 astaxanthin Substances 0.000 description 1
- 229940022405 astaxanthin Drugs 0.000 description 1
- MQZIGYBFDRPAKN-ZWAPEEGVSA-N astaxanthin Chemical compound C([C@H](O)C(=O)C=1C)C(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)C(=O)[C@@H](O)CC1(C)C MQZIGYBFDRPAKN-ZWAPEEGVSA-N 0.000 description 1
- XNEFYCZVKIDDMS-UHFFFAOYSA-N avobenzone Chemical compound C1=CC(OC)=CC=C1C(=O)CC(=O)C1=CC=C(C(C)(C)C)C=C1 XNEFYCZVKIDDMS-UHFFFAOYSA-N 0.000 description 1
- 235000021302 avocado oil Nutrition 0.000 description 1
- 239000008163 avocado oil Substances 0.000 description 1
- IWWCATWBROCMCW-UHFFFAOYSA-N batyl alcohol Natural products CCCCCCCCCCCCCCCCCCOC(O)CO IWWCATWBROCMCW-UHFFFAOYSA-N 0.000 description 1
- 239000012179 bayberry wax Substances 0.000 description 1
- 239000011324 bead Substances 0.000 description 1
- 235000013871 bee wax Nutrition 0.000 description 1
- 239000012166 beeswax Substances 0.000 description 1
- 229940116226 behenic acid Drugs 0.000 description 1
- 125000002511 behenyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- FUFAPKOCRZYSHH-CVTBAMPXSA-N benzyl (1s,2r,4as,6ar,6as,6br,8ar,10s,12ar,14bs)-10-hydroxy-1,2,6a,6b,9,9,12a-heptamethyl-2,3,4,5,6,6a,7,8,8a,10,11,12,13,14b-tetradecahydro-1h-picene-4a-carboxylate Chemical compound O=C([C@]12CC[C@H]([C@@H]([C@H]1C=1[C@@]([C@@]3(CC[C@H]4C(C)(C)[C@@H](O)CC[C@]4(C)[C@H]3CC=1)C)(C)CC2)C)C)OCC1=CC=CC=C1 FUFAPKOCRZYSHH-CVTBAMPXSA-N 0.000 description 1
- SRBFZHDQGSBBOR-UHFFFAOYSA-N beta-D-Pyranose-Lyxose Natural products OC1COC(O)C(O)C1O SRBFZHDQGSBBOR-UHFFFAOYSA-N 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 description 1
- 235000013734 beta-carotene Nutrition 0.000 description 1
- 239000011648 beta-carotene Substances 0.000 description 1
- TUPZEYHYWIEDIH-WAIFQNFQSA-N beta-carotene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2=CCCCC2(C)C TUPZEYHYWIEDIH-WAIFQNFQSA-N 0.000 description 1
- GUBGYTABKSRVRQ-QUYVBRFLSA-N beta-maltose Chemical compound OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O GUBGYTABKSRVRQ-QUYVBRFLSA-N 0.000 description 1
- 229960002747 betacarotene Drugs 0.000 description 1
- 229960003237 betaine Drugs 0.000 description 1
- QGJZLNKBHJESQX-FZFNOLFKSA-N betulinic acid Chemical compound C1C[C@H](O)C(C)(C)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C(O)=O)CC[C@@H](C(=C)C)[C@@H]5[C@H]4CC[C@@H]3[C@]21C QGJZLNKBHJESQX-FZFNOLFKSA-N 0.000 description 1
- 229960002685 biotin Drugs 0.000 description 1
- 235000020958 biotin Nutrition 0.000 description 1
- 239000011616 biotin Substances 0.000 description 1
- HGKOWIQVWAQWDS-UHFFFAOYSA-N bis(16-methylheptadecyl) 2-hydroxybutanedioate Chemical compound CC(C)CCCCCCCCCCCCCCCOC(=O)CC(O)C(=O)OCCCCCCCCCCCCCCCC(C)C HGKOWIQVWAQWDS-UHFFFAOYSA-N 0.000 description 1
- ZFMQKOWCDKKBIF-UHFFFAOYSA-N bis(3,5-difluorophenyl)phosphane Chemical compound FC1=CC(F)=CC(PC=2C=C(F)C=C(F)C=2)=C1 ZFMQKOWCDKKBIF-UHFFFAOYSA-N 0.000 description 1
- FQUNFJULCYSSOP-UHFFFAOYSA-N bisoctrizole Chemical compound N1=C2C=CC=CC2=NN1C1=CC(C(C)(C)CC(C)(C)C)=CC(CC=2C(=C(C=C(C=2)C(C)(C)CC(C)(C)C)N2N=C3C=CC=CC3=N2)O)=C1O FQUNFJULCYSSOP-UHFFFAOYSA-N 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- BMRWNKZVCUKKSR-UHFFFAOYSA-N butane-1,2-diol Chemical compound CCC(O)CO BMRWNKZVCUKKSR-UHFFFAOYSA-N 0.000 description 1
- 235000019437 butane-1,3-diol Nutrition 0.000 description 1
- ZWDXPDXYAGHZJM-UHFFFAOYSA-N butyl 2-methoxy-3-phenylprop-2-enoate Chemical compound CCCCOC(=O)C(OC)=CC1=CC=CC=C1 ZWDXPDXYAGHZJM-UHFFFAOYSA-N 0.000 description 1
- 239000004204 candelilla wax Substances 0.000 description 1
- 235000013868 candelilla wax Nutrition 0.000 description 1
- 229940073532 candelilla wax Drugs 0.000 description 1
- 239000004202 carbamide Substances 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 239000001768 carboxy methyl cellulose Substances 0.000 description 1
- 125000002057 carboxymethyl group Chemical group [H]OC(=O)C([H])([H])[*] 0.000 description 1
- 239000004203 carnauba wax Substances 0.000 description 1
- 235000013869 carnauba wax Nutrition 0.000 description 1
- 235000021466 carotenoid Nutrition 0.000 description 1
- 150000001747 carotenoids Chemical class 0.000 description 1
- 235000010418 carrageenan Nutrition 0.000 description 1
- 239000000679 carrageenan Substances 0.000 description 1
- 229920001525 carrageenan Polymers 0.000 description 1
- 229940113118 carrageenan Drugs 0.000 description 1
- 239000005018 casein Substances 0.000 description 1
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 description 1
- 235000021240 caseins Nutrition 0.000 description 1
- 239000003093 cationic surfactant Substances 0.000 description 1
- 150000001768 cations Chemical class 0.000 description 1
- ZVEQCJWYRWKARO-UHFFFAOYSA-N ceramide Natural products CCCCCCCCCCCCCCC(O)C(=O)NC(CO)C(O)C=CCCC=C(C)CCCCCCCCC ZVEQCJWYRWKARO-UHFFFAOYSA-N 0.000 description 1
- 229940048864 ceramide 1 Drugs 0.000 description 1
- 229940099417 ceramide 2 Drugs 0.000 description 1
- 229940044176 ceramide 3 Drugs 0.000 description 1
- 229940095137 ceramide 6 ii Drugs 0.000 description 1
- 150000001783 ceramides Chemical class 0.000 description 1
- 229960000541 cetyl alcohol Drugs 0.000 description 1
- 239000002738 chelating agent Substances 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 229940073724 cholesteryl isostearate Drugs 0.000 description 1
- 229940006423 chondroitin sulfate sodium Drugs 0.000 description 1
- 239000004927 clay Substances 0.000 description 1
- 235000019868 cocoa butter Nutrition 0.000 description 1
- 229940110456 cocoa butter Drugs 0.000 description 1
- 235000017471 coenzyme Q10 Nutrition 0.000 description 1
- ACTIUHUUMQJHFO-UPTCCGCDSA-N coenzyme Q10 Chemical compound COC1=C(OC)C(=O)C(C\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CCC=C(C)C)=C(C)C1=O ACTIUHUUMQJHFO-UPTCCGCDSA-N 0.000 description 1
- 229920001436 collagen Polymers 0.000 description 1
- 239000013065 commercial product Substances 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 239000002285 corn oil Substances 0.000 description 1
- 235000012343 cottonseed oil Nutrition 0.000 description 1
- 239000002385 cottonseed oil Substances 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 125000004122 cyclic group Chemical group 0.000 description 1
- BOUIEBMBWBCUPB-UHFFFAOYSA-N decyl tetradecanoate Chemical compound CCCCCCCCCCCCCC(=O)OCCCCCCCCCC BOUIEBMBWBCUPB-UHFFFAOYSA-N 0.000 description 1
- 238000004925 denaturation Methods 0.000 description 1
- 230000036425 denaturation Effects 0.000 description 1
- 230000006866 deterioration Effects 0.000 description 1
- PZXJOHSZQAEJFE-UHFFFAOYSA-N dihydrobetulinic acid Natural products C1CC(O)C(C)(C)C2CCC3(C)C4(C)CCC5(C(O)=O)CCC(C(C)C)C5C4CCC3C21C PZXJOHSZQAEJFE-UHFFFAOYSA-N 0.000 description 1
- 235000013870 dimethyl polysiloxane Nutrition 0.000 description 1
- REZZEXDLIUJMMS-UHFFFAOYSA-M dimethyldioctadecylammonium chloride Chemical compound [Cl-].CCCCCCCCCCCCCCCCCC[N+](C)(C)CCCCCCCCCCCCCCCCCC REZZEXDLIUJMMS-UHFFFAOYSA-M 0.000 description 1
- MIMDHDXOBDPUQW-UHFFFAOYSA-N dioctyl decanedioate Chemical compound CCCCCCCCOC(=O)CCCCCCCCC(=O)OCCCCCCCC MIMDHDXOBDPUQW-UHFFFAOYSA-N 0.000 description 1
- HNPSIPDUKPIQMN-UHFFFAOYSA-N dioxosilane;oxo(oxoalumanyloxy)alumane Chemical compound O=[Si]=O.O=[Al]O[Al]=O HNPSIPDUKPIQMN-UHFFFAOYSA-N 0.000 description 1
- 229940101029 dipotassium glycyrrhizinate Drugs 0.000 description 1
- SZXQTJUDPRGNJN-UHFFFAOYSA-N dipropylene glycol Chemical compound OCCCOCCCO SZXQTJUDPRGNJN-UHFFFAOYSA-N 0.000 description 1
- PMMYEEVYMWASQN-UHFFFAOYSA-N dl-hydroxyproline Natural products OC1C[NH2+]C(C([O-])=O)C1 PMMYEEVYMWASQN-UHFFFAOYSA-N 0.000 description 1
- 229960000735 docosanol Drugs 0.000 description 1
- FBZANXDWQAVSTQ-UHFFFAOYSA-N dodecamethylpentasiloxane Chemical compound C[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)C FBZANXDWQAVSTQ-UHFFFAOYSA-N 0.000 description 1
- 229940087203 dodecamethylpentasiloxane Drugs 0.000 description 1
- 125000003438 dodecyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 230000037336 dry skin Effects 0.000 description 1
- 235000006694 eating habits Nutrition 0.000 description 1
- 229960001484 edetic acid Drugs 0.000 description 1
- 235000013345 egg yolk Nutrition 0.000 description 1
- 210000002969 egg yolk Anatomy 0.000 description 1
- 230000001804 emulsifying effect Effects 0.000 description 1
- 229960003720 enoxolone Drugs 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 229960002061 ergocalciferol Drugs 0.000 description 1
- IVTMALDHFAHOGL-UHFFFAOYSA-N eriodictyol 7-O-rutinoside Natural products OC1C(O)C(O)C(C)OC1OCC1C(O)C(O)C(O)C(OC=2C=C3C(C(C(O)=C(O3)C=3C=C(O)C(O)=CC=3)=O)=C(O)C=2)O1 IVTMALDHFAHOGL-UHFFFAOYSA-N 0.000 description 1
- UNXHWFMMPAWVPI-ZXZARUISSA-N erythritol Chemical compound OC[C@H](O)[C@H](O)CO UNXHWFMMPAWVPI-ZXZARUISSA-N 0.000 description 1
- 229940009714 erythritol Drugs 0.000 description 1
- 235000019414 erythritol Nutrition 0.000 description 1
- UQPHVQVXLPRNCX-UHFFFAOYSA-N erythrulose Chemical compound OCC(O)C(=O)CO UQPHVQVXLPRNCX-UHFFFAOYSA-N 0.000 description 1
- 235000019325 ethyl cellulose Nutrition 0.000 description 1
- 229920001249 ethyl cellulose Polymers 0.000 description 1
- 229940035423 ethyl ether Drugs 0.000 description 1
- 229960001617 ethyl hydroxybenzoate Drugs 0.000 description 1
- 235000010228 ethyl p-hydroxybenzoate Nutrition 0.000 description 1
- 239000004403 ethyl p-hydroxybenzoate Substances 0.000 description 1
- NUVBSKCKDOMJSU-UHFFFAOYSA-N ethylparaben Chemical compound CCOC(=O)C1=CC=C(O)C=C1 NUVBSKCKDOMJSU-UHFFFAOYSA-N 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 238000004108 freeze drying Methods 0.000 description 1
- FTSSQIKWUOOEGC-RULYVFMPSA-N fructooligosaccharide Chemical compound OC[C@H]1O[C@@](CO)(OC[C@@]2(OC[C@@]3(OC[C@@]4(OC[C@@]5(OC[C@@]6(OC[C@@]7(OC[C@@]8(OC[C@@]9(OC[C@@]%10(OC[C@@]%11(O[C@H]%12O[C@H](CO)[C@@H](O)[C@H](O)[C@H]%12O)O[C@H](CO)[C@@H](O)[C@@H]%11O)O[C@H](CO)[C@@H](O)[C@@H]%10O)O[C@H](CO)[C@@H](O)[C@@H]9O)O[C@H](CO)[C@@H](O)[C@@H]8O)O[C@H](CO)[C@@H](O)[C@@H]7O)O[C@H](CO)[C@@H](O)[C@@H]6O)O[C@H](CO)[C@@H](O)[C@@H]5O)O[C@H](CO)[C@@H](O)[C@@H]4O)O[C@H](CO)[C@@H](O)[C@@H]3O)O[C@H](CO)[C@@H](O)[C@@H]2O)[C@@H](O)[C@@H]1O FTSSQIKWUOOEGC-RULYVFMPSA-N 0.000 description 1
- 229940107187 fructooligosaccharide Drugs 0.000 description 1
- FBPFZTCFMRRESA-GUCUJZIJSA-N galactitol Chemical compound OC[C@H](O)[C@@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-GUCUJZIJSA-N 0.000 description 1
- 235000021255 galacto-oligosaccharides Nutrition 0.000 description 1
- 150000003271 galactooligosaccharides Chemical class 0.000 description 1
- 229930182830 galactose Natural products 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 235000010492 gellan gum Nutrition 0.000 description 1
- 239000000216 gellan gum Substances 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 229940108690 glucosyl hesperidin Drugs 0.000 description 1
- 229960002989 glutamic acid Drugs 0.000 description 1
- 235000013922 glutamic acid Nutrition 0.000 description 1
- 239000004220 glutamic acid Substances 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- 150000002339 glycosphingolipids Chemical class 0.000 description 1
- 235000010417 guar gum Nutrition 0.000 description 1
- 239000000665 guar gum Substances 0.000 description 1
- 229960002154 guar gum Drugs 0.000 description 1
- 229920000591 gum Polymers 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- IUJAMGNYPWYUPM-UHFFFAOYSA-N hentriacontane Chemical compound CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC IUJAMGNYPWYUPM-UHFFFAOYSA-N 0.000 description 1
- NFVSFLUJRHRSJG-UHFFFAOYSA-N hexadecamethylheptasiloxane Chemical compound C[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)C NFVSFLUJRHRSJG-UHFFFAOYSA-N 0.000 description 1
- IPCSVZSSVZVIGE-UHFFFAOYSA-M hexadecanoate Chemical compound CCCCCCCCCCCCCCCC([O-])=O IPCSVZSSVZVIGE-UHFFFAOYSA-M 0.000 description 1
- FPMPNVIMFPEKRN-UHFFFAOYSA-N hexyl 16-methylheptadecanoate Chemical compound CCCCCCOC(=O)CCCCCCCCCCCCCCC(C)C FPMPNVIMFPEKRN-UHFFFAOYSA-N 0.000 description 1
- 229940100463 hexyl laurate Drugs 0.000 description 1
- 229940051250 hexylene glycol Drugs 0.000 description 1
- 235000019447 hydroxyethyl cellulose Nutrition 0.000 description 1
- 229960002591 hydroxyproline Drugs 0.000 description 1
- 235000010977 hydroxypropyl cellulose Nutrition 0.000 description 1
- 239000001863 hydroxypropyl cellulose Substances 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 229940035429 isobutyl alcohol Drugs 0.000 description 1
- 229940078568 isocetyl myristate Drugs 0.000 description 1
- 229940078545 isocetyl stearate Drugs 0.000 description 1
- NNQSGBRGJHSRFN-UHFFFAOYSA-N isoflavan Chemical class C1OC2=CC=CC=C2CC1C1=CC=CC=C1 NNQSGBRGJHSRFN-UHFFFAOYSA-N 0.000 description 1
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 1
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- 229940093629 isopropyl isostearate Drugs 0.000 description 1
- 229940060384 isostearyl isostearate Drugs 0.000 description 1
- 229940113915 isostearyl palmitate Drugs 0.000 description 1
- 229940119170 jojoba wax Drugs 0.000 description 1
- NLYAJNPCOHFWQQ-UHFFFAOYSA-N kaolin Chemical compound O.O.O=[Al]O[Si](=O)O[Si](=O)O[Al]=O NLYAJNPCOHFWQQ-UHFFFAOYSA-N 0.000 description 1
- BJHIKXHVCXFQLS-PQLUHFTBSA-N keto-D-tagatose Chemical compound OC[C@@H](O)[C@H](O)[C@H](O)C(=O)CO BJHIKXHVCXFQLS-PQLUHFTBSA-N 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 229960004488 linolenic acid Drugs 0.000 description 1
- KQQKGWQCNNTQJW-UHFFFAOYSA-N linolenic acid Natural products CC=CCCC=CCC=CCCCCCCCC(O)=O KQQKGWQCNNTQJW-UHFFFAOYSA-N 0.000 description 1
- JXNPEDYJTDQORS-UHFFFAOYSA-N linoleyl alcohol Natural products CCCCCC=CCC=CCCCCCCCCO JXNPEDYJTDQORS-UHFFFAOYSA-N 0.000 description 1
- 235000021388 linseed oil Nutrition 0.000 description 1
- 239000000944 linseed oil Substances 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 229940057995 liquid paraffin Drugs 0.000 description 1
- 241000238565 lobster Species 0.000 description 1
- 235000010420 locust bean gum Nutrition 0.000 description 1
- 239000000711 locust bean gum Substances 0.000 description 1
- 230000005923 long-lasting effect Effects 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 235000012661 lycopene Nutrition 0.000 description 1
- 229960004999 lycopene Drugs 0.000 description 1
- 239000001751 lycopene Substances 0.000 description 1
- OAIJSZIZWZSQBC-GYZMGTAESA-N lycopene Chemical compound CC(C)=CCC\C(C)=C\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C=C(/C)CCC=C(C)C OAIJSZIZWZSQBC-GYZMGTAESA-N 0.000 description 1
- 229920002521 macromolecule Polymers 0.000 description 1
- 229940074358 magnesium ascorbate Drugs 0.000 description 1
- AIOKQVJVNPDJKA-ZZMNMWMASA-L magnesium;(2r)-2-[(1s)-1,2-dihydroxyethyl]-4-hydroxy-5-oxo-2h-furan-3-olate Chemical compound [Mg+2].OC[C@H](O)[C@H]1OC(=O)C(O)=C1[O-].OC[C@H](O)[C@H]1OC(=O)C(O)=C1[O-] AIOKQVJVNPDJKA-ZZMNMWMASA-L 0.000 description 1
- 150000003272 mannan oligosaccharides Chemical class 0.000 description 1
- 239000000594 mannitol Substances 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- FYGDTMLNYKFZSV-UHFFFAOYSA-N mannotriose Natural products OC1C(O)C(O)C(CO)OC1OC1C(CO)OC(OC2C(OC(O)C(O)C2O)CO)C(O)C1O FYGDTMLNYKFZSV-UHFFFAOYSA-N 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- QWIZNVHXZXRPDR-WSCXOGSTSA-N melezitose Chemical compound O([C@@]1(O[C@@H]([C@H]([C@@H]1O[C@@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)O)CO)CO)[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O QWIZNVHXZXRPDR-WSCXOGSTSA-N 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- 230000008018 melting Effects 0.000 description 1
- 230000003340 mental effect Effects 0.000 description 1
- 229940041616 menthol Drugs 0.000 description 1
- 125000005641 methacryl group Chemical group 0.000 description 1
- 229920000609 methyl cellulose Polymers 0.000 description 1
- 235000010270 methyl p-hydroxybenzoate Nutrition 0.000 description 1
- 239000004292 methyl p-hydroxybenzoate Substances 0.000 description 1
- 239000001923 methylcellulose Substances 0.000 description 1
- 229960002216 methylparaben Drugs 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 235000010446 mineral oil Nutrition 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- RZRNAYUHWVFMIP-UHFFFAOYSA-N monoelaidin Natural products CCCCCCCCC=CCCCCCCCC(=O)OCC(O)CO RZRNAYUHWVFMIP-UHFFFAOYSA-N 0.000 description 1
- 239000000178 monomer Substances 0.000 description 1
- 239000012170 montan wax Substances 0.000 description 1
- 229940105132 myristate Drugs 0.000 description 1
- JXTPJDDICSTXJX-UHFFFAOYSA-N n-Triacontane Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC JXTPJDDICSTXJX-UHFFFAOYSA-N 0.000 description 1
- GOQYKNQRPGWPLP-UHFFFAOYSA-N n-heptadecyl alcohol Natural products CCCCCCCCCCCCCCCCCO GOQYKNQRPGWPLP-UHFFFAOYSA-N 0.000 description 1
- MQYXUWHLBZFQQO-UHFFFAOYSA-N nepehinol Natural products C1CC(O)C(C)(C)C2CCC3(C)C4(C)CCC5(C)CCC(C(=C)C)C5C4CCC3C21C MQYXUWHLBZFQQO-UHFFFAOYSA-N 0.000 description 1
- 230000003472 neutralizing effect Effects 0.000 description 1
- VVGIYYKRAMHVLU-UHFFFAOYSA-N newbouldiamide Natural products CCCCCCCCCCCCCCCCCCCC(O)C(O)C(O)C(CO)NC(=O)CCCCCCCCCCCCCCCCC VVGIYYKRAMHVLU-UHFFFAOYSA-N 0.000 description 1
- 235000005152 nicotinamide Nutrition 0.000 description 1
- 239000011570 nicotinamide Substances 0.000 description 1
- 229920001778 nylon Polymers 0.000 description 1
- 239000007764 o/w emulsion Substances 0.000 description 1
- UZIBPBFWHMZFKP-UHFFFAOYSA-N octadecanoic acid propane-1,2,3-triol Chemical compound OCC(O)CO.OCC(O)CO.OCC(O)CO.OCC(O)CO.OCC(O)CO.CCCCCCCCCCCCCCCCCC(O)=O.CCCCCCCCCCCCCCCCCC(O)=O.CCCCCCCCCCCCCCCCCC(O)=O.CCCCCCCCCCCCCCCCCC(O)=O.CCCCCCCCCCCCCCCCCC(O)=O.CCCCCCCCCCCCCCCCCC(O)=O UZIBPBFWHMZFKP-UHFFFAOYSA-N 0.000 description 1
- HMMGMWAXVFQUOA-UHFFFAOYSA-N octamethylcyclotetrasiloxane Chemical compound C[Si]1(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O1 HMMGMWAXVFQUOA-UHFFFAOYSA-N 0.000 description 1
- 229960003921 octisalate Drugs 0.000 description 1
- WCJLCOAEJIHPCW-UHFFFAOYSA-N octyl 2-hydroxybenzoate Chemical compound CCCCCCCCOC(=O)C1=CC=CC=C1O WCJLCOAEJIHPCW-UHFFFAOYSA-N 0.000 description 1
- SFBIZPBTKROSDE-UHFFFAOYSA-N octyl 2-hydroxypropanoate Chemical compound CCCCCCCCOC(=O)C(C)O SFBIZPBTKROSDE-UHFFFAOYSA-N 0.000 description 1
- 125000002347 octyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- IIGMITQLXAGZTL-UHFFFAOYSA-N octyl octadecanoate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCCCCCCCC IIGMITQLXAGZTL-UHFFFAOYSA-N 0.000 description 1
- 229940073665 octyldodecyl myristate Drugs 0.000 description 1
- 229940071203 oleanolate Drugs 0.000 description 1
- 229940100243 oleanolic acid Drugs 0.000 description 1
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 1
- 235000021313 oleic acid Nutrition 0.000 description 1
- ALSTYHKOOCGGFT-MDZDMXLPSA-N oleyl alcohol Chemical compound CCCCCCCC\C=C\CCCCCCCCO ALSTYHKOOCGGFT-MDZDMXLPSA-N 0.000 description 1
- 229940055577 oleyl alcohol Drugs 0.000 description 1
- XMLQWXUVTXCDDL-UHFFFAOYSA-N oleyl alcohol Natural products CCCCCCC=CCCCCCCCCCCO XMLQWXUVTXCDDL-UHFFFAOYSA-N 0.000 description 1
- 235000008390 olive oil Nutrition 0.000 description 1
- 239000004006 olive oil Substances 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- BJRNKVDFDLYUGJ-UHFFFAOYSA-N p-hydroxyphenyl beta-D-alloside Natural products OC1C(O)C(O)C(CO)OC1OC1=CC=C(O)C=C1 BJRNKVDFDLYUGJ-UHFFFAOYSA-N 0.000 description 1
- 239000003346 palm kernel oil Substances 0.000 description 1
- 235000019865 palm kernel oil Nutrition 0.000 description 1
- 229940055726 pantothenic acid Drugs 0.000 description 1
- 235000019161 pantothenic acid Nutrition 0.000 description 1
- 239000011713 pantothenic acid Substances 0.000 description 1
- 235000019809 paraffin wax Nutrition 0.000 description 1
- 239000000312 peanut oil Substances 0.000 description 1
- WCVRQHFDJLLWFE-UHFFFAOYSA-N pentane-1,2-diol Chemical compound CCCC(O)CO WCVRQHFDJLLWFE-UHFFFAOYSA-N 0.000 description 1
- 229940066842 petrolatum Drugs 0.000 description 1
- 229960005323 phenoxyethanol Drugs 0.000 description 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 1
- AERBNCYCJBRYDG-KSZLIROESA-N phytosphingosine Chemical compound CCCCCCCCCCCCCC[C@@H](O)[C@@H](O)[C@@H](N)CO AERBNCYCJBRYDG-KSZLIROESA-N 0.000 description 1
- 229940033329 phytosphingosine Drugs 0.000 description 1
- 229940075999 phytosterol ester Drugs 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 230000003169 placental effect Effects 0.000 description 1
- 239000000419 plant extract Substances 0.000 description 1
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 description 1
- 229920003229 poly(methyl methacrylate) Polymers 0.000 description 1
- 229920001495 poly(sodium acrylate) polymer Polymers 0.000 description 1
- 229920002432 poly(vinyl methyl ether) polymer Polymers 0.000 description 1
- 229920001083 polybutene Polymers 0.000 description 1
- 229920000120 polyethyl acrylate Polymers 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 239000004926 polymethyl methacrylate Substances 0.000 description 1
- 229920000166 polytrimethylene carbonate Polymers 0.000 description 1
- 229920002689 polyvinyl acetate Polymers 0.000 description 1
- 239000011118 polyvinyl acetate Substances 0.000 description 1
- 229920002451 polyvinyl alcohol Polymers 0.000 description 1
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 1
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 1
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 1
- 235000015277 pork Nutrition 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 235000011118 potassium hydroxide Nutrition 0.000 description 1
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 1
- XATKDVHSLQMHSY-RMKNXTFCSA-N propan-2-yl (e)-3-(4-methoxyphenyl)prop-2-enoate Chemical compound COC1=CC=C(\C=C\C(=O)OC(C)C)C=C1 XATKDVHSLQMHSY-RMKNXTFCSA-N 0.000 description 1
- NEOZOXKVMDBOSG-UHFFFAOYSA-N propan-2-yl 16-methylheptadecanoate Chemical compound CC(C)CCCCCCCCCCCCCCC(=O)OC(C)C NEOZOXKVMDBOSG-UHFFFAOYSA-N 0.000 description 1
- 235000010409 propane-1,2-diol alginate Nutrition 0.000 description 1
- 239000000770 propane-1,2-diol alginate Substances 0.000 description 1
- 235000010232 propyl p-hydroxybenzoate Nutrition 0.000 description 1
- 239000004405 propyl p-hydroxybenzoate Substances 0.000 description 1
- 229960003415 propylparaben Drugs 0.000 description 1
- HZLWUYJLOIAQFC-UHFFFAOYSA-N prosapogenin PS-A Natural products C12CC(C)(C)CCC2(C(O)=O)CCC(C2(CCC3C4(C)C)C)(C)C1=CCC2C3(C)CCC4OC1OCC(O)C(O)C1O HZLWUYJLOIAQFC-UHFFFAOYSA-N 0.000 description 1
- 235000019423 pullulan Nutrition 0.000 description 1
- 229940095042 pyridoxine dipalmitate Drugs 0.000 description 1
- ZUFQODAHGAHPFQ-UHFFFAOYSA-N pyridoxine hydrochloride Chemical compound Cl.CC1=NC=C(CO)C(CO)=C1O ZUFQODAHGAHPFQ-UHFFFAOYSA-N 0.000 description 1
- 229960004172 pyridoxine hydrochloride Drugs 0.000 description 1
- 235000019171 pyridoxine hydrochloride Nutrition 0.000 description 1
- 239000011764 pyridoxine hydrochloride Substances 0.000 description 1
- DQAKJEWZWDQURW-UHFFFAOYSA-N pyrrolidonecarboxylic acid Chemical class OC(=O)N1CCCC1=O DQAKJEWZWDQURW-UHFFFAOYSA-N 0.000 description 1
- FDRQPMVGJOQVTL-UHFFFAOYSA-N quercetin rutinoside Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 FDRQPMVGJOQVTL-UHFFFAOYSA-N 0.000 description 1
- MUPFEKGTMRGPLJ-ZQSKZDJDSA-N raffinose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO[C@@H]2[C@@H]([C@@H](O)[C@@H](O)[C@@H](CO)O2)O)O1 MUPFEKGTMRGPLJ-ZQSKZDJDSA-N 0.000 description 1
- 229960003471 retinol Drugs 0.000 description 1
- 235000020944 retinol Nutrition 0.000 description 1
- 239000011607 retinol Substances 0.000 description 1
- 229960000342 retinol acetate Drugs 0.000 description 1
- 150000004609 retinol derivatives Chemical class 0.000 description 1
- QGNJRVVDBSJHIZ-QHLGVNSISA-N retinyl acetate Chemical compound CC(=O)OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C QGNJRVVDBSJHIZ-QHLGVNSISA-N 0.000 description 1
- 235000019173 retinyl acetate Nutrition 0.000 description 1
- 239000011770 retinyl acetate Substances 0.000 description 1
- 229940108325 retinyl palmitate Drugs 0.000 description 1
- 235000019172 retinyl palmitate Nutrition 0.000 description 1
- 239000011769 retinyl palmitate Substances 0.000 description 1
- 239000008165 rice bran oil Substances 0.000 description 1
- WBHHMMIMDMUBKC-QJWNTBNXSA-M ricinoleate Chemical compound CCCCCC[C@@H](O)C\C=C/CCCCCCCC([O-])=O WBHHMMIMDMUBKC-QJWNTBNXSA-M 0.000 description 1
- 229940109850 royal jelly Drugs 0.000 description 1
- ALABRVAAKCSLSC-UHFFFAOYSA-N rutin Natural products CC1OC(OCC2OC(O)C(O)C(O)C2O)C(O)C(O)C1OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5 ALABRVAAKCSLSC-UHFFFAOYSA-N 0.000 description 1
- 235000005493 rutin Nutrition 0.000 description 1
- 229960004555 rutoside Drugs 0.000 description 1
- 235000005713 safflower oil Nutrition 0.000 description 1
- 239000003813 safflower oil Substances 0.000 description 1
- 230000001953 sensory effect Effects 0.000 description 1
- 239000012176 shellac wax Substances 0.000 description 1
- 239000004332 silver Substances 0.000 description 1
- 229910052709 silver Inorganic materials 0.000 description 1
- 235000010413 sodium alginate Nutrition 0.000 description 1
- 239000000661 sodium alginate Substances 0.000 description 1
- 229940005550 sodium alginate Drugs 0.000 description 1
- WXMKPNITSTVMEF-UHFFFAOYSA-M sodium benzoate Chemical compound [Na+].[O-]C(=O)C1=CC=CC=C1 WXMKPNITSTVMEF-UHFFFAOYSA-M 0.000 description 1
- 235000010234 sodium benzoate Nutrition 0.000 description 1
- 239000004299 sodium benzoate Substances 0.000 description 1
- 229960003885 sodium benzoate Drugs 0.000 description 1
- 235000019812 sodium carboxymethyl cellulose Nutrition 0.000 description 1
- 229920001027 sodium carboxymethylcellulose Polymers 0.000 description 1
- 235000019259 sodium dehydroacetate Nutrition 0.000 description 1
- 229940079839 sodium dehydroacetate Drugs 0.000 description 1
- HRZFUMHJMZEROT-UHFFFAOYSA-L sodium disulfite Chemical compound [Na+].[Na+].[O-]S(=O)S([O-])(=O)=O HRZFUMHJMZEROT-UHFFFAOYSA-L 0.000 description 1
- 229940010747 sodium hyaluronate Drugs 0.000 description 1
- 235000011121 sodium hydroxide Nutrition 0.000 description 1
- 235000010262 sodium metabisulphite Nutrition 0.000 description 1
- NNMHYFLPFNGQFZ-UHFFFAOYSA-M sodium polyacrylate Chemical compound [Na+].[O-]C(=O)C=C NNMHYFLPFNGQFZ-UHFFFAOYSA-M 0.000 description 1
- 229940045920 sodium pyrrolidone carboxylate Drugs 0.000 description 1
- DSOWAKKSGYUMTF-GZOLSCHFSA-M sodium;(1e)-1-(6-methyl-2,4-dioxopyran-3-ylidene)ethanolate Chemical compound [Na+].C\C([O-])=C1/C(=O)OC(C)=CC1=O DSOWAKKSGYUMTF-GZOLSCHFSA-M 0.000 description 1
- YWIVKILSMZOHHF-QJZPQSOGSA-N sodium;(2s,3s,4s,5r,6r)-6-[(2s,3r,4r,5s,6r)-3-acetamido-2-[(2s,3s,4r,5r,6r)-6-[(2r,3r,4r,5s,6r)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2- Chemical compound [Na+].CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 YWIVKILSMZOHHF-QJZPQSOGSA-N 0.000 description 1
- HYRLWUFWDYFEES-UHFFFAOYSA-M sodium;2-oxopyrrolidine-1-carboxylate Chemical compound [Na+].[O-]C(=O)N1CCCC1=O HYRLWUFWDYFEES-UHFFFAOYSA-M 0.000 description 1
- 239000007962 solid dispersion Substances 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 235000011069 sorbitan monooleate Nutrition 0.000 description 1
- 239000001593 sorbitan monooleate Substances 0.000 description 1
- 229940035049 sorbitan monooleate Drugs 0.000 description 1
- 229950011392 sorbitan stearate Drugs 0.000 description 1
- 235000012424 soybean oil Nutrition 0.000 description 1
- 239000003549 soybean oil Substances 0.000 description 1
- WWUZIQQURGPMPG-KRWOKUGFSA-N sphingosine Chemical compound CCCCCCCCCCCCC\C=C\[C@@H](O)[C@@H](N)CO WWUZIQQURGPMPG-KRWOKUGFSA-N 0.000 description 1
- 238000001694 spray drying Methods 0.000 description 1
- 229940032094 squalane Drugs 0.000 description 1
- 230000006641 stabilisation Effects 0.000 description 1
- 238000011105 stabilization Methods 0.000 description 1
- 230000000087 stabilizing effect Effects 0.000 description 1
- UQZIYBXSHAGNOE-XNSRJBNMSA-N stachyose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO[C@@H]2[C@@H]([C@@H](O)[C@@H](O)[C@@H](CO[C@@H]3[C@@H]([C@@H](O)[C@@H](O)[C@@H](CO)O3)O)O2)O)O1 UQZIYBXSHAGNOE-XNSRJBNMSA-N 0.000 description 1
- 229920003179 starch-based polymer Polymers 0.000 description 1
- 239000004628 starch-based polymer Substances 0.000 description 1
- 229960004274 stearic acid Drugs 0.000 description 1
- 229940012831 stearyl alcohol Drugs 0.000 description 1
- OGBUMNBNEWYMNJ-UHFFFAOYSA-N stearyl monoglyceride Natural products CCCCCCCCCCCCCCCCCCOCC(O)CO OGBUMNBNEWYMNJ-UHFFFAOYSA-N 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 230000035882 stress Effects 0.000 description 1
- 239000000454 talc Substances 0.000 description 1
- 229910052623 talc Inorganic materials 0.000 description 1
- 239000011975 tartaric acid Substances 0.000 description 1
- 235000002906 tartaric acid Nutrition 0.000 description 1
- 230000002123 temporal effect Effects 0.000 description 1
- GSANOGQCVHBHIF-UHFFFAOYSA-N tetradecamethylcycloheptasiloxane Chemical compound C[Si]1(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O1 GSANOGQCVHBHIF-UHFFFAOYSA-N 0.000 description 1
- 229940008424 tetradecamethylhexasiloxane Drugs 0.000 description 1
- TUNFSRHWOTWDNC-HKGQFRNVSA-N tetradecanoic acid Chemical compound CCCCCCCCCCCCC[14C](O)=O TUNFSRHWOTWDNC-HKGQFRNVSA-N 0.000 description 1
- HBPNTDBLHQHPLH-UHFFFAOYSA-N tetradecyl 16-methylheptadecanoate Chemical compound CCCCCCCCCCCCCCOC(=O)CCCCCCCCCCCCCCC(C)C HBPNTDBLHQHPLH-UHFFFAOYSA-N 0.000 description 1
- 239000010936 titanium Substances 0.000 description 1
- 229910052719 titanium Inorganic materials 0.000 description 1
- OGIDPMRJRNCKJF-UHFFFAOYSA-N titanium oxide Inorganic materials [Ti]=O OGIDPMRJRNCKJF-UHFFFAOYSA-N 0.000 description 1
- 229940042585 tocopherol acetate Drugs 0.000 description 1
- 150000003611 tocopherol derivatives Chemical class 0.000 description 1
- 125000003944 tolyl group Chemical group 0.000 description 1
- FGMPLJWBKKVCDB-UHFFFAOYSA-N trans-L-hydroxy-proline Natural products ON1CCCC1C(O)=O FGMPLJWBKKVCDB-UHFFFAOYSA-N 0.000 description 1
- ZCIHMQAPACOQHT-ZGMPDRQDSA-N trans-isorenieratene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/c1c(C)ccc(C)c1C)C=CC=C(/C)C=Cc2c(C)ccc(C)c2C ZCIHMQAPACOQHT-ZGMPDRQDSA-N 0.000 description 1
- ODLHGICHYURWBS-LKONHMLTSA-N trappsol cyclo Chemical compound CC(O)COC[C@H]([C@H]([C@@H]([C@H]1O)O)O[C@H]2O[C@@H]([C@@H](O[C@H]3O[C@H](COCC(C)O)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](COCC(C)O)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](COCC(C)O)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](COCC(C)O)[C@H]([C@@H]([C@H]3O)O)O3)[C@H](O)[C@H]2O)COCC(O)C)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@@H]3O[C@@H]1COCC(C)O ODLHGICHYURWBS-LKONHMLTSA-N 0.000 description 1
- 229940118594 trimethylolpropane triisostearate Drugs 0.000 description 1
- RULSWEULPANCDV-PIXUTMIVSA-N turanose Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](C(=O)CO)O[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O RULSWEULPANCDV-PIXUTMIVSA-N 0.000 description 1
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 1
- 239000006097 ultraviolet radiation absorber Substances 0.000 description 1
- 229940045136 urea Drugs 0.000 description 1
- 229940096998 ursolic acid Drugs 0.000 description 1
- PLSAJKYPRJGMHO-UHFFFAOYSA-N ursolic acid Natural products CC1CCC2(CCC3(C)C(C=CC4C5(C)CCC(O)C(C)(C)C5CCC34C)C2C1C)C(=O)O PLSAJKYPRJGMHO-UHFFFAOYSA-N 0.000 description 1
- 239000004474 valine Substances 0.000 description 1
- 229920002554 vinyl polymer Polymers 0.000 description 1
- 235000019156 vitamin B Nutrition 0.000 description 1
- 239000011720 vitamin B Substances 0.000 description 1
- 235000019166 vitamin D Nutrition 0.000 description 1
- 239000011710 vitamin D Substances 0.000 description 1
- 150000003710 vitamin D derivatives Chemical class 0.000 description 1
- 235000001892 vitamin D2 Nutrition 0.000 description 1
- 239000011653 vitamin D2 Substances 0.000 description 1
- MECHNRXZTMCUDQ-RKHKHRCZSA-N vitamin D2 Chemical compound C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)/C=C/[C@H](C)C(C)C)=C\C=C1\C[C@@H](O)CCC1=C MECHNRXZTMCUDQ-RKHKHRCZSA-N 0.000 description 1
- 235000005282 vitamin D3 Nutrition 0.000 description 1
- 239000011647 vitamin D3 Substances 0.000 description 1
- QYSXJUFSXHHAJI-YRZJJWOYSA-N vitamin D3 Chemical compound C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C\C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-YRZJJWOYSA-N 0.000 description 1
- 229940046008 vitamin d Drugs 0.000 description 1
- 229940021056 vitamin d3 Drugs 0.000 description 1
- 239000003021 water soluble solvent Substances 0.000 description 1
- 239000010497 wheat germ oil Substances 0.000 description 1
- 229920001285 xanthan gum Polymers 0.000 description 1
- 235000010493 xanthan gum Nutrition 0.000 description 1
- 239000000230 xanthan gum Substances 0.000 description 1
- 229940082509 xanthan gum Drugs 0.000 description 1
- 239000010457 zeolite Substances 0.000 description 1
- 239000011787 zinc oxide Substances 0.000 description 1
- UHVMMEOXYDMDKI-JKYCWFKZSA-L zinc;1-(5-cyanopyridin-2-yl)-3-[(1s,2s)-2-(6-fluoro-2-hydroxy-3-propanoylphenyl)cyclopropyl]urea;diacetate Chemical compound [Zn+2].CC([O-])=O.CC([O-])=O.CCC(=O)C1=CC=C(F)C([C@H]2[C@H](C2)NC(=O)NC=2N=CC(=CC=2)C#N)=C1O UHVMMEOXYDMDKI-JKYCWFKZSA-L 0.000 description 1
- 239000004711 α-olefin Substances 0.000 description 1
- FYGDTMLNYKFZSV-BYLHFPJWSA-N β-1,4-galactotrioside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@H](CO)O[C@@H](O[C@@H]2[C@@H](O[C@@H](O)[C@H](O)[C@H]2O)CO)[C@H](O)[C@H]1O FYGDTMLNYKFZSV-BYLHFPJWSA-N 0.000 description 1
- OENHQHLEOONYIE-JLTXGRSLSA-N β-Carotene Chemical compound CC=1CCCC(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C OENHQHLEOONYIE-JLTXGRSLSA-N 0.000 description 1
Landscapes
- Cosmetics (AREA)
Abstract
Description
本発明は塗布後の潤いが長時間に亘って持続し、かつ、乳化の経時安定性、皮膚安全性、使用感触に優れたクリーム状の油中水型乳化化粧料に関する。 The present invention relates to a creamy water-in-oil emulsified cosmetic that maintains moisture after application for a long time and is excellent in stability over time of emulsification, skin safety, and feel upon use.
近年、気候変動や都市部での環境悪化、食生活の変化や精神的なストレスなどの影響により、乾燥肌の人が多くなってきている。また、女性の就業率も高くなり長時間外で働くことも多くなってきている。こうした背景から、化粧料を塗布した後、潤いが長時間持続する化粧料を使用したいという要望が年々強まってきている。 In recent years, the number of people with dry skin has increased due to the effects of climate change, environmental deterioration in urban areas, changes in dietary habits, and mental stress. In addition, the employment rate of women is increasing, and the number of people working outside for a long time is increasing. Against this background, after applying cosmetics, the desire to use cosmetics that last for a long time is increasing.
水中油型乳化剤型より油中水型乳化剤型の方が閉塞性、保水性とも優れているという結果が報告されており(例えば、非特許文献1参照)、また、潤いの持続感も油中水型乳化剤型の方が優れていることは経験から知られている。 It has been reported that the water-in-oil emulsifier type is superior in both occlusive property and water retention (see, for example, Non-Patent Document 1), and the persistence of moisture is also in the oil. It is known from experience that the water emulsifier type is superior.
このように、優れた潤い感、持続感が期待されるにも関わらず、潤い感に優れた油分である炭化水素油、エステル油、及び植物油などを主たる油分として含む油中水型乳化製剤のクリーム状商品はほとんど上市されていないのが現状である。
その理由として、水中油型乳化製剤に比べ油中水型乳化製剤においては、油中水型乳化粒子の経時安定性を維持することの困難さが挙げられる。特に、シリコーン油や鉱物油などに比較して、化粧料として有用な潤い性に優れた炭化水素油、エステル油、及び植物油などを主たる油分として含む油中水型乳化製剤の経時安定性を保つのは一段と困難であるのが現状である。In this way, the water-in-oil emulsion preparation containing hydrocarbon oil, ester oil, vegetable oil, etc., which are oils having excellent moisturizing feeling as the main oil, despite the expectation of excellent moisturizing feeling and sustainability. At present, almost no creamy products are on the market.
The reason is that it is difficult to maintain the temporal stability of the water-in-oil emulsion particles in the water-in-oil emulsion formulation as compared to the oil-in-water emulsion formulation. In particular, water-in-oil emulsion preparations containing hydrocarbon oils, ester oils, vegetable oils, etc., which are useful as cosmetics and have excellent moisturizing properties as the main oil components, are maintained over time compared to silicone oils and mineral oils. The current situation is much more difficult.
従来、油中水型乳化製剤の経時安定性を保つために、液状の油分に加え、ワックス類などの常温で固形の油分を配合して乳化系の安定化を向上させる方法が行われていたが、高温条件下、具体的にはワックス類の融点近傍以上の温度条件下で保存された場合などには油分の分離が生じる懸念があり、そのような状態となった場合、商品価値を著しく低下させてしまうという問題があった。 Conventionally, in order to maintain the stability over time of water-in-oil emulsion preparations, a method has been used to improve the stabilization of an emulsified system by adding a solid oil component at normal temperature such as waxes in addition to a liquid oil component. However, there is a concern that oil content may be separated when stored under high temperature conditions, specifically, near the melting point of waxes. There was a problem of lowering.
このような従来技術に鑑み、様々な乳化技術の向上が試みられている。例えば、油中水型乳化組成物に対し、アミノ酸と特定の界面活性剤を添加してゲル状とすることで乳化粒子を安定化する技術が提案されている(例えば、非特許文献2参照)、しかしながら、製造工程が複雑であり、且つ、乳化に高剪断力が必要であり、高価な機械装置を特定条件で操作しなければならず、簡易に安定な乳化物を持続的に製造するのは困難であるという欠点がある。
また、有機変性粘土鉱物と特定のHLB値を持つ界面活性剤を添加することで、安定な油中水型乳化製剤を得ることが報告されているが(例えば、非特許文献3参照。)、得られた油中水型乳化製剤の粘度が低いために、乳化化粧料の主たる用途であるクリーム状の製品とするためには、内水相比を高めるか有機変性粘土鉱物の配合量を増やす必要があり、内水相比を高めれば高めるほど水分が失われやすく、潤い感の持続面で欠点があり、有機変性粘土鉱物を増やすほどべたつくなどの欠点がある。また、同様な技術を用いたシリコーン油主体の技術開発(例えば、特許文献1参照。)が行われている、シリコーン油が主体のため潤い感が乏しく、また、得られる油中水型乳化製剤の粘度が低く、さらに、ビーズミルを用いて有機変性粘土鉱物を薄片化しなければならず製造するのに手間がかかるという欠点がある。また、特定の界面活性剤と特定のアミノ酸誘導体およびその塩を使用し、内水相比を高めた技術開発(例えば、特許文献2参照。)が行なわれているが、内相比を高めれば高めるほど水分が失われやすく、潤い感の持続面で欠点がある。また、特定の界面活性剤と特定の油溶性高分子と粉末を高配合した技術開発(例えば、特許文献3参照。)が行なわれているが、高分子特有のべたつき感が生じ、また、粉末による乾燥感が生じるなど目的とする高い潤い感を有するクリーム状商品を得るのは難しいという欠点がある。In view of such conventional techniques, attempts have been made to improve various emulsification techniques. For example, a technique has been proposed for stabilizing emulsified particles by adding an amino acid and a specific surfactant to a water-in-oil emulsion composition to form a gel (for example, see Non-Patent Document 2). However, the production process is complicated, and high shearing force is required for emulsification, and an expensive mechanical device must be operated under specific conditions, and a stable emulsion can be produced easily and continuously. Has the disadvantage of being difficult.
Further, it has been reported that a stable water-in-oil emulsion preparation is obtained by adding an organically modified clay mineral and a surfactant having a specific HLB value (see, for example, Non-Patent Document 3). Since the resulting water-in-oil emulsion formulation has a low viscosity, in order to obtain a cream-like product, which is the main use of emulsified cosmetics, increase the internal water phase ratio or increase the amount of organically modified clay minerals. It is necessary, and the higher the internal water phase ratio, the more easily moisture is lost, and there are drawbacks in terms of sustaining the moist feeling, and there are drawbacks such as stickiness as the amount of organically modified clay mineral increases. In addition, silicone oil-based technology development using the same technology (see, for example, Patent Document 1) is being performed. Silicone oil is the main component, resulting in a lack of moist feeling. In addition, the viscosity of the organically modified clay mineral has to be thinned by using a bead mill, and it takes time and effort to manufacture. In addition, technical development (for example, see Patent Document 2) in which a specific surfactant and a specific amino acid derivative and a salt thereof are used to increase the internal water phase ratio has been performed. The higher it is, the easier it is to lose moisture, and there is a drawback in terms of maintaining a moist feeling. In addition, technical development (for example, see Patent Document 3) in which a specific surfactant, a specific oil-soluble polymer, and a powder are highly blended has been performed. There is a drawback that it is difficult to obtain a cream-like product having a high moisturizing feeling, such as a dry feeling caused by.
以上のような状況に鑑みなされた本発明の目的は、使用時のベタつきがなく、潤い感が良好であり、且つ、潤い感の持続に優れた、経時安定性、皮膚安全性、使用感触が良好な油中水型乳化化粧料を提供することにある。 The object of the present invention made in view of the above situation is that there is no stickiness at the time of use, a moist feeling is good, and the aging stability, skin safety, and feeling of use are excellent. The object is to provide a good water-in-oil emulsified cosmetic.
上記事情を鑑み、本発明者等が鋭意検討を行った結果、有機変性粘土鉱物と特定の界面活性剤とワックス類を組み合わせて使用することで、炭化水素油、エステル油、及び植物油などを主たる油分として用いた場合でも、潤い感の持続に優れ、経時安定性、皮膚安全性、使用感触が良好であり、消費者の安全性志向や肌への効果期待感を満足させ得るクリーム状化粧料に好適な油中水型乳化化粧料が得られることを見出し、本発明を完成した。
すなわち、本発明の構成は、以下に示すとおりである。
<1> (A)有機変性粘土鉱物と、(B)HLB5〜8のエチレンオキサイド付加のエステル系ノニオン界面活性剤と、(C)HLB5未満の常温で固形のノニオン界面活性剤と、(D)HLB5未満の常温で液状のノニオン界面活性剤と、(E)ワックス類と、(F)保湿剤と、(G)前記(E)ワックス類とは異なる油分と、(H)水と、を含有する油中水型乳化化粧料である。
<2> 前記(A)有機変性粘土鉱物が、アルキルアンモニウム変性粘土鉱物である<1>に記載の油中水型乳化化粧料である。
<3> 前記(B)HLB5〜8のエチレンオキサイド付加のエステル系ノニオン界面活性剤が、イソステアリン酸硬化ヒマシ油、トリイソステアリン酸硬化ヒマシ油、ラウリン酸硬化ヒマシ油、トリイソステアリン酸グリセリル、トリステアリン酸グリセリル、及びジイソステアリン酸グリセリルのPOE付加物からなる群より選ばれる1種以上である<1>又は<2>に記載の油中水型乳化化粧料である。
<4> 前記(C)HLB5未満の常温で固形のノニオン界面活性剤が、脂肪酸ソルビタン及び脂肪酸グリセリドからなる群より選ばれる1種以上である<1>〜<3>のいずれか1項に記載の油中水型乳化化粧料である。
<5> 油中水型乳化化粧料における内相の比率が、45質量%〜70質量%であり、且つ、外相の比率が55質量%〜30質量%である<1>〜<4>のいずれか1項に記載の油中水型乳化化粧料である。
本発明によれば、幅広い使用感触を有する消費者の化粧品使用に対する効果期待感を満足させる油中水型乳化化粧料を得ることができる。本発明の油中水型乳化化粧料はクリーム剤型の化粧料(例えば、医薬部外品)として好適に使用することができる。As a result of intensive studies by the present inventors in view of the above circumstances, hydrocarbon oils, ester oils, vegetable oils and the like are mainly used by combining organically modified clay minerals, specific surfactants and waxes. Even when used as an oil, it has excellent moisturizing feeling, stability over time, skin safety, and feel in use, and it can satisfy consumer's safety orientation and expectation of effect on the skin. It was found that a water-in-oil emulsified cosmetic suitable for use in the present invention was obtained, and the present invention was completed.
That is, the configuration of the present invention is as follows.
<1> (A) an organically modified clay mineral, (B) an ethylene oxide-added ester-based nonionic surfactant of HLB5-8, (C) a nonionic surfactant that is solid at room temperature less than HLB5, and (D) Contains a nonionic surfactant that is liquid at room temperature below HLB5, (E) waxes, (F) a humectant, (G) an oil different from (E) waxes, and (H) water. It is a water-in-oil emulsified cosmetic.
<2> The water-in-oil emulsified cosmetic according to <1>, wherein the (A) organically modified clay mineral is an alkylammonium modified clay mineral.
<3> The ethylene oxide-added ester-based nonionic surfactant of (B) HLB 5 to 8 is isostearic acid hydrogenated castor oil, triisostearic acid hydrogenated castor oil, lauric acid hydrogenated castor oil, glyceryl triisostearate, tristearic acid The water-in-oil emulsion cosmetic according to <1> or <2>, which is at least one selected from the group consisting of glyceryl and POE adducts of glyceryl diisostearate.
<4> The nonionic surfactant that is solid at room temperature below (C) HLB5 is one or more selected from the group consisting of fatty acid sorbitan and fatty acid glyceride, and any one of <1> to <3>. This is a water-in-oil emulsified cosmetic.
<5> The ratio of the inner phase in the water-in-oil emulsified cosmetic is 45% to 70% by mass, and the ratio of the outer phase is 55% to 30% by mass of <1> to <4>. It is a water-in-oil type emulsified cosmetic of any one of Claims.
ADVANTAGE OF THE INVENTION According to this invention, the water-in-oil type emulsified cosmetics which satisfy the effect expectation effect with respect to the cosmetics use of the consumer who has a wide use feeling can be obtained. The water-in-oil emulsified cosmetic of the present invention can be suitably used as a cream type cosmetic (for example, quasi drug).
本発明によれば、使用時のベタつきがなく、潤い感が良好であり、且つ、潤い感の持続に優れた、経時安定性、皮膚安全性、使用感触が良好な油中水型乳化化粧料を提供することができる。 According to the present invention, a water-in-oil emulsified cosmetic that has no stickiness during use, has a good moisturizing feeling, and is excellent in the persistence of moisturizing, has excellent stability over time, skin safety, and feel in use. Can be provided.
以下、本発明について詳細に説明する。
本発明の油中水型乳化化粧料(以下、単に「乳化化粧料」又は「本発明の乳化化粧料」と称することがある)は、油中水型乳化粒子の水相の主成分としての(H)水、水溶性又は油溶性の(F)保湿剤、及び油相の主成分としての常温で液状の(G)油分を含有し、さらに(A)有機変性粘土鉱物、(B)HLB5〜8のエチレンオキサイド付加型エステル系ノニオン界面活性剤、(C)HLB5未満の常温で固形のノニオン界面活性剤、(D)HLB5未満の常温で液状のノニオン界面活性剤、及び(E)ワックス類を含むものである。
以下、それぞれの成分について説明する。Hereinafter, the present invention will be described in detail.
The water-in-oil emulsified cosmetic of the present invention (hereinafter sometimes simply referred to as “emulsified cosmetic” or “emulsified cosmetic of the present invention”) is used as the main component of the water phase of the water-in-oil emulsified particles. (H) Water, water-soluble or oil-soluble (F) moisturizer, and (G) oil component that is liquid at room temperature as the main component of the oil phase, and (A) organically modified clay mineral, (B) HLB5 ~ 8 ethylene oxide addition type ester nonionic surfactant, (C) nonionic surfactant solid at room temperature below HLB5, (D) nonionic surfactant liquid at room temperature below HLB5, and (E) waxes Is included.
Hereinafter, each component will be described.
なお、本明細書では、ポリオキシブチレンを「POB」、ポリオキシエチレンを「POE」、ポリオキシプロピレンを「POP」と、それぞれ略称することがある。
また、「アクリル」、「メタクリル」のいずれか或いは双方を指す場合「(メタ)アクリル」と記載することがあり、「アクリレート」、「メタクリレート」のいずれか或いは双方を指す場合「(メタ)アクリレート」と記載することがある。In this specification, polyoxybutylene may be abbreviated as “POB”, polyoxyethylene as “POE”, and polyoxypropylene as “POP”.
Further, when referring to either or both of “acryl” and “methacryl”, it may be described as “(meth) acryl”, and when referring to either or both of “acrylate” and “methacrylate”, “(meth) acrylate” May be described.
(A)有機変性粘土鉱物
本発明に用いられる有機変性粘土鉱物は、粘土鉱物(例えばモンモリロナイト、サポナイト、ヘクトライト、ベントナイト、スメクタイトなど)の結晶層間に介在する変換性カチオンを有機極性化合物や有機カチオンで置換したものなどが挙げられる。
即ち、本発明に用いうる有機変性粘土鉱物は、ヘクトライト、モンモリロナイト、サポナイト、ヘクトライト、ベントナイト、スメクタイトなどの公知の粘土鉱物を、有機カチオンで処理したものが挙げられる。処理方法としては、有機カチオンを適切な溶剤に溶解又は分散させ、ここに粘土鉱物を浸漬後、ろ過した後、ろ液を乾燥して有機変性された粘土鉱物を作製する方法が好ましい。乾燥方法としては、ニーダーを用いて乾燥する方法、スプレードライを用いて乾燥する方法、凍結乾燥する方法などが挙げられる。乾燥方法としてはコスト面からニーダーを用いて乾燥する方法が好ましい。
なお、粘土鉱物の変性に用いられる有機カチオンとしては、アルキルアンモニウムクロライドなどのアンモニウム化合物から選ばれる1種以上が挙げられ、なかでも、ジメチルジステアリルアンモニウムクロライドが好ましい。(A) Organically modified clay mineral The organically modified clay mineral used in the present invention includes a convertible cation interposed between crystal layers of a clay mineral (for example, montmorillonite, saponite, hectorite, bentonite, smectite, etc.) as an organic polar compound or an organic cation. And the like substituted with.
That is, examples of the organically modified clay mineral that can be used in the present invention include those obtained by treating known clay minerals such as hectorite, montmorillonite, saponite, hectorite, bentonite, and smectite with an organic cation. As a treatment method, a method is preferred in which an organic cation is dissolved or dispersed in a suitable solvent, and after the clay mineral is immersed therein and filtered, the filtrate is dried to prepare an organically modified clay mineral. Examples of the drying method include a method of drying using a kneader, a method of drying using spray drying, and a method of freeze drying. As a drying method, a method of drying using a kneader is preferable from the viewpoint of cost.
In addition, as an organic cation used for modification | denaturation of a clay mineral, 1 or more types chosen from ammonium compounds, such as an alkyl ammonium chloride, are mentioned, Especially, a dimethyl distearyl ammonium chloride is preferable.
なお、本発明における(A)有機変性粘土鉱物は、乳化化粧料中において、有機変性粘土鉱物の状態で存在すればよく、既述の予め有機変性された粘土鉱物を乳化化粧料に添加する以外、例えば、合成スメクタイト(ケイ酸アルミニウムマグネシウム)などの未変性粘土鉱物と該粘土鉱物を有機変性させうる有機カチオンであるカチオン界面活性剤を別々に配合し、乳化組成物製造工程において、系中で粘土鉱物を有機変性させてもよい。この場合においても、得られた乳化化粧料中に、有機変性粘土鉱物が存在することになる。 In addition, the (A) organically modified clay mineral in the present invention may be present in the state of the organically modified clay mineral in the emulsified cosmetic, except that the previously described organically modified clay mineral is added to the emulsified cosmetic. For example, an unmodified clay mineral such as synthetic smectite (aluminum magnesium silicate) and a cationic surfactant that is an organic cation capable of organically modifying the clay mineral are separately blended, and in the emulsion composition manufacturing process, The clay mineral may be organically modified. Even in this case, the organically modified clay mineral is present in the obtained emulsified cosmetic.
本発明に用いうる有機変性粘土鉱物の具体例としては、例えば、ジメチルジステアリルアンモニウムヘクトライト(=クオタニウム−18ヘクトライト)、ジメチルジステアリルアンモニウムベントナイト(=クオタニウム−18ベントナイト)、ベンジルジメチルステアリルアンモニウムヘクトライト、ジオクタデシルジメチルアンモニウム塩変性モンモリロナイト、オクタデシルジメチルベンジルアンモニウム塩変性モンモリロナイト、及びジヘキサデシルジメチルアンモニウム塩変性モンモリロナイト、ジメチルジステアリルアンモニウムスメクタイト等が挙げられる。
本発明に用いられる有機変性粘土鉱物は、例えば、「ベントン38V」(化学名:クオタニウム−18ヘクトライト)、「ベントン34」(化学名:クオタニウム−18ベントナイト)、「ベントン27」(化学名:ベンジルジメチルステアリルアンモニウムヘクトライト)(以上商品名:いずれもレオックス社製)、「クレイトーン40」、「クレイトーンSO」(以上商品名:いずれもサザン・クレイ社製)等として市販されており、商業的に入手可能である。Specific examples of the organically modified clay mineral that can be used in the present invention include, for example, dimethyl distearyl ammonium hectorite (= quaternium-18 hectorite), dimethyl distearyl ammonium bentonite (= quaternium-18 bentonite), and benzyldimethylstearyl ammonium hector. Examples include lite, dioctadecyldimethylammonium salt-modified montmorillonite, octadecyldimethylbenzylammonium salt-modified montmorillonite, dihexadecyldimethylammonium salt-modified montmorillonite, and dimethyldistearylammonium smectite.
Examples of the organically modified clay mineral used in the present invention include “Benton 38V” (chemical name: quaternium-18 hectorite), “Benton 34” (chemical name: quaternium-18 bentonite), “Benton 27” (chemical name: Benzyldimethylstearylammonium hectorite) (all trade names: all manufactured by Leox Co., Ltd.), “Claytone 40”, “Claytone SO” (all trade names: all manufactured by Southern Clay), etc. It is commercially available.
本発明の乳化化粧料に用いられる上記有機変性粘度鉱物としては、ヘクトライトを有機変性したものが好適であり、より具体的には、経時での安定性向上の観点から、ベンジルジメチルステアリルアンモウニウムヘクトライト、ジメチルジステアリルアンモニウムヘクトライト等が好ましく、ジメチルジステアリルアンモニウムヘクトライトを用いることが特に好ましい。 The organically modified viscosity mineral used in the emulsified cosmetic of the present invention is preferably one obtained by organically modifying hectorite, and more specifically, from the viewpoint of improving the stability over time, benzyldimethylstearyl ammonium. Nitric hectorite, dimethyl distearyl ammonium hectorite, and the like are preferable, and dimethyl distearyl ammonium hectorite is particularly preferable.
(A)有機変性粘土鉱物は、本発明の油中水型乳化化粧料全量に対して1種のみを用いてもよく、2種以上を併用してもよい。
(A)有機変性粘土鉱物の配合率は、本発明の油中水型乳化化粧料全量に対して0.5〜5質量%程度が好ましく、特には1.0質量%〜3質量%の範囲である。なお、2種以上の有機変性粘土鉱物を併用する場合には、上記配合率は、総含有量の配合比率を意味する。(A) Only 1 type may be used for an organic modified clay mineral with respect to the water-in-oil type emulsified cosmetics whole quantity of this invention, and may use 2 or more types together.
(A) About 0.5-5 mass% is preferable with respect to the whole quantity of the water-in-oil type emulsified cosmetics of this invention, and the compounding ratio of the organic modified clay mineral is the range of 1.0 mass%-3 mass% especially. It is. In addition, when using together 2 or more types of organic modified clay minerals, the said compounding ratio means the compounding ratio of total content.
(B)HLB5〜8のエチレンオキサイド付加型エステル系ノニオン界面活性剤
本発明で用いられるHLB5〜8のエチレンオキサイド付加のエステル系ノニオン界面活性剤(以下、適宜(B)界面活性剤と称する)は、上記HLB及び構造を満たすものであれば、適宜選択して使用することができる。
なお、本明細書においては、ノニオン界面活性剤のHLBは、ノニオン界面活性剤が市販品である場合には、メーカーカタログ記載のHLB値又はメーカーカタログ記載のIOB値×10の値を採用しており、また、市販品ではない場合には、当該ノニオン界面活性剤における、〔(文献に記載のIOB値)×10〕の値を採用している。(B) HLB 5-8 ethylene oxide addition type ester nonionic surfactant HLB5-8 ethylene oxide addition ester nonionic surfactant used in the present invention (hereinafter referred to as (B) surfactant as appropriate) As long as the above HLB and structure are satisfied, they can be appropriately selected and used.
In this specification, when the nonionic surfactant is a commercially available product, the nonionic surfactant HLB adopts the HLB value described in the manufacturer catalog or the IOB value x 10 described in the manufacturer catalog. If it is not a commercial product, the value of [(IOB value described in literature) × 10] in the nonionic surfactant is adopted.
以下、本発明で用いられるHLB5〜8のエチレンオキサイド付加型エステル系ノニオン界面活性剤を挙げるが本発明はこれに限定されない。なお、以下の化合物において「POE(20−30)」と記載した場合、当該界面活性剤のPOE(ポリエチレンオキサイド)付加モル数が20〜30の範囲であることを意味する。
本発明に用いうる(B)界面活性剤としては、脂肪酸エステルのPOE付加物が好ましく、脂肪酸硬化ひまし油のPOE付加物、脂肪酸グリセリルのPOE付加物であって、POE付加モル数が3〜30程度のものが好ましい。具体的には、例えば、トリイソステアリン酸POE(20−30)硬化ヒマシ油(HLB:5.7〜7.2)、イソステアリン酸POE(10−20)硬化ヒマシ油(HLB:5.4〜7.8)、トリイソステアリン酸POE(10−20)グリセリル(HLB:5.0〜7.8)、イソステアリン酸POE(3−5)グリセリル(HLB:6.0〜7.7)、ジイソステアリン酸POE(10)グリセリル(HLB:6.9)、トリオレイン酸POE(10−20)グリセリル(HLB:5.0〜7.8)、イソステアリン酸POE(3)(HLB:6.6)、POE(5−10)硬化ヒマシ油(HLB:5.1〜6.9)、ステアリン酸POE(8)ラウリルエーテル(HLB:6.6)、イソステアリンPOE(8)ラウリルエーテル(HLB:6.6)、ステアリン酸POE(7)セチルエーテル(HLB:5.5)、ステアリン酸POE(9−12)ステアリルエーテル(HLB:6.3〜7.5)、ジラウリン酸POE(5−6)(HLB:5.4〜6.9)、ジステアリン酸POE(6−12)(HLB:5.2〜7.9)、ジイソステアリン酸POE(6−12)(HLB:5.2〜7.9)、ジオレイン酸POE(6−12)(HLB:5.2〜7.9)、トリイソステアリン酸POE(20)トリメチロールプロパン(HLB:7.8)などが挙げられる。Hereinafter, although HLB5-8 ethylene oxide addition type ester nonionic surfactant used by this invention is mentioned, this invention is not limited to this. In addition, when it describes as "POE (20-30)" in the following compounds, it means that the POE (polyethylene oxide) addition mole number of the said surfactant is the range of 20-30.
The surfactant (B) that can be used in the present invention is preferably a fatty acid ester POE adduct, a fatty acid-hardened castor oil POE adduct, or a fatty acid glyceryl POE adduct having a POE addition mole number of about 3 to 30. Are preferred. Specifically, for example, triisostearic acid POE (20-30) hydrogenated castor oil (HLB: 5.7 to 7.2), isostearic acid POE (10-20) hydrogenated castor oil (HLB: 5.4 to 7) .8), triisostearic acid POE (10-20) glyceryl (HLB: 5.0 to 7.8), isostearic acid POE (3-5) glyceryl (HLB: 6.0 to 7.7), diisostearic acid POE (10) Glyceryl (HLB: 6.9), trioleic acid POE (10-20) glyceryl (HLB: 5.0 to 7.8), isostearic acid POE (3) (HLB: 6.6), POE ( 5-10) hydrogenated castor oil (HLB: 5.1-6.9), stearic acid POE (8) lauryl ether (HLB: 6.6), isostearic POE (8) lauryl ether HLB: 6.6), stearic acid POE (7) cetyl ether (HLB: 5.5), stearic acid POE (9-12) stearyl ether (HLB: 6.3-7.5), dilauric acid POE (5 -6) (HLB: 5.4 to 6.9), distearic acid POE (6-12) (HLB: 5.2 to 7.9), diisostearic acid POE (6-12) (HLB: 5.2) 7.9), dioleic acid POE (6-12) (HLB: 5.2-7.9), triisostearic acid POE (20) trimethylolpropane (HLB: 7.8), and the like.
なかでも、POEが10〜30付加した脂肪酸硬化ヒマシ油、又はPOEが10〜30付加した脂肪酸グリセリルが好ましく、イソステアリン酸硬化ヒマシ油、トリイソステアリン酸硬化ヒマシ油、ラウリン酸硬化ヒマシ油、トリイソステアリン酸グリセリル、トリステアリン酸グリセリル、ジイソステアリン酸グリセリルなどにPOEが10〜30モル付加した化合物がさらに好ましい。
上記の中でも、トリイソステアリン酸POE(20)硬化ヒマシ油が特に好ましい。Among these, fatty acid-hardened castor oil to which POE is added at 10 to 30 or fatty acid glyceryl to which POE is added at 10 to 30 is preferable. More preferred is a compound obtained by adding 10 to 30 moles of POE to glyceryl, glyceryl tristearate, glyceryl diisostearate or the like.
Among the above, triisostearic acid POE (20) hydrogenated castor oil is particularly preferable.
本発明で用いられるHLB5〜8のエチレンオキサイド付加のエステル系ノニオン界面活性剤の配合量は有機変性粘土鉱物の配合量に対し質量比で0.5〜7.0の範囲で用いるのが好ましく、特に好ましくは0.7〜5.0の範囲で用いるのが好ましい。HLB5〜8のエチレンオキサイド付加のエステル系ノニオン界面活性剤は1種または2種以上を用いることができる。 The blending amount of the HLB5-8 ethylene oxide-added ester-based nonionic surfactant used in the present invention is preferably 0.5 to 7.0 in terms of mass ratio with respect to the blending amount of the organically modified clay mineral. It is particularly preferable to use in the range of 0.7 to 5.0. 1 type, or 2 or more types can be used for the ester nonionic surfactant of HLB5-8 ethylene oxide addition.
(C)HLB5未満の常温で固形のノニオン界面活性剤
ここで、「常温で固形」とは、常温、即ち25℃の温度条件下で流動性を有しないことを示す。
本発明で用いられるHLB5未満の常温で固形のノニオン界面活性剤(以下、適宜、(C)界面活性剤と称する)としては、この物性を満たすものであれば特に制限なく用いられ、例えば、脂肪酸グリセリド、脂肪酸ソルビタン、蔗糖脂肪酸エステルなどの常温で固形の化合物が挙げられ、具体的には、例えば、オレイン酸モノグリセリド(HLB:2.5)、ステアリン酸モノグリセリド(HLB:3.0)、モノ・ジステアリン酸ソルビタン(HLB:4.2)、ペンタステアリン酸デカグリセリン(HLB:3.5)などが挙げられる。また、以下に示す常温で固形であってHLBが5未満のノニオン性界面活性剤も好ましく使用される。例えば、パーム油硬化モノグリセリド、ナタネ硬化油モノ・ジグリセリド、ステアリン酸モノ・ジグリセリド、モノ・ジパルミチン酸ソルビタン、ペンタステアリン酸デカグリセリン、デカステアリン酸デカグリセリン、ヘキサステアリン酸ペンタグリセリン、50%アセチル化ステアリン酸モノグリセリド、ステアリン酸・リンゴ酸モノグリセリド、蔗糖ステアリン酸エステルなどである。
なお、上記例示化合物中、ステアリン酸モノ・ジグリセリドは、ステアリン酸グリセリドとステアリン酸ジグリセリドとの混合物を指し、モノ・ジステアリン酸ソルビタンとは、ステアリン酸ソルビタンとジステアリン酸ソルビタンとの混合物を指し、ステアリン酸・リンゴ酸モノグリセリドとはステアリン酸モノグリセリドとリンゴ酸モノグリセリドとの混合物を指す。(C) Nonionic surfactant that is solid at room temperature below HLB5 Here, “solid at room temperature” indicates that it does not have fluidity at room temperature, that is, at 25 ° C.
Any nonionic surfactant that is solid at room temperature below HLB5 used in the present invention (hereinafter referred to as (C) a surfactant as appropriate) can be used without particular limitation as long as it satisfies this physical property. Examples include solid compounds at room temperature such as glycerides, fatty acid sorbitans, and sucrose fatty acid esters. Specifically, for example, oleic acid monoglyceride (HLB: 2.5), stearic acid monoglyceride (HLB: 3.0), mono- Examples include sorbitan distearate (HLB: 4.2) and decaglycerin pentastearate (HLB: 3.5). Nonionic surfactants that are solid at room temperature and have an HLB of less than 5 are also preferably used. For example, palm oil hydrogenated monoglyceride, rapeseed oil mono-diglyceride, stearic acid mono-diglyceride, sorbitan mono-dipalmitate, decaglycerin pentastearate, decaglycerin decastearate, pentaglycerin hexastearate, 50% acetylated stearin Acid monoglyceride, stearic acid / malic acid monoglyceride, sucrose stearate and the like.
In the above exemplified compounds, stearic acid mono-diglyceride refers to a mixture of stearic acid glyceride and stearic acid diglyceride, mono-distearic acid sorbitan refers to a mixture of sorbitan stearate and sorbitan distearate, stearic acid -Malic acid monoglyceride refers to a mixture of stearic acid monoglyceride and malic acid monoglyceride.
上記の中でも、モノステアリン酸ソルビタンとジステアリン酸ソルビタンとの混合物、及び、ステアリン酸モノグリセリドから選ばれる1種以上が特に好ましい。 Among these, at least one selected from a mixture of sorbitan monostearate and sorbitan distearate and monoglyceride stearate is particularly preferable.
HLB5未満の常温で固形のノニオン界面活性剤の配合量は、本発明化粧料全量に対して0.2〜5質量%程度が好ましく、特には0.5〜3質量%程度が好ましい。HLB5未満の常温で固形のノニオン界面活性剤は1種または2種以上を用いることができる。 The blending amount of the nonionic surfactant solid at room temperature below HLB5 is preferably about 0.2 to 5% by mass, and particularly preferably about 0.5 to 3% by mass with respect to the total amount of the cosmetic of the present invention. One kind or two or more kinds of nonionic surfactants which are solid at room temperature below HLB5 can be used.
(D)HLB5未満の常温で液状のノニオン界面活性剤
ここで、「常温で液状」とは、常温、即ち25℃の温度条件下で流動性を有することを示す。
本発明で用いられるHLB5未満の常温で液状のノニオン界面活性剤(以下、適宜、(D)界面活性剤と称する)としては、この物性を満たすものであれば特に制限なく用いられるが、例えば、モノイソステアリン酸グリセリド(HLB:4.0)、モノ・ジイソステアリン酸ソルビタン(HLB:4.5)、モノオレイン酸ソルビタン(HLB:4.3)などが挙げられる。また、以下に示す常温で液状であってHLBが5未満のノニオン性界面活性剤も好ましく使用される。例えば、ジイソステアリン酸グリセリド、ジオレイン酸グリセリド、モノイソステアリン酸ソルビタン、モノオレイン酸プロピレングリコール、ジイソステアリンジグリセリン、ペンタオレイン酸デカグリセリン、デカオレイン酸デカグリセリン、(ステアリン酸/リンゴ酸)グリセリド、イソステアリン酸POE(3)ソルビットなどが挙げられる。(D) Nonionic surfactant that is liquid at normal temperature less than HLB5 Here, “liquid at normal temperature” indicates that it has fluidity at normal temperature, that is, at 25 ° C.
The nonionic surfactant that is liquid at room temperature below HLB5 used in the present invention (hereinafter referred to as (D) surfactant as appropriate) can be used without particular limitation as long as it satisfies this physical property. Examples include glyceryl monoisostearate (HLB: 4.0), sorbitan monoisodistearate (HLB: 4.5), and sorbitan monooleate (HLB: 4.3). Nonionic surfactants that are liquid at room temperature and have an HLB of less than 5 are also preferably used. For example, diisostearic acid glyceride, dioleic acid glyceride, sorbitan monoisostearate, propylene glycol monooleate, diisostearate diglycerin, pentaoleic acid decaglycerin, dekaoleic acid decaglycerin, (stearic acid / malic acid) glyceride, isostearic acid POE (3 ) Sorbit.
HLB5未満の常温で液状のノニオン界面活性剤の配合量は、本発明化粧料全量に対して0.2〜5質量%程度が好ましく、特には0.5〜3質量%程度が好ましい。HLB5未満の常温で液状のノニオン界面活性剤は1種または2種以上を用いることができる。 The blending amount of the nonionic surfactant that is liquid at room temperature below HLB5 is preferably about 0.2 to 5% by mass, and particularly preferably about 0.5 to 3% by mass with respect to the total amount of the cosmetic of the present invention. One kind or two or more kinds of nonionic surfactants which are liquid at room temperature below HLB5 can be used.
(E)ワックス類
本発明の化粧料に用いられるワックス類としては、常温(25℃)で固形の油性成分であって、通常化粧料に用いられるものであれば制限なく使用することができる。
本発明で用いるワックス類として、モクロウ、硬化ヒマシ油、ミツロウ、キャンデリラロウ、綿ロウ、カルナウバロウ、ベイベリーロウ、イボタロウ、鯨ロウ、モンタンロウ、ヌカロウ、カポックロウ、サトウキビロウ、ジョジョバロウ、セラックロウ、マイクロクリスタリンワックス、セレシン、パラフィンなどのロウ・パラフィンワックス類、ベヘニルアルコール、ステアリルアルコール、セチルアルコール等の高級アルコール類、ベヘニン酸、ステアリン酸、ミリスチン酸等の高級脂肪酸類、カカオ脂、ヤシ油、馬脂、硬化ヤシ油、パーム油、牛脂、羊脂、硬化牛脂、パーム核油、豚脂、牛骨脂、モクロウ核油、硬化油、牛脚脂、ラウリン酸ヘキシル、デキストリンパルミチン酸エステル、ワセリン、ポリエチレン、バチルアルコールなどの固形油分、コレステロール、フィトステロール、12−ヒドロキシステアリン酸コレステリル、ラノリン脂肪酸コレステリル、イソステアリン酸コレステリル、リシノール酸コレステリル、マカデミアナッツ油脂肪酸コレステリル等のコレステロールエステル、12−ヒドロキシステアリン酸フィトステリル、ラノリン脂肪酸フィトステリル、イソステアリン酸フィトステリル、リシノール酸フィトステリル、マカデミアナッツ油脂肪酸フィトステリル等のフィトステロールエステル、ラノリン、ラノリンアルコール、水添ラノリンアルコール、ラノリン脂肪酸、ヘキサ(ヒドロキシステアリン酸/ステアリン酸/ロジン酸)ジペンタエリスリチル、(ヒドロキシステアリン酸/イソステアリン酸)ジペンタエリスリチル等のジペンタエリトリット、N−ラウロイル−L−グルタミン酸ジ(コレステリル又はフィトステリル/ベヘニル/オクチルドデシル)、N−ラウロイル−L−グルタミン酸ジ(コレステリル又はフィトステリル/オクチルドデシル)などが挙げられる。
ワックス類は、乳化化粧料を加熱調製される際には溶融状態で油相に含まれ、乳化化粧料の調整後には、外相中に、液状油との相溶状態で存在するか、或いは、固体分散状態で存在することになる。(E) Waxes The waxes used in the cosmetic of the present invention can be used without limitation as long as they are oily components that are solid at room temperature (25 ° C.) and are usually used in cosmetics.
As waxes used in the present invention, moles, hardened castor oil, beeswax, candelilla wax, cotton wax, carnauba wax, bayberry wax, lobster wax, whale wax, montan wax, nuka wax, kapok wax, sugar cane wax, jojoballow, shellac wax, microcrystalline wax, Wax and paraffin waxes such as ceresin and paraffin, higher alcohols such as behenyl alcohol, stearyl alcohol and cetyl alcohol, higher fatty acids such as behenic acid, stearic acid and myristic acid, cocoa butter, coconut oil, horse fat and hydrogenated coconut oil , Palm oil, beef tallow, sheep fat, hardened beef tallow, palm kernel oil, pork tallow, beef bone fat, owl kernel oil, hardened oil, beef leg oil, hexyl laurate, dextrin palmitate, petrolatum, polyethylene, batyl alcohol Cholesterol esters such as solid oil, cholesterol, phytosterol, cholesteryl 12-hydroxystearate, cholesteryl lanolin fatty acid, cholesteryl isostearate, cholesteryl ricinoleate, macadamia nut oil fatty acid cholesteryl, phytosteryl 12-hydroxystearate, phytosteryl lanolin fatty acid, phytosteryl isostearate Phytosterol esters such as phytosteryl ricinoleate, macadamia nut oil fatty acid phytosteryl, lanolin, lanolin alcohol, hydrogenated lanolin alcohol, lanolin fatty acid, hexa (hydroxystearic acid / stearic acid / rosinic acid) dipentaerythrityl, (hydroxystearic acid / isostearic acid) dipentaerythrityl Dipenta etc. Ritoritto, N- lauroyl -L- glutamic acid di (cholesteryl or phytosteryl / behenyl / octyldodecyl), N- lauroyl -L- glutamic acid di (cholesteryl or phytosteryl / octyldodecyl), and the like.
The wax is contained in the oil phase in a molten state when the emulsified cosmetic is prepared by heating, and after the preparation of the emulsified cosmetic is present in the outer phase in a compatible state with the liquid oil, or It exists in a solid dispersion state.
ワックス類は本発明の乳化化粧料に1種のみ含まれてもよく、2種以上を併用してもよい。
ワックス類の配合量は、本発明の化粧料全量に対して0.5質量%〜8質量%程度が好ましく、特には0.7〜5質量%程度が好ましい。Only one type of wax may be included in the emulsified cosmetic of the present invention, or two or more types may be used in combination.
The blending amount of the wax is preferably about 0.5 to 8% by mass, and particularly preferably about 0.7 to 5% by mass with respect to the total amount of the cosmetic of the present invention.
本発明の油中水型乳化化粧料は、前記(A)成分〜(E)成分に加え、油中水型乳化粒子の水相の主成分としての(H)水、水溶性又は油溶性の(F)保湿剤、及び油相の主成分としての常温で液状であり、前記(E)ワックス類とは異なる(G)油分を含有することを要する。
(F)保湿剤
本発明の乳化化粧料に用いられる保湿剤としては、化粧料に用いられる公知の保湿剤であれば、特に制限はなく、例えば、プロピレングリコール、1,3−プロパンジオール、1,2−ブチレングリコール、1,3−ブチレングリコール、1,2−ペンタンジオール、ヘキシレングリコール、グリセリン、トリメチロールプロパンなどの多価アルコール、ジプロピレングリコール、ポリプロピレングリコール、ポリエチレングリコール、ジグリセリン、トリグリセリン、テトラグリセリン、ポリグリセリンなどの多価アルコール重合体、ジプロピレングリコールエチルエーテル、ポリオキシブチレン(以下、POB)ポリオキシエチレン(以下、POE)ポリオキシプロピレン(以下、POP)グリセリルエーテル、POPジグリセリルエーテル、POEジグリセリルエーテルなどの多価アルコール誘導体、エリトロース、エリトルロース、トレオース、デオキシリボース、リキソース、アラビノース、リボース、リブロース、キシルロース、グルコース、タロース、プシコース、ガラクトース、マンノース、タガトース、フコース、フクロース、ラムノース、セドヘブツロース、スクロース、マルトース、ツラノース、セロビオース、ラクトース、トレハロース、ラフィノース、メレジトース、マルトトリオース、アカルボース、スタキオース、フラクトオリゴ糖、ガラクトオリゴ糖、マンナンオリゴ糖、デキストリンなどの糖類、エリトリトール、アラビニトール、キシリトール、ソルビトール、マルチトール、マンニトール、ダルシトールなどの糖アルコール、グルコシルトレハロース、アスコルビン酸グルコシド、POEメチルグルコシド、POPメチルグルコシド、ヒドロキシプロピル−β−シクロデキストリンなどの糖誘導体、ソルビトールリン酸エステル、キシリトールリン酸エステル、POEマルチトールなどの糖アルコール誘導体、グリシン、トレオニン、アラニン、チロシン、バリン、ロイシン、アルギニン、リジン、プロリン、アスパラギン酸、グルタミン酸、セリン、ヒドロキシプロリンなどのアミノ酸およびこれらの誘導体、ピロリドンカルボン酸ナトリウム等のピロリドンカルボン酸塩、コンドロイチン硫酸ナトリウム、ヒアルロン酸ナトリウム、ベタイン、尿素、POE・POPジメチルエーテルなどが挙げられる。単独で用いることも2種以上を配合することもできる。
これらの保湿剤は、油溶性の材料であれば、油中水型乳化化粧料の油相に含まれればよく、水溶性の材料であれば水相に含まれればよい。また、微細な固形分として系中に均一分散されて含まれてもよい。
保湿剤には、特に制限はなく、本発明の化粧料の目的や、併用される成分との親和性などを考慮して適宜選択して用いればよい。
保湿剤の含有率としては、化粧料に用いられる全成分に対し、2質量%〜30質量%の範囲であることが好ましい。The water-in-oil emulsified cosmetic of the present invention has (H) water, water-soluble or oil-soluble as a main component of the water phase of the water-in-oil emulsified particles in addition to the components (A) to (E). (F) It is liquid at normal temperature as a moisturizing agent and the main component of the oil phase, and it is necessary to contain (G) an oil component different from the (E) wax.
(F) Moisturizer The moisturizer used in the emulsified cosmetic of the present invention is not particularly limited as long as it is a known moisturizer used in cosmetics. For example, propylene glycol, 1,3-propanediol, 1 , 2-butylene glycol, 1,3-butylene glycol, 1,2-pentanediol, hexylene glycol, glycerin, trimethylolpropane and other polyhydric alcohols, dipropylene glycol, polypropylene glycol, polyethylene glycol, diglycerin, triglycerin , Tetraglycerin, polyglycerin and other polyhydric alcohol polymers, dipropylene glycol ethyl ether, polyoxybutylene (hereinafter POB) polyoxyethylene (hereinafter POE) polyoxypropylene (hereinafter POP) glyceryl ether, POP jig Polyhydric alcohol derivatives such as lyseryl ether and POE diglyceryl ether, erythrose, erythrulose, threose, deoxyribose, lyxose, arabinose, ribose, ribulose, xylulose, glucose, talose, psicose, galactose, mannose, tagatose, fucose, fucose, Rhamnose, sedhebutulose, sucrose, maltose, turanose, cellobiose, lactose, trehalose, raffinose, melezitose, maltotriose, acarbose, stachyose, fructooligosaccharide, galactooligosaccharide, mannan oligosaccharide, dextrin saccharide, erythritol, arabinitol, xylitol, sorbitol Sugar alcohols such as maltitol, mannitol and dulcitol, Sugar derivatives such as lucosyl trehalose, ascorbyl glucoside, POE methyl glucoside, POP methyl glucoside, hydroxypropyl-β-cyclodextrin, sugar alcohol derivatives such as sorbitol phosphate, xylitol phosphate, POE maltitol, glycine, threonine Amino acids such as alanine, tyrosine, valine, leucine, arginine, lysine, proline, aspartic acid, glutamic acid, serine, hydroxyproline, pyrrolidone carboxylates such as sodium pyrrolidonecarboxylate, chondroitin sulfate sodium, sodium hyaluronate , Betaine, urea, POE / POP dimethyl ether and the like. It can be used alone or in combination of two or more.
These humectants may be included in the oil phase of the water-in-oil emulsified cosmetic if they are oil-soluble materials, and may be included in the water phase if they are water-soluble materials. Moreover, it may be uniformly dispersed in the system as a fine solid content.
The moisturizing agent is not particularly limited, and may be appropriately selected and used in consideration of the purpose of the cosmetic of the present invention and the affinity with components used in combination.
As a content rate of a moisturizer, it is preferable that it is the range of 2 mass%-30 mass% with respect to all the components used for cosmetics.
(H)水
本発明の乳化化粧料には、水相成分の主成分として水を含有する。乳化化粧料に含まれる水は不純物を含まないことが好ましいため、イオン交換水や純粋を用いることが好ましい。水の含有量は、本発明の乳化化粧料の好ましい剤形に応じて適宜選択されるが、後述する、内相、即ち乳化粒子を構成する水相の好ましい含有量に依存して決定される。(H) Water The emulsified cosmetic of the present invention contains water as the main component of the water phase component. Since the water contained in the emulsified cosmetic preferably contains no impurities, it is preferable to use ion-exchanged water or pure water. The water content is appropriately selected according to the preferred dosage form of the emulsified cosmetic of the present invention, but is determined depending on the preferred content of the inner phase, that is, the water phase constituting the emulsified particles, which will be described later. .
〔水相に含まれうるその他の成分〕
また、水相(内相)には、水に加えて、さらにその他の水相成分を併用してもよい。
水と併用可能な、水相に配合しうる成分としては水と相溶性を有するもの、水に溶解或いは均一に分散しうるものであれば特に制限はなく、水性の有機溶媒、各種水溶性、及び水分散性の有効成分などを併用してもよい。
所望により水相に添加される成分としては、例えば、エタノール、プロパノール、イソプロパノール、イソブチルアルコール、t−ブチルアルコールなどの1価アルコール;
アミノカプロン酸、クエン酸、乳酸、グリコール酸、酒石酸などのα−ヒドロキシ酸およびこれらのナトリウム、カリウム等の塩;
アスコルビン酸、ピロ亜硫酸ナトリウムなどの酸化防止剤;
メチルパラベン、デヒドロ酢酸ナトリウム、安息香酸ナトリウム、フェノキシエタノールなどの防腐剤;
サリチル酸、エデト酸、メタリン酸などのキレート剤
胎盤抽出物、ニコチン酸アミド、パントテニールエチルエーテル、パントテン酸、グリチルリチン酸ジカリウム、ビオチン、ピリドキシン塩酸塩、アデノシン三リン酸、α−リポ酸、ローヤルゼリー、3−O−エチルアスコルビン酸、アスコルビン酸リン酸マグネシウム、アルブチン、グルコシルヘスペリジン、グルコシルルチンなどの薬剤;
などが挙げられる。[Other components that can be contained in the aqueous phase]
In addition to water, the water phase (inner phase) may further contain other water phase components.
The components that can be used in combination with water and can be blended in the water phase are not particularly limited as long as they are compatible with water, can be dissolved or uniformly dispersed in water, aqueous organic solvents, various water-soluble substances, In addition, an active ingredient having water dispersibility may be used in combination.
Examples of the component added to the aqueous phase as desired include monohydric alcohols such as ethanol, propanol, isopropanol, isobutyl alcohol, and t-butyl alcohol;
Α-hydroxy acids such as aminocaproic acid, citric acid, lactic acid, glycolic acid and tartaric acid and salts thereof such as sodium and potassium;
Antioxidants such as ascorbic acid and sodium pyrosulfite;
Preservatives such as methylparaben, sodium dehydroacetate, sodium benzoate, phenoxyethanol;
Chelating agent placental extract such as salicylic acid, edetic acid, metaphosphoric acid, nicotinic acid amide, pantotenyl ethyl ether, pantothenic acid, dipotassium glycyrrhizinate, biotin, pyridoxine hydrochloride, adenosine triphosphate, α-lipoic acid, royal jelly, 3 -Drugs such as O-ethyl ascorbic acid, magnesium ascorbate phosphate, arbutin, glucosyl hesperidin, glucosyl rutin;
Etc.
また、乳化粒子の安定性を向上させるために水溶性増粘剤を用いてもよく、水溶性増粘剤として、例えば、アラビアガム、トラガントガム、ガラクタン、グアガム、キャロブガム、カラヤガム、ジェランガム、カラギーナン等の植物系高分子;
キサンタンガム、デキストラン、サクシノグルカン、プルラン、バイオヒアルロン酸ナトリウム等の微生物系高分子;
コラーゲン、カゼイン、アルブミン、ゼラチン等の動物系高分子;
カルボキシメチルデンプン、メチルヒドロキシプロピルデンプン等のデンプン系高分子;
メチルセルロース、エチルセルロース、メチルヒドロキシプロピルセルロース、ヒドロキシエチルセルロース、セルロース硫酸ナトリウム、ヒドロキシプロピルセルロース、カルボキシメチルセルロースナトリウム、結晶セルロース等のセルロース系高分子;
アルギン酸ナトリウム、アルギン酸プロピレングリコールエステル等のアルギン酸系高分子;
ポリビニルアルコール、ポリビニルアセテート、ポリビニルメチルエーテル、ポリビニルピロリドン、ビニルピロリドンとビニルアセテート共重合物、カルボキシビニルポリマー等のビニル系高分子;
ポリアクリル酸ナトリウム、ポリエチルアクリレート、ポリアクリル酸アルカノールアミン、アルキルメタクリレートとジメチルアミノエチルメタクリレート共重合物、ポリ2−アクリルアミド−2−メチルプロパンスルホン酸、ポリメタクリロイルオキシトリメチルアンモニウムなどのアクリル系高分子;
2−メタクリロイルオキシエチルホスホリルコリンをモノマーとして含む高分子;
などが挙げられる。In addition, a water-soluble thickener may be used to improve the stability of the emulsified particles. Examples of the water-soluble thickener include gum arabic, gum tragacanth, galactan, guar gum, carob gum, caraya gum, gellan gum, carrageenan and the like. Plant polymers;
Microbial polymers such as xanthan gum, dextran, succinoglucan, pullulan, sodium biohyaluronate;
Animal macromolecules such as collagen, casein, albumin, gelatin;
Starch-based polymers such as carboxymethyl starch and methylhydroxypropyl starch;
Cellulose polymers such as methylcellulose, ethylcellulose, methylhydroxypropylcellulose, hydroxyethylcellulose, sodium cellulose sulfate, hydroxypropylcellulose, sodium carboxymethylcellulose, crystalline cellulose;
Alginate polymers such as sodium alginate, propylene glycol alginate;
Vinyl polymers such as polyvinyl alcohol, polyvinyl acetate, polyvinyl methyl ether, polyvinyl pyrrolidone, vinyl pyrrolidone and vinyl acetate copolymer, carboxy vinyl polymer;
Acrylic polymers such as sodium polyacrylate, polyethyl acrylate, alkanolamine polyacrylate, alkyl methacrylate and dimethylaminoethyl methacrylate copolymer, poly-2-acrylamido-2-methylpropanesulfonic acid, polymethacryloyloxytrimethylammonium;
A polymer comprising 2-methacryloyloxyethyl phosphorylcholine as a monomer;
Etc.
(G)前記(E)ワックス類とは異なる油分
本発明において油相に含まれる(G)前記(E)ワックス類とは異なる油分とは、常温(25℃)において液体の油性成分を指す。本発明に用いうる(G)油分としては、常温で液状であり、化粧料に使用しうる油分であれば特に制限はなく、炭化水素油、エステル油、植物油、動物性油分、鉱物油、シリコーンオイルなどが挙げられ、肌への感触や潤い性を付与しうるという観点からは、炭化水素油、エステル油、及び植物油から選ばれる1種以上が好ましい。
植物油としては、例えば、アボガド油、ツバキ油、マカデミアナッツ油、トウモロコシ油、オリーブ油、ナタネ油、マ油、パーシック油、小麦胚芽油、サザンカ油、ヒマシ油、アマニ油、サフラワー油、綿実油、エノ油、大豆油、落花生油、茶実油、カヤ油、コメヌカ油、シナギリ油、日本キリ油、ホホバ油、及び胚芽油などが挙げられる。
動物性油分としては、例えば、スクワラン、タートル油、ミンク油、及び卵黄油などが挙げられる。
エステル油としては、例えば、トリイソオクタン酸グリセリル、トリイソパルミチン酸グリセリル、イソパルミチン酸オクチル、イソステアリン酸イソプロピル、イソステアリン酸イソステアリル、イソステアリン酸イソセチル、イソステアリン酸ヘキシル、イソステアリン酸ミリスチル、オクタン酸イソセチル、イソオクタン酸セチル、オクタン酸イソステアリル、イソノナン酸イソデシル、ジメチルオクタン酸オクチルドデシル、ミリスチン酸オレイル、エルカ酸イソステアリル、ステアリン酸イソセチル、ステアリン酸オクチル、パルミチン酸イソステアリル、パルミチン酸イソセチル、パルミチン酸オクチル、ミリスチン酸イソステアリル、ミリスチン酸イソセチル、ミリスチン酸オクチルドデシル、ミリスチン酸デシル、パルミチン酸イソプロピル、ミリスチン酸イソプロピル、トリイソステアリン酸トリメチロールプロパン、ジカプリン酸ネオペンチルグリコール、セバシン酸ジオクチル、12−ステアロイルオキシステアリン酸オクチルドデシル、ステアロイルグルタミン酸ジオクチルドデシル、アジピン酸ジオクチル、リンゴ酸ジイソステアリル、乳酸オクチルドデシル、乳酸イソステアリル、パラジメチルアミノ安息香酸オクチルなどが挙げられる。
また、炭化水素油としては、流動パラフィン、イソパラフィン、α−オレフィンオリゴマー、ポリブテン、2−オクチルドデカノール、イソステアリルアルコール、オレイルアルコール、ホホバアルコール、エライジルアルコール、リノレイルアルコール、リノレニルアルコール、イソステアリン酸、オレイン酸、リノール酸、リノレン酸、2−オクチルドデカン酸などが挙げられる。
シリコーンオイルとしては、例えば、デカメチルテトラシロキサン、ドデカメチルペンタシロキサン、テトラデカメチルヘキサシロキサン、ヘキサデカメチルヘプタシロキサンなどのジメチルポリシロキサン類;
オクタメチルシクロテトラシロキサン、デカメチルシクロペンタシロキサン、ドデカメチルシクロヘキサシロキサン、テトラデカメチルシクロヘプタシロキサンなどの環状ポリシロキサン類;
メチルフェニルポリシロキサンなどが挙げられる。これらは単独で用いることも2種以上を配合することもできる。(G) Oil content different from the (E) wax In the present invention, the (G) oil content different from the (E) wax contained in the oil phase refers to an oily component that is liquid at room temperature (25 ° C.). The oil component (G) that can be used in the present invention is not particularly limited as long as it is liquid at room temperature and can be used in cosmetics. Hydrocarbon oil, ester oil, vegetable oil, animal oil, mineral oil, silicone From the viewpoint that oil and the like can be given, and that the skin feel and moisture can be imparted, one or more selected from hydrocarbon oils, ester oils, and vegetable oils are preferable.
Examples of vegetable oils include avocado oil, camellia oil, macadamia nut oil, corn oil, olive oil, rapeseed oil, maize oil, persic oil, wheat germ oil, sasanqua oil, castor oil, linseed oil, safflower oil, cottonseed oil, eno oil , Soybean oil, peanut oil, tea seed oil, kaya oil, rice bran oil, snail oil, Japanese drill oil, jojoba oil, and germ oil.
Examples of animal oils include squalane, turtle oil, mink oil, and egg yolk oil.
Examples of ester oils include glyceryl triisooctanoate, glyceryl triisopalmitate, octyl isopalmitate, isopropyl isostearate, isostearyl isostearate, isocetyl isostearate, hexyl isostearate, myristyl isostearate, isocetyl octanoate, isooctanoic acid Cetyl, isostearyl octoate, isodecyl isononanoate, octyldodecyl dimethyloctanoate, oleyl myristate, isostearyl erucate, isocetyl stearate, octyl stearate, isostearyl palmitate, isocetyl palmitate, octyl palmitate, isomyristate myristate Stearyl, isocetyl myristate, octyldodecyl myristate, decyl myristate, palmiti Isopropyl acid, isopropyl myristate, trimethylolpropane triisostearate, neopentyl glycol dicaprate, dioctyl sebacate, octyldodecyl 12-stearoyloxystearate, dioctyldecyl stearoylglutamate, dioctyl adipate, diisostearyl malate, octyl lactate Examples include dodecyl, isostearyl lactate, and octyl paradimethylaminobenzoate.
Hydrocarbon oils include liquid paraffin, isoparaffin, α-olefin oligomer, polybutene, 2-octyldodecanol, isostearyl alcohol, oleyl alcohol, jojoba alcohol, elaidyl alcohol, linoleyl alcohol, linolenyl alcohol, isostearin. Examples include acids, oleic acid, linoleic acid, linolenic acid, 2-octyldodecanoic acid and the like.
Examples of the silicone oil include dimethylpolysiloxanes such as decamethyltetrasiloxane, dodecamethylpentasiloxane, tetradecamethylhexasiloxane, and hexadecamethylheptasiloxane;
Cyclic polysiloxanes such as octamethylcyclotetrasiloxane, decamethylcyclopentasiloxane, dodecamethylcyclohexasiloxane, tetradecamethylcycloheptasiloxane;
Examples include methylphenyl polysiloxane. These can be used alone or in combination of two or more.
〔油相に含まれうるその他の成分〕
油相は、液状の油分に溶解或いは分散しうる種々の化合物を含んでいてもよい。
油相には、例えば、潤い性や肌に対する種々の効果が期待される有効成分を含むことも好ましい。油相に添加しうる有効成分としては、例えば、セラミド1、セラミド2、セラミド3、セラミド4、セラミド5、セラミド6I、セラミド6IIなどのセラミド類;
スフィンゴシン、フィトスフィンゴシン、スフィンゴ糖脂質、スフィンゴリン脂質などの脂質類;
グリチルレチン酸、グリチルレチン酸アルキル、ベツリン酸、ベツリン酸アルキル、オレアノール酸、オレアノール酸アルキル、ウルソル酸、ウルソル酸アルキル、ウルソル酸ベンジルなどの環式トリテルペン化合物とその誘導体;
グラブリジンなどのイソフラバン類;
補酵素Qなどのベンゾキノン誘導体、チオクト酸などの酵素補助因子;
β−カロチン、リコピン、アスタキサンチンなどのカロテノイド類;
レチノール、酢酸レチノール、パルミチン酸レチノールなどのレチノール誘導体;
リボフラビン酪酸エステル、ジカプリル酸ピリドキシン、ジパルミチン酸ピリドキシン、ジラウリン酸ピリドキシンなどのビタミンB類縁化合物の誘導体;
ジパルミチン酸アスコルビル、テトラヘキシルデカン酸アスコルビルなどのアスコルビン酸誘導体;
エルゴカルシフェロール、コレカルシフェロールなどのビタミンD関連化合物;
酢酸トコフェロールなどのトコフェロール誘導体などの油溶性薬剤;
などが挙げられる。[Other ingredients that can be contained in the oil phase]
The oil phase may contain various compounds that can be dissolved or dispersed in a liquid oil.
The oil phase preferably contains, for example, active ingredients that are expected to have various effects on moisture and skin. Examples of active ingredients that can be added to the oil phase include ceramides such as ceramide 1, ceramide 2, ceramide 3, ceramide 4, ceramide 5, ceramide 6I, and ceramide 6II;
Lipids such as sphingosine, phytosphingosine, glycosphingolipid, and sphingophospholipid;
Cyclic triterpene compounds such as glycyrrhetinic acid, alkyl glycyrrhetinate, betulinic acid, alkyl betulinate, oleanolic acid, alkyl oleanolate, ursolic acid, alkyl ursolate, benzyl ursolate and their derivatives;
Isoflavans such as grablizine;
Benzoquinone derivatives such as coenzyme Q, enzyme cofactors such as thioctic acid;
carotenoids such as β-carotene, lycopene, astaxanthin;
Retinol derivatives such as retinol, retinol acetate and retinol palmitate;
Derivatives of vitamin B analogues such as riboflavin butyrate, pyridoxine dicaprylate, pyridoxine dipalmitate, pyridoxine dilaurate;
Ascorbic acid derivatives such as ascorbyl dipalmitate and ascorbyl tetrahexyldecanoate;
Vitamin D related compounds such as ergocalciferol and cholecalciferol;
Oil-soluble drugs such as tocopherol derivatives such as tocopherol acetate;
Etc.
また、例えば、エチルパラベン、プロピルパラベンなどの防腐剤、油溶性の紫外線吸収剤などを配合してもよい。
油溶性紫外線吸収剤として、例えば、メトキシ桂皮酸オクチル、メトキシ桂皮酸ブチル、メトキシ桂皮酸イソプロピル、トリメトキシ桂皮酸メチルビス(トリメチルシロキシ)シリルイソペンチル、ジパラメトキシ桂皮酸モノ−2−エチルヘキサン酸グリセリル、4−tert−ブチル−4’−メトキシジベンゾイルメタン、2,4,6−トリス[4−(2−エチルヘキシルオキシカルボニル)アニリノ]1,3,5−トリアジン、ヒドロキシメトキシベンゾフェノンスルホン酸ナトリウム、サリチル酸オクチル、サリチル酸ホモメンチル、メチルベンジリデンカンファー、2−シアノ−3,3−ジフェニルプロパ−2−エン酸−2−エチルヘキシルエステル、2,4−ビス{[4−(2−エチルヘキシルオキシ)−2−ヒドロキシ]フェニル}−6−(4−メトキシフェニル)1,3,5−トリアジン、2,2’−メチレン−ビス{6−(2H−ベンゾトリアゾール−2−イル)−4−(1,1,3,3−テトラメチルブチル)フェノール}などが挙げられる。Further, for example, preservatives such as ethyl paraben and propyl paraben, oil-soluble ultraviolet absorbers and the like may be blended.
Examples of the oil-soluble ultraviolet absorber include octyl methoxycinnamate, butyl methoxycinnamate, isopropyl methoxycinnamate, methylbis (trimethylsiloxy) silylisopentyl trimethoxycinnamate, glyceryl di-2-methoxycinnamate mono-2-ethylhexanoate, 4- tert-butyl-4'-methoxydibenzoylmethane, 2,4,6-tris [4- (2-ethylhexyloxycarbonyl) anilino] 1,3,5-triazine, sodium hydroxymethoxybenzophenonesulfonate, octyl salicylate, salicylic acid Homomenthyl, methylbenzylidene camphor, 2-cyano-3,3-diphenylprop-2-enoic acid-2-ethylhexyl ester, 2,4-bis {[4- (2-ethylhexyloxy) -2-hydroxy] phenyl } -6- (4-Methoxyphenyl) 1,3,5-triazine, 2,2′-methylene-bis {6- (2H-benzotriazol-2-yl) -4- (1,1,3,3) -Tetramethylbutyl) phenol} and the like.
〔化粧料に含みうるその他の成分〕
その他の化粧料に配合する成分として、銀ゼオライト、クロルヒドロキシアルミニウム、メントールなどの薬剤、酸化チタン、酸化亜鉛、タルク、マイカ、カオリン、酸化鉄、チタンマイカ、シリカ、多孔質シリカ、ナイロン、ポリエチレン、ポリメタクリル酸メチル、セルロースなどの粉末、苛性カリ、苛性ソーダ、トリエタノールアミン、2−アミノ−2−メチル−1−プロパノール、2−アミノ−2−メチル−1,3−プロパンジオールなどの中和剤、植物抽出液、香料、色素などが挙げられる。[Other ingredients that can be included in cosmetics]
Other ingredients to be blended in cosmetics include drugs such as silver zeolite, chlorohydroxyaluminum, menthol, titanium oxide, zinc oxide, talc, mica, kaolin, iron oxide, titanium mica, silica, porous silica, nylon, polyethylene, Powders such as polymethyl methacrylate and cellulose, caustic potash, caustic soda, triethanolamine, 2-amino-2-methyl-1-propanol, neutralizing agents such as 2-amino-2-methyl-1,3-propanediol, A plant extract, a fragrance | flavor, a pigment | dye, etc. are mentioned.
本発明の油中水型乳化化粧料においては、内相の比率が、45質量%〜70質量%であり、且つ、外相の比率が55質量%〜30質量%であることが好ましく、内相の比率が、47質量%〜67質量%であり、且つ、外相の比率が53質量%〜33質量%であることがより好ましい。本発明における内相は、油中水型乳化組成物に含まれる水相からなる乳化粒子にふくれる成分を包含し、例えば、水、水溶性溶剤、水溶性保湿剤、及び水溶性の各種添加剤が内相に含まれる。また、外相には、液状油成分などの油相及び油相に分散されて存在する有機変性粘度鉱物、ワックス類などが含まれる。内相と外相との比率は、含有する成分の種類と量により適宜調整しうる。 In the water-in-oil emulsified cosmetic of the present invention, the ratio of the inner phase is preferably 45% by mass to 70% by mass, and the ratio of the outer phase is preferably 55% by mass to 30% by mass. Is more preferably 47 mass% to 67 mass%, and the outer phase ratio is more preferably 53 mass% to 33 mass%. The internal phase in the present invention includes components that swell the emulsified particles composed of the aqueous phase contained in the water-in-oil emulsion composition, such as water, water-soluble solvents, water-soluble humectants, and various water-soluble additives. Is included in the internal phase. In addition, the outer phase includes an oil phase such as a liquid oil component, and organic modified viscosity minerals, waxes and the like that are dispersed in the oil phase. The ratio of the internal phase to the external phase can be adjusted as appropriate depending on the type and amount of the component to be contained.
本発明の油中水型乳化化粧料は通常用いられている方法で製造することができる。
製造方法としては、水に水溶性の各種成分を添加した水相成分と、液状の油相にワックス類や油溶性の有効成分を添加した油相成分とを調整し、これらをホモミキサーなどの乳化機を使用して油中水型乳化化粧料を調製する方法が挙げられ、これが最も簡便な製造方法である。しかしながら、本発明の化粧料の製造方法は、一般的な乳化装置による調製法には限定されず、目的とする品質特性値等によって適宜決定すればよい。The water-in-oil emulsified cosmetic of the present invention can be produced by a commonly used method.
As a production method, an aqueous phase component in which various water-soluble components are added to water and an oil phase component in which waxes or oil-soluble active ingredients are added to a liquid oil phase are prepared, and these are mixed with a homomixer or the like. A method of preparing a water-in-oil emulsified cosmetic using an emulsifier is mentioned, and this is the simplest production method. However, the method for producing the cosmetic of the present invention is not limited to a preparation method using a general emulsifying apparatus, and may be appropriately determined depending on the intended quality characteristic value and the like.
本発明の油中水型乳化化粧料は塗布直後の潤い感と長時間に亘るうるおい持続感に優れたクリーム剤型であり、また、使用感触に優れ、幅広い使用感触を有しているので、特に化粧料(医薬部外品)として好適に使用することができる。 The water-in-oil type emulsified cosmetic of the present invention is a cream type with excellent moist feeling immediately after application and a long-lasting moisturizing feeling, and also has excellent use feeling and has a wide use feeling. In particular, it can be suitably used as a cosmetic (quasi-drug).
以下に実施例を挙げて本発明をさらに具体的に説明する。以下の実施例に示す材料、使用量、割合、処理内容、処理手順等は、本発明の趣旨を逸脱しない限り、適宜、変更することができる。従って、本発明の範囲は以下に示す具体例に限定されるものではない。 The present invention will be described more specifically with reference to the following examples. The materials, amounts used, ratios, processing details, processing procedures, and the like shown in the following examples can be changed as appropriate without departing from the spirit of the present invention. Therefore, the scope of the present invention is not limited to the specific examples shown below.
〔実施例1〜2、比較例1〜2〕
下記表1に記載の処方に従い、まず、No.1〜10を秤量して混合し水相を調製し、これを70℃に加熱したものを、別容器にて、No.11〜25を秤量して混合し、70℃に加熱溶解して油相を調製し、油相中に調製済みの前記水相を添加し、乳化装置(プライミックス社製、ホモミキサー)にて剪断力を加え、乳化組成物を得た。得られた乳化物を、さらに同じ乳化装置(プライミックス社製、ホモミキサー)にて温度を70℃に維持しつつ、10分間攪拌して均一微細に乳化処理した後、35℃まで攪拌冷却し美白保湿クリームを得た。
光学顕微鏡観察により観察したところ、油中水型乳化粒子(粒径:1μm〜5μm)が確認された。[Examples 1-2, Comparative Examples 1-2]
In accordance with the prescription described in Table 1 below, 1 to 10 were weighed and mixed to prepare an aqueous phase, which was heated to 70 ° C. 11-25 are weighed and mixed, heated and dissolved at 70 ° C. to prepare an oil phase, the prepared aqueous phase is added to the oil phase, and the emulsifier (Plymix Co., Ltd., homomixer) is used. A shearing force was applied to obtain an emulsified composition. The obtained emulsion was further stirred and cooled to 35 ° C. by stirring for 10 minutes while maintaining the temperature at 70 ° C. in the same emulsifier (Plymix, Homomixer). A whitening moisturizing cream was obtained.
As a result of observation with an optical microscope, water-in-oil type emulsified particles (particle size: 1 μm to 5 μm) were confirmed.
なお、下記表1における各成分の詳細は以下の通りである。
15)オレフィンオリゴマー、(2)水添ポリ(C6−12オレフィン)(日光ケミカルズ社製、商品名:シンセラン4S)
16)シュガーワックス(第一工業製薬社製、商品名:シュガーワックスA−10E)
19)マカデミアナッツ脂肪酸フィトステアリル(日本精化社製、商品名:YOFCO MAS)
22)トリイソステアリン酸POE(30)硬化ヒマシ油(商品名:EMALEX RWIS−330、日本エマルジョン社製) HLB7.2:本発明における(B)HLB5〜8のエチレンオキサイド付加のエステル系ノニオン界面活性剤。
24)トリイソステアリン酸POE(20)硬化ヒマシ油(商品名:EMALEX RWIS−320、日本エマルジョン社製) HLB5.7:本発明における(B)HLB5〜8のエチレンオキサイド付加のエステル系ノニオン界面活性剤。
21)トリイソステアリン酸POE(40)硬化ヒマシ油(商品名:EMALEX RWIS−340、日本エマルジョン社製) HLB8.4:エチレンオキサイド付加のエステル系ノニオン界面活性剤であって、HLBが本発明の範囲外の比較界面活性剤。
23)トリイソステアリン酸POE(20)硬化ヒマシ油(商品名:EMALEX RWIS−320、日本エマルジョン社製) HLB5.7:エチレンオキサイド付加のエステル系ノニオン界面活性剤であって、HLBが本発明の範囲外の比較界面活性剤。
25)モノ・ジステアリン酸ソルビタン(商品名:ニッコールSS−15V、日光ケミカルズ社製)HLB:4.2:本発明における(C)HLB5未満の常温で固形のノニオン界面活性剤。
26)ジイソステアリン酸ジグリセリン(商品名:コスモール42V、日清オイリオ社製)HLB:4.0:本発明における(D)HLB5未満の常温で液状のノニオン界面活性剤。In addition, the detail of each component in following Table 1 is as follows.
15) Olefin oligomer, (2) Hydrogenated poly (C6-12 olefin) (manufactured by Nikko Chemicals, trade name: Synthelan 4S)
16) Sugar wax (Daiichi Kogyo Seiyaku Co., Ltd., trade name: Sugar Wax A-10E)
19) Macadamia nut fatty acid phytostearyl (manufactured by Nippon Seika Co., Ltd., trade name: YOFCO MAS)
22) Triisostearic acid POE (30) hydrogenated castor oil (trade name: EMALEX RWIS-330, manufactured by Nippon Emulsion Co., Ltd.) HLB7.2: (B) an ester-based nonionic surfactant of ethylene oxide addition of HLB5-8 in the present invention .
24) Triisostearic acid POE (20) hydrogenated castor oil (trade name: EMALEX RWIS-320, manufactured by Nippon Emulsion Co., Ltd.) HLB5.7: (B) HB5-8 ethylene oxide addition ester-based nonionic surfactant in the present invention .
21) Triisostearic acid POE (40) hydrogenated castor oil (trade name: EMALEX RWIS-340, manufactured by Nippon Emulsion Co., Ltd.) HLB8.4: Ester-based nonionic surfactant added with ethylene oxide, where HLB is within the scope of the present invention Outside comparative surfactant.
23) Triisostearic acid POE (20) hydrogenated castor oil (trade name: EMALEX RWIS-320, manufactured by Nippon Emulsion Co., Ltd.) HLB5.7: Ester-based nonionic surfactant added with ethylene oxide, where HLB is within the scope of the present invention Outside comparative surfactant.
25) Sorbitan mono-stearate (trade name: Nikkor SS-15V, manufactured by Nikko Chemicals Co., Ltd.) HLB: 4.2: (C) Nonionic surfactant solid at room temperature below HLB5 in the present invention.
26) Diglycerin diisostearate (trade name: Cosmol 42V, manufactured by Nisshin Oilio Co., Ltd.) HLB: 4.0: (D) Nonionic surfactant which is liquid at room temperature below HLB5 in the present invention.
次に、得られた乳化化粧料を、以下に記載の評価方法及び評価基準で評価した。結果を下記表1に併記する。
(1)長期安定性
0℃、室温、40℃及び50℃の各温度条件下に1ヶ月間保存後、目視により乳化化粧料の分離などの外観変化の有無を確認し、以下の基準にて評価した。なお、◎及び○と評価されたものは実用上充分な安定性を示すものである。
◎:各温度で外観変化、粘度変化、分離等の異常は全く認められない。
○:50℃で保存の場合、僅かに外観変化、粘度変化、分離等の異常が認められる。
△:40℃及び50℃で保存の場合、外観変化、粘度変化、分離等の異常が認められる。
×:いずれの温度下でも、外観変化、粘度変化、分離等の異常が認められる。Next, the obtained emulsified cosmetic was evaluated by the evaluation methods and evaluation criteria described below. The results are also shown in Table 1 below.
(1) Long-term stability After storage for 1 month under each temperature condition of 0 ° C, room temperature, 40 ° C and 50 ° C, visually check for changes in appearance such as separation of emulsified cosmetics and follow the criteria below. evaluated. In addition, what was evaluated as (double-circle) and (circle) shows stability sufficient practically.
A: No abnormality such as appearance change, viscosity change, separation, etc. is observed at each temperature.
○: When stored at 50 ° C., slight abnormalities such as changes in appearance, changes in viscosity, and separation are observed.
Δ: Abnormalities such as change in appearance, change in viscosity, separation, etc. are observed when stored at 40 ° C. and 50 ° C.
X: Abnormalities such as changes in appearance, changes in viscosity, and separation are observed at any temperature.
(2)使用性
女性パネル12名に、調製直後の乳化化粧料を使用してもらい、直後の使用性及び3時間後の使用感について官能評価してもらい、次の基準に従って評価した。
〔潤い感と持続性〕
◎:塗布直後の潤い感が非常に優れ、3時間後の潤い感も非常にあると評価したパネルが10名以上
○:塗布直後の潤い感が非常に優れ、3時間後の潤い感も非常にあると評価したパネルが6〜9名
△:塗布直後の潤い感が非常に優れ、3時間後の潤い感も非常にあると評価したパネルが4〜5名
×:塗布直後の潤い感が非常に優れ、3時間後の潤い感も非常にあると評価したパネルが3名以下
〔べたつき感〕
◎:皮膚への塗布時にべたつきがなく、伸びが良好と評価したパネルが10名以上
○:皮膚への塗布時にべたつきがなく、伸びが良好と評価したパネルが6〜9名
△:皮膚への塗布時にべたつきがなく、伸びが良好と評価したパネルが4〜5名
×:皮膚への塗布時にべたつきがなく、伸びが良好と評価したパネルが3名以下(2) Usability Twelve female panels were allowed to use the emulsified cosmetic immediately after preparation, and were subjected to sensory evaluation on usability immediately after use and a feeling of use after 3 hours, and evaluated according to the following criteria.
[Moisture and sustainability]
◎: More than 10 panelists evaluated that the moist feeling immediately after application was very excellent and the moist feeling after 3 hours was very good ○: Moist feeling immediately after application was very excellent, and the moist feeling after 3 hours was also very high 6 to 9 panels evaluated as being in the surface Δ: Moisture feeling immediately after application is very excellent, and 4 to 5 panels evaluated as having a very moist feeling after 3 hours ×: Moisture feeling immediately after application Less than 3 panelists rated it as excellent and very moist after 3 hours [stickiness]
◎: 10 or more panels evaluated as having no stickiness when applied to the skin and good elongation ○: 6 to 9 panels evaluated as having no stickiness when applied to the skin and good elongation Δ: Applying to the skin 4 to 5 panelists evaluated as having no stickiness when applied and good elongation x: 3 or less panels evaluated as having no stickiness when applied to skin and good stretch
表1の結果よりに示したように、本発明で得られる実施例1〜2の保湿クリームは安定性が良好で、潤い感、潤い持続感に優れた保湿クリームであることがわかる。
他方、本発明にかかる(B)界面活性剤に代えて、HLBが本発明の範囲外の比較界面活性剤を用いた比較例1〜2では、当初の潤い感はややあるものの、持続性が低いことがわかる。As shown in the results of Table 1, it can be seen that the moisturizing creams of Examples 1 and 2 obtained in the present invention are excellent in stability and are moisturizing and moisturizing excellent in moisturizing feeling.
On the other hand, instead of the surfactant (B) according to the present invention, in Comparative Examples 1 and 2 in which the HLB uses a comparative surfactant outside the scope of the present invention, although the initial moist feeling is somewhat, the sustainability is somewhat It turns out that it is low.
〔実施例3、比較例3〜5〕
下記表2に記載の処方に従い、まず、No.1〜10を秤量して混合し水相を調製し、これを70℃に加熱したものを、別容器にて、No.11〜25を秤量して混合し、70℃に加熱溶解して油相を調製し、油相中に調製済みの前記水相を添加し、実施例1と同様にして、乳化装置にて70℃で、均一微細に乳化処理した後、35℃まで攪拌冷却し美白保湿クリームを得た。
光学顕微鏡観察により油中水型乳化粒子(粒径1μm〜7μm)が確認された。[Example 3, Comparative Examples 3 to 5]
According to the prescription described in Table 2 below, 1 to 10 were weighed and mixed to prepare an aqueous phase, which was heated to 70 ° C. 11 to 25 are weighed and mixed, heated and dissolved at 70 ° C. to prepare an oil phase, and the prepared aqueous phase is added to the oil phase. The emulsion was uniformly and finely emulsified at ℃, and then stirred and cooled to 35 ℃ to obtain a whitening moisturizing cream.
Water-in-oil emulsified particles (particle size: 1 μm to 7 μm) were confirmed by observation with an optical microscope.
なお、下記表2における成分の詳細は以下の通りである。
19)トリイソステアリン酸POE(20)硬化ヒマシ油(商品名:EMALEX RWIS−320、日本エマルジョン社製) HLB5.7:本発明における(B)HLB5〜8のエチレンオキサイド付加のエステル系ノニオン界面活性剤。
20)トリイソステアリン酸POE(20)グリセリル(商品名:EMALEX GWIS−32、日本エマルジョン社製) HLB7.9:本発明における(B)HLB5〜8のエチレンオキサイド付加のエステル系ノニオン界面活性剤。
21)ステアリン酸モノグリセリド(商品名:ニッコール MGS−BMV、日光ケミカルズ社製)HLB:3.0、mp:本発明における(D)HLB5未満の常温で液状のノニオン界面活性剤。
22)モノ・ジイソステアリン酸ソルビタン(商品名:ニッコール SI−15RV、日光ケミカルズ社製)、HLB:4.5:本発明における(C)HLB5未満の常温で固体のノニオン界面活性剤。In addition, the detail of the component in following Table 2 is as follows.
19) Triisostearic acid POE (20) hydrogenated castor oil (trade name: EMALEX RWIS-320, manufactured by Nippon Emulsion Co., Ltd.) HLB5.7: (B) an ester-based nonionic surfactant of ethylene oxide addition of HLB5-8 in the present invention .
20) Triisostearic acid POE (20) Glyceryl (trade name: EMALEX GWIS-32, manufactured by Nippon Emulsion Co., Ltd.) HLB 7.9: (B) an ester-based nonionic surfactant added with ethylene oxide of HLB 5-8 in the present invention.
21) Stearic acid monoglyceride (trade name: Nikkor MGS-BMV, manufactured by Nikko Chemicals Co., Ltd.) HLB: 3.0, mp: (D) Nonionic surfactant that is liquid at room temperature below HLB5 in the present invention.
22) Sorbitan mono-diisostearate (trade name: Nikkor SI-15RV, manufactured by Nikko Chemicals), HLB: 4.5: (C) Nonionic surfactant that is solid at room temperature below HLB5 in the present invention.
表2に示したように、本発明に係る実施例3の美白保湿クリームは安定性が良好で、使用時の潤い感、潤い持続感に優れた美白保湿クリームであることがわかる。他方、(B)界面活性剤を含有しない比較例3は安定なクリーム状の油中水型乳化組成物が得られなかった。また、(D)界面活性剤を含有しない比較例4の化粧料は、安定性には優れるものの、化粧料としての使用感に劣り、(C)界面活性剤を含有しない比較例5の化粧料では乳化安定性、使用感のいずれも実施例よりも劣るものであった。 As shown in Table 2, it can be seen that the whitening moisturizing cream of Example 3 according to the present invention has good stability and is a whitening moisturizing cream excellent in moisturizing feeling and moisturizing feeling during use. On the other hand, in Comparative Example 3 containing no surfactant (B), a stable creamy water-in-oil emulsion composition could not be obtained. In addition, (D) the cosmetic of Comparative Example 4 that does not contain a surfactant is excellent in stability but is inferior in the feeling of use as a cosmetic, and (C) the cosmetic of Comparative Example 5 that does not contain a surfactant. Thus, both the emulsion stability and the feeling of use were inferior to those of the examples.
Claims (5)
(B)HLB5〜8のエチレンオキサイド付加のエステル系ノニオン界面活性剤と、
(C)HLB5未満の常温で固形のノニオン界面活性剤と、
(D)HLB5未満の常温で液状のノニオン界面活性剤と、
(E)ワックス類と、
(F)保湿剤と、
(G)前記(E)ワックス類とは異なる油分と、
(H)水と、を
含有する油中水型乳化化粧料。(A) an organically modified clay mineral;
(B) HLB 5-8 ethylene oxide addition ester-based nonionic surfactant;
(C) a nonionic surfactant that is solid at room temperature below HLB5;
(D) a nonionic surfactant that is liquid at room temperature below HLB5;
(E) waxes;
(F) a moisturizer;
(G) (E) an oil different from the waxes,
(H) Water-in-oil emulsified cosmetic containing water.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2011270658A JP5777162B2 (en) | 2011-11-22 | 2011-11-22 | Water-in-oil emulsified cosmetic |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2011270658A JP5777162B2 (en) | 2011-11-22 | 2011-11-22 | Water-in-oil emulsified cosmetic |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2013107865A true JP2013107865A (en) | 2013-06-06 |
JP5777162B2 JP5777162B2 (en) | 2015-09-09 |
Family
ID=48705026
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2011270658A Active JP5777162B2 (en) | 2011-11-22 | 2011-11-22 | Water-in-oil emulsified cosmetic |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP5777162B2 (en) |
Cited By (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2016017188A3 (en) * | 2015-08-03 | 2016-03-24 | Shiseido Company, Ltd. | Water-in-oil emulsion solid cosmetic |
WO2017170576A1 (en) * | 2016-03-30 | 2017-10-05 | 住友精化株式会社 | Carboxyl-group-containing polymer composition |
JP2018095588A (en) * | 2016-12-13 | 2018-06-21 | ライオン株式会社 | W/o emulsion composition |
WO2018221603A1 (en) * | 2017-05-30 | 2018-12-06 | 花王株式会社 | Water-in-oil emulsion composition |
WO2018221602A1 (en) * | 2017-05-30 | 2018-12-06 | 花王株式会社 | Water-in-oil emulsion composition |
JP2019188294A (en) * | 2018-04-20 | 2019-10-31 | ミヨシ油脂株式会社 | Method for stabilizing emulsified product, and emulsified product and emulsion fuel using the same |
WO2021131948A1 (en) * | 2019-12-27 | 2021-07-01 | 株式会社資生堂 | Oil-based composition |
CN113226480A (en) * | 2018-12-28 | 2021-08-06 | 日本乐敦制药株式会社 | Water-in-oil type emulsified composition containing nicotinamide |
WO2022176670A1 (en) * | 2021-02-16 | 2022-08-25 | 株式会社資生堂 | Oil-in-water type composition |
CN116322617A (en) * | 2020-10-30 | 2023-06-23 | 株式会社资生堂 | Water-in-oil emulsion composition containing salicylic acid |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2004067628A (en) * | 2002-08-08 | 2004-03-04 | Shiseido Co Ltd | Water-in-oil type emulsified composition |
JP2010132621A (en) * | 2008-12-05 | 2010-06-17 | Shiseido Co Ltd | Water-in-oil type emulsified cosmetic |
-
2011
- 2011-11-22 JP JP2011270658A patent/JP5777162B2/en active Active
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2004067628A (en) * | 2002-08-08 | 2004-03-04 | Shiseido Co Ltd | Water-in-oil type emulsified composition |
JP2010132621A (en) * | 2008-12-05 | 2010-06-17 | Shiseido Co Ltd | Water-in-oil type emulsified cosmetic |
Cited By (36)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US10434043B2 (en) | 2015-08-03 | 2019-10-08 | Shiseido Company, Ltd. | Water-in-oil emulsion solid cosmetic |
JP2017031149A (en) * | 2015-08-03 | 2017-02-09 | 株式会社 資生堂 | Water-in-oil type emulsified solid cosmetic |
US20170056302A1 (en) * | 2015-08-03 | 2017-03-02 | Shiseido Company, Ltd. | Water-in-oil emulsion solid cosmetic |
CN106561081A (en) * | 2015-08-03 | 2017-04-12 | 株式会社资生堂 | Water-in-oil emulsion solid cosmetic |
KR20180033433A (en) * | 2015-08-03 | 2018-04-03 | 가부시키가이샤 시세이도 | Water-in-oil emulsion solid cosmetic |
WO2016017188A3 (en) * | 2015-08-03 | 2016-03-24 | Shiseido Company, Ltd. | Water-in-oil emulsion solid cosmetic |
KR102496893B1 (en) * | 2015-08-03 | 2023-02-07 | 가부시키가이샤 시세이도 | Water-in-oil emulsion solid cosmetic |
CN106561081B (en) * | 2015-08-03 | 2021-10-12 | 株式会社资生堂 | Water-in-oil type emulsified solid cosmetic |
TWI693945B (en) * | 2015-08-03 | 2020-05-21 | 日商資生堂股份有限公司 | Water-in-oil emulsion solid cosmetic |
RU2698327C2 (en) * | 2015-08-03 | 2019-08-26 | Шисейдо Компани, Лтд. | Solid cosmetic in form of emulsion of "water-in-oil" type |
WO2017170576A1 (en) * | 2016-03-30 | 2017-10-05 | 住友精化株式会社 | Carboxyl-group-containing polymer composition |
JP2018095588A (en) * | 2016-12-13 | 2018-06-21 | ライオン株式会社 | W/o emulsion composition |
JP2023033464A (en) * | 2017-05-30 | 2023-03-10 | 花王株式会社 | Water-in-oil type emulsion composition |
WO2018221602A1 (en) * | 2017-05-30 | 2018-12-06 | 花王株式会社 | Water-in-oil emulsion composition |
CN110691580A (en) * | 2017-05-30 | 2020-01-14 | 花王株式会社 | Water-in-oil type emulsified composition |
CN110709058A (en) * | 2017-05-30 | 2020-01-17 | 花王株式会社 | Water-in-oil type emulsified composition |
JP2019085390A (en) * | 2017-05-30 | 2019-06-06 | 花王株式会社 | Water-in-oil type emulsion composition |
JP7565141B2 (en) | 2017-05-30 | 2024-10-10 | 花王株式会社 | Water-in-oil emulsion composition |
JP7565142B2 (en) | 2017-05-30 | 2024-10-10 | 花王株式会社 | Water-in-oil emulsion composition |
TWI823851B (en) * | 2017-05-30 | 2023-12-01 | 日商花王股份有限公司 | Water-in-oil emulsion composition |
JP2018203729A (en) * | 2017-05-30 | 2018-12-27 | 花王株式会社 | Water-in-oil type emulsion composition |
JP7502488B2 (en) | 2017-05-30 | 2024-06-18 | 花王株式会社 | Water-in-oil emulsion composition |
US11337901B2 (en) | 2017-05-30 | 2022-05-24 | Kao Corporation | Water-in-oil emulsion composition |
WO2018221603A1 (en) * | 2017-05-30 | 2018-12-06 | 花王株式会社 | Water-in-oil emulsion composition |
TWI847959B (en) * | 2017-05-30 | 2024-07-11 | 日商花王股份有限公司 | Water-in-oil emulsion |
JP7502489B2 (en) | 2017-05-30 | 2024-06-18 | 花王株式会社 | Water-in-oil emulsion composition |
JP2023033465A (en) * | 2017-05-30 | 2023-03-10 | 花王株式会社 | Water-in-oil type emulsion composition |
JP2019188294A (en) * | 2018-04-20 | 2019-10-31 | ミヨシ油脂株式会社 | Method for stabilizing emulsified product, and emulsified product and emulsion fuel using the same |
JP7063703B2 (en) | 2018-04-20 | 2022-05-09 | ミヨシ油脂株式会社 | Emulsion stabilization method and emulsion and emulsion fuel using it |
CN113226480A (en) * | 2018-12-28 | 2021-08-06 | 日本乐敦制药株式会社 | Water-in-oil type emulsified composition containing nicotinamide |
CN114867451A (en) * | 2019-12-27 | 2022-08-05 | 株式会社资生堂 | Oily composition |
JP7445425B2 (en) | 2019-12-27 | 2024-03-07 | 株式会社 資生堂 | oily composition |
JP2021107365A (en) * | 2019-12-27 | 2021-07-29 | 株式会社 資生堂 | Oily composition |
WO2021131948A1 (en) * | 2019-12-27 | 2021-07-01 | 株式会社資生堂 | Oil-based composition |
CN116322617A (en) * | 2020-10-30 | 2023-06-23 | 株式会社资生堂 | Water-in-oil emulsion composition containing salicylic acid |
WO2022176670A1 (en) * | 2021-02-16 | 2022-08-25 | 株式会社資生堂 | Oil-in-water type composition |
Also Published As
Publication number | Publication date |
---|---|
JP5777162B2 (en) | 2015-09-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP5777162B2 (en) | Water-in-oil emulsified cosmetic | |
US8673326B2 (en) | Oil-in-water emulsion composition and method for producing the same | |
JP7009481B2 (en) | A cosmetic composition containing one or more polar oils, C2-C6 aliphatic monoalcohols and polyols, at least one hydrophilic active agent, and less than 7% by mass of water. | |
JP2008231010A (en) | External preparation for skin | |
EP0646368B1 (en) | A gel-resembling composition containing organopolysiloxane, without a gelling agent used in cosmetic and dermatology | |
WO2007136067A1 (en) | External preparation for skin | |
JP2012153622A (en) | Oil-in-water type emulsion composition and method for producing the same | |
JP5695388B2 (en) | Oil-in-water emulsion composition | |
KR20180023537A (en) | Oil-in-water type emulsion composition containing high content of ceramide and cosmetic composition comprising the same | |
JP7179248B2 (en) | Composition, especially multiple emulsion type composition and method for producing the same | |
JP2011195460A (en) | External preparation for skin | |
JP2006327952A (en) | Oil in water type emulsion composition and method for producing the same | |
JP2005187465A (en) | Emulsified skin care preparation for external use containing salt of higher fatty acid ester of ascorbic acid-2-phosphoric acid ester, method for producing the same, and method for stabilizing the salt of ester | |
JP2005281133A (en) | Skin care preparation for external use | |
JP5995453B2 (en) | Cosmetics and method for producing the same | |
JP4672328B2 (en) | Skin external preparation containing ascorbic acid derivative salt, method for stabilizing skin external preparation, and stabilizer | |
JP6010307B2 (en) | Aqueous cosmetics | |
JP6954895B2 (en) | Hyperfat and personal care compositions | |
JP7002461B2 (en) | Gel-like composition | |
JP2006290762A (en) | Oil-in-water emulsified composition | |
JPH11228378A (en) | Emulsion cosmetic | |
JP2018118958A (en) | Emulsified composition | |
JP6296437B2 (en) | Emulsified cosmetic and method for producing the same | |
KR20210050208A (en) | Oil-in-water type cosmetic composition having excellent formulation stability | |
KR20170003189A (en) | Multi ceramide lamellar structure comprising fatty acid and neutralizing agent |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20140609 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A821 Effective date: 20140609 |
|
A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20150129 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20150303 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20150428 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20150602 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20150702 |
|
R150 | Certificate of patent or registration of utility model |
Ref document number: 5777162 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20150428 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |